{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import spacy\n",
    "import scispacy\n",
    "from gensim.models import Word2Vec\n",
    "import matplotlib.pyplot as plt\n",
    "from sklearn.manifold import TSNE"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# **Load and Filter Data**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/29/8ncbdz4n013f2p__f12f36qr0000gn/T/ipykernel_71784/3558525759.py:2: DtypeWarning: Columns (4,5) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  noteevents_df = pd.read_csv(\"data/NOTEEVENTS.csv\")\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "âœ… Found 1287 records for ICD-9 Code '5715'.\n",
      "ðŸ“Œ SUBJECT_IDs: [117, 78, 4, 246, 188, 188, 188, 188, 143, 480]\n",
      "     SUBJECT_ID           CATEGORY  \\\n",
      "111        5458  Discharge summary   \n",
      "120       68109  Discharge summary   \n",
      "285       23637  Discharge summary   \n",
      "286       23637  Discharge summary   \n",
      "287       23637  Discharge summary   \n",
      "\n",
      "                                                  TEXT  \n",
      "111  Admission Date:  [**2137-3-7**]              D...  \n",
      "120  Admission Date:  [**2189-9-7**]              D...  \n",
      "285  Admission Date:  [**2194-7-24**]     Discharge...  \n",
      "286  Admission Date:  [**2195-6-17**]       Dischar...  \n",
      "287  Admission Date:  [**2195-6-17**]       Dischar...  \n"
     ]
    }
   ],
   "source": [
    "# Load MIMIC-III dataset files\n",
    "noteevents_df = pd.read_csv(\"data/NOTEEVENTS.csv\")\n",
    "diagnoses_icd_df = pd.read_csv(\"data/DIAGNOSES_ICD.csv\")\n",
    "\n",
    "# Ensure column names are consistent\n",
    "diagnoses_icd_df.columns = diagnoses_icd_df.columns.str.upper()\n",
    "\n",
    "# Filter ICD-9 Code '5715' (Liver disease)\n",
    "filtered_df = diagnoses_icd_df[diagnoses_icd_df[\"ICD9_CODE\"] == \"5715\"]\n",
    "\n",
    "# Extract SUBJECT_IDs & HADM_IDs\n",
    "arr_subject_id = filtered_df[\"SUBJECT_ID\"].tolist()\n",
    "arr_hadm_id = filtered_df[\"HADM_ID\"].tolist()\n",
    "\n",
    "# Print summary\n",
    "print(f\"âœ… Found {len(arr_subject_id)} records for ICD-9 Code '5715'.\")\n",
    "print(\"ðŸ“Œ SUBJECT_IDs:\", arr_subject_id[:10])  # Show first 10 IDs\n",
    "\n",
    "# **Optimized Filtering using .isin() instead of loops**\n",
    "filtered_notes_df = noteevents_df[noteevents_df[\"SUBJECT_ID\"].isin(arr_subject_id)][[\"SUBJECT_ID\", \"CATEGORY\", \"TEXT\"]]\n",
    "\n",
    "# Display filtered data\n",
    "print(filtered_notes_df.head())\n",
    "\n",
    "# Save filter note to a csv\n",
    "filtered_notes_df.to_csv('liver_notes.csv', index= False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# **Spacy**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Idx: 0 Entities Found: 276\n",
      "Entity: Admission Date:  , Label: ORG\n",
      "Entity: 2137-3-7, Label: DATE\n",
      "Entity: 2137-3-16, Label: DATE\n",
      "Entity: 2060-10-8, Label: DATE\n",
      "Entity: Name3 (LF, Label: ORG\n",
      "Entity: 348, Label: CARDINAL\n",
      "Entity: 76, Label: DATE\n",
      "Entity: 1-31, Label: CARDINAL\n",
      "Entity: NASH, Label: ORG\n",
      "Entity: PSC, Label: ORG\n",
      "Entity: Grade II, Label: PRODUCT\n",
      "Entity: PSC, Label: ORG\n",
      "Entity: CAD, Label: ORG\n",
      "Entity: 1.8, Label: CARDINAL\n",
      "Entity: 4.8, Label: CARDINAL\n",
      "Entity: 5.8, Label: CARDINAL\n",
      "Entity: 1-31, Label: CARDINAL\n",
      "Entity: 3.5L, Label: CARDINAL\n",
      "Entity: SBP, Label: GPE\n",
      "Entity: the past several weeks, Label: DATE\n",
      "Entity: NSAIDS, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Grade 2, Label: PRODUCT\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Cholangiocarcinoma, Label: ORG\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 8), Label: CARDINAL\n",
      "Entity: MIB, Label: ORG\n",
      "Entity: 1-3, Label: CARDINAL\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: Hypoalbuminemia\n",
      "\n",
      "\n",
      "Social History, Label: ORG\n",
      "Entity: 378, Label: CARDINAL\n",
      "Entity: MI @ 75, Label: ORG\n",
      "Entity: VS, Label: PRODUCT\n",
      "Entity: 97.0 HR 67, Label: CARDINAL\n",
      "Entity: RR 16, Label: PRODUCT\n",
      "Entity: 95%, Label: PERCENT\n",
      "Entity: RA, Label: GPE\n",
      "Entity: BS, Label: ORG\n",
      "Entity: CARDIAC, Label: ORG\n",
      "Entity: MRG, Label: ORG\n",
      "Entity: Guaiac, Label: PERSON\n",
      "Entity: 2-1**]+, Label: CARDINAL\n",
      "Entity: Neuro, Label: PERSON\n",
      "Entity: 132, Label: CARDINAL\n",
      "Entity: 5.8, Label: CARDINAL\n",
      "Entity: 18 4.7 \\, Label: QUANTITY\n",
      "Entity: 8.0 Mg, Label: PERSON\n",
      "Entity: 2.8, Label: CARDINAL\n",
      "Entity: 6.9, Label: CARDINAL\n",
      "Entity: 97, Label: CARDINAL\n",
      "Entity: 6.6 \\, Label: QUANTITY\n",
      "Entity: 35.3, Label: CARDINAL\n",
      "Entity: Anisocy, Label: PERSON\n",
      "Entity: 2+, Label: DATE\n",
      "Entity: 1+, Label: CARDINAL\n",
      "Entity: 3+, Label: CARDINAL\n",
      "Entity: 1+, Label: CARDINAL\n",
      "Entity: 1+, Label: CARDINAL\n",
      "Entity: 15.0, Label: CARDINAL\n",
      "Entity: 24.6, Label: CARDINAL\n",
      "Entity: 1.3, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: INDICATIONS, Label: ORG\n",
      "Entity: 76-year-old, Label: DATE\n",
      "Entity: 2137-2-28, Label: DATE\n",
      "Entity: 10.5 cm, Label: QUANTITY\n",
      "Entity: 10.9 cm, Label: QUANTITY\n",
      "Entity: 2137-3-11, Label: DATE\n",
      "Entity: 76 year old, Label: DATE\n",
      "Entity: NASH, Label: ORG\n",
      "Entity: GI, Label: ORG\n",
      "Entity: 2137-3-11, Label: DATE\n",
      "Entity: 76-year-old, Label: DATE\n",
      "Entity: GI, Label: ORG\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 379, Label: CARDINAL\n",
      "Entity: 380, Label: CARDINAL\n",
      "Entity: 380, Label: CARDINAL\n",
      "Entity: 5 cc of, Label: CARDINAL\n",
      "Entity: 1%, Label: PERCENT\n",
      "Entity: anesthesia, Label: GPE\n",
      "Entity: 21, Label: CARDINAL\n",
      "Entity: 0.018, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: 0.035, Label: CARDINAL\n",
      "Entity: 14, Label: CARDINAL\n",
      "Entity: 20-cm, Label: QUANTITY\n",
      "Entity: Two, Label: CARDINAL\n",
      "Entity: two, Label: CARDINAL\n",
      "Entity: 20-cm, Label: QUANTITY\n",
      "Entity: 2137-3-8, Label: DATE\n",
      "Entity: 5:26 pm, Label: TIME\n",
      "Entity: 2137-3-14, Label: DATE\n",
      "Entity: 2137-3-8, Label: DATE\n",
      "Entity: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN, Label: ORG\n",
      "Entity: NO MICROORGANISMS SEEN, Label: LAW\n",
      "Entity: 2137-3-11, Label: DATE\n",
      "Entity: CULTURE, Label: NORP\n",
      "Entity: 2137-3-14, Label: DATE\n",
      "Entity: Brief Hospital Course, Label: ORG\n",
      "Entity: 76, Label: DATE\n",
      "Entity: 1-31, Label: CARDINAL\n",
      "Entity: NASH, Label: ORG\n",
      "Entity: 1-31, Label: CARDINAL\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 2137-3-8, Label: DATE\n",
      "Entity: 4u, Label: CARDINAL\n",
      "Entity: 1.1, Label: CARDINAL\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: ARF, Label: ORG\n",
      "Entity: several days, Label: DATE\n",
      "Entity: Renal, Label: ORG\n",
      "Entity: un, Label: ORG\n",
      "Entity: 381, Label: CARDINAL\n",
      "Entity: Urine, Label: PERSON\n",
      "Entity: ATN, Label: ORG\n",
      "Entity: 500cc, Label: CARDINAL\n",
      "Entity: NS, Label: GPE\n",
      "Entity: day, Label: DATE\n",
      "Entity: Patient, Label: PERSON\n",
      "Entity: three, Label: CARDINAL\n",
      "Entity: HRS, Label: ORG\n",
      "Entity: 12.5, Label: CARDINAL\n",
      "Entity: GI, Label: ORG\n",
      "Entity: ED, Label: ORG\n",
      "Entity: Grade II, Label: PRODUCT\n",
      "Entity: GI, Label: ORG\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 5 days, Label: DATE\n",
      "Entity: two, Label: CARDINAL\n",
      "Entity: the next several days, Label: DATE\n",
      "Entity: T&S, Label: ORG\n",
      "Entity: two\n",
      "weeks later, Label: DATE\n",
      "Entity: day, Label: DATE\n",
      "Entity: KUB, Label: ORG\n",
      "Entity: Foley, Label: PERSON\n",
      "Entity: Bladder, Label: ORG\n",
      "Entity: Patient, Label: PERSON\n",
      "Entity: 1-31, Label: CARDINAL\n",
      "Entity: NASH, Label: ORG\n",
      "Entity: PSC, Label: ORG\n",
      "Entity: 32, Label: CARDINAL\n",
      "Entity: SBP, Label: GPE\n",
      "Entity: 1.1L, Label: CARDINAL\n",
      "Entity: 1500cc/day, Label: DATE\n",
      "Entity: Vit K SC, Label: ORG\n",
      "Entity: 1-31, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: Senna, Label: PERSON\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: NI, Label: ORG\n",
      "Entity: 382**]-, Label: DATE\n",
      "Entity: NI, Label: ORG\n",
      "Entity: 383, Label: CARDINAL\n",
      "Entity: 384, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 385, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 250 mg--1 tablet(s, Label: QUANTITY\n",
      "Entity: twice daily, Label: DATE\n",
      "Entity: FERGON 240MG, Label: FAC\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: un, Label: ORG\n",
      "Entity: 387, Label: CARDINAL\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: U/ML--Sliding, Label: ORG\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: un, Label: ORG\n",
      "Entity: 387, Label: CARDINAL\n",
      "Entity: 30GX0.312\"--Use, Label: CARDINAL\n",
      "Entity: 30GX0.375\"--Use, Label: CARDINAL\n",
      "Entity: LANTUS, Label: ORG\n",
      "Entity: U/ML--16, Label: ORG\n",
      "Entity: 40MG--[**12, Label: CARDINAL\n",
      "Entity: NADOLOL, Label: ORG\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: every day, Label: DATE\n",
      "Entity: ONE, Label: CARDINAL\n",
      "Entity: Identifier 389, Label: DATE\n",
      "Entity: U/ML, Label: ORG\n",
      "Entity: 20,000, Label: CARDINAL\n",
      "Entity: every week, Label: DATE\n",
      "Entity: 25MG--[**12-31, Label: DATE\n",
      "Entity: every day, Label: DATE\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: TEDS HOSE - KNEE, Label: PERSON\n",
      "Entity: daily, Label: DATE\n",
      "Entity: un, Label: ORG\n",
      "Entity: 390, Label: CARDINAL\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: three, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 2 %, Label: PERCENT\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Fentanyl, Label: PERSON\n",
      "Entity: Patch 72HR Sig, Label: ORG\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: every 72 hours, Label: TIME\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 10, Label: CARDINAL\n",
      "Entity: Thirty, Label: CARDINAL\n",
      "Entity: 30, Label: CARDINAL\n",
      "Entity: ML PO TID, Label: ORG\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Morphine Concentrate, Label: PERSON\n",
      "Entity: mg/mL Solution, Label: ORG\n",
      "Entity: Ten, Label: CARDINAL\n",
      "Entity: 10, Label: CARDINAL\n",
      "Entity: PO, Label: GPE\n",
      "Entity: every 3 hours, Label: TIME\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: Morphine Concentrate, Label: PERSON\n",
      "Entity: mg/mL Solution, Label: ORG\n",
      "Entity: 5-10, Label: CARDINAL\n",
      "Entity: PO Q1-2H, Label: ORG\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: Morphine Concentrate, Label: PERSON\n",
      "Entity: mg/mL Solution, Label: ORG\n",
      "Entity: Five, Label: CARDINAL\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: PO, Label: GPE\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: 0.25, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 8 mg/25 hours, Label: TIME\n",
      "Entity: 30 ml\n",
      "8, Label: QUANTITY\n",
      "Entity: Patch 72HR Sig, Label: ORG\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: seventy-two, Label: CARDINAL\n",
      "Entity: hours, Label: TIME\n",
      "Entity: Discharge Disposition, Label: PERSON\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 391, Label: CARDINAL\n",
      "Entity: 392, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: GI, Label: ORG\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: mellitus, Label: ORG\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: 10, Label: CARDINAL\n",
      "Entity: Discharge Condition, Label: ORG\n",
      "Entity: 393, Label: CARDINAL\n",
      "Entity: 394**]/[**Name8, Label: CARDINAL\n",
      "Entity: MD, Label: GPE\n",
      "Entity: 395, Label: CARDINAL\n",
      "Entity: M.D. Date/, Label: ORG\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 396, Label: CARDINAL\n",
      "Entity: 397, Label: CARDINAL\n",
      "Entity: MD Phone:[**Telephone/Fax, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 22, Label: CARDINAL\n",
      "Entity: 11:00, Label: CARDINAL\n",
      "****************************************************************************************************\n",
      "Idx: 1 Entities Found: 196\n",
      "Entity: Admission Date:  , Label: ORG\n",
      "Entity: 2189-9-7, Label: DATE\n",
      "Entity: 2189-9-9, Label: TIME\n",
      "Entity: 2129-3-28, Label: DATE\n",
      "Entity: F\n",
      "\n",
      "Service, Label: ORG\n",
      "Entity: Lomotil\n",
      "\n",
      "Attending:[**Last Name, Label: PRODUCT\n",
      "Entity: Pyelonephritis, Label: NORP\n",
      "Entity: 496, Label: CARDINAL\n",
      "Entity: 60 yo F, Label: QUANTITY\n",
      "Entity: ED, Label: ORG\n",
      "Entity: 4 days, Label: DATE\n",
      "Entity: first, Label: ORDINAL\n",
      "Entity: hematuria, Label: GPE\n",
      "Entity: Saturday, Label: DATE\n",
      "Entity: 3 days, Label: DATE\n",
      "Entity: the day, Label: DATE\n",
      "Entity: Bell, Label: ORG\n",
      "Entity: ED, Label: ORG\n",
      "Entity: 99.0, Label: CARDINAL\n",
      "Entity: 102, Label: CARDINAL\n",
      "Entity: 103/59, Label: DATE\n",
      "Entity: RR\n",
      "16, Label: PERSON\n",
      "Entity: O2 98%, Label: PERCENT\n",
      "Entity: RA, Label: GPE\n",
      "Entity: 104F, Label: CARDINAL\n",
      "Entity: BP 80/30, Label: ORG\n",
      "Entity: U/A, Label: ORG\n",
      "Entity: CT Abd/Pelvis, Label: PERSON\n",
      "Entity: 5L, Label: CARDINAL\n",
      "Entity: ED, Label: ORG\n",
      "Entity: 1L, Label: CARDINAL\n",
      "Entity: ROS, Label: PERSON\n",
      "Entity: SOB, Label: ORG\n",
      "Entity: dysphagia, Label: GPE\n",
      "Entity: Past Medical History, Label: ORG\n",
      "Entity: 2185, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 0, Label: CARDINAL\n",
      "Entity: 497, Label: CARDINAL\n",
      "Entity: 14 years of age, Label: DATE\n",
      "Entity: Bell, Label: ORG\n",
      "Entity: Social History, Label: ORG\n",
      "Entity: 498, Label: CARDINAL\n",
      "Entity: 2164, Label: DATE\n",
      "Entity: Family History, Label: PERSON\n",
      "Entity: 85, Label: DATE\n",
      "Entity: 83, Label: DATE\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: 55, Label: DATE\n",
      "Entity: Three, Label: CARDINAL\n",
      "Entity: C. Paternal, Label: PERSON\n",
      "Entity: NI, Label: ORG\n",
      "Entity: 499, Label: CARDINAL\n",
      "Entity: NI, Label: ORG\n",
      "Entity: 500, Label: CARDINAL\n",
      "Entity: 37.8, Label: CARDINAL\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: 37.7, Label: CARDINAL\n",
      "Entity: 99.8, Label: CARDINAL\n",
      "Entity: 89, Label: CARDINAL\n",
      "Entity: 77, Label: CARDINAL\n",
      "Entity: 104/61(72, Label: CARDINAL\n",
      "Entity: 11, Label: CARDINAL\n",
      "Entity: 11 - 30, Label: DATE\n",
      "Entity: 98%, Label: PERCENT\n",
      "Entity: 66 Inch\n",
      "\n",
      "Gen, Label: QUANTITY\n",
      "Entity: MMM, Label: PERSON\n",
      "Entity: LAD, Label: ORG\n",
      "Entity: LVD, Label: ORG\n",
      "Entity: nl, Label: ORG\n",
      "Entity: nl S3/4, Label: PERSON\n",
      "Entity: CVA, Label: PERSON\n",
      "Entity: Extrem, Label: PERSON\n",
      "Entity: 2+ dp, Label: CARDINAL\n",
      "Entity: Neuro, Label: PERSON\n",
      "Entity: nl, Label: ORG\n",
      "Entity: nl sensation, Label: ORG\n",
      "Entity: 2189-9-9, Label: TIME\n",
      "Entity: 2189-9-9, Label: TIME\n",
      "Entity: 2189-9-8, Label: TIME\n",
      "Entity: 2189-9-7, Label: DATE\n",
      "Entity: 02:30PM, Label: CARDINAL\n",
      "Entity: 2189-9-7, Label: DATE\n",
      "Entity: 02:30PM, Label: CARDINAL\n",
      "Entity: 2189-9-7, Label: DATE\n",
      "Entity: 09:25PM, Label: CARDINAL\n",
      "Entity: U/A, Label: ORG\n",
      "Entity: Mod LE, Label: PERSON\n",
      "Entity: Nitr, Label: ORG\n",
      "Entity: 50, Label: CARDINAL\n",
      "Entity: WBC, Label: ORG\n",
      "Entity: 1-21, Label: CARDINAL\n",
      "Entity: Urine, Label: PERSON\n",
      "Entity: 9-7**]-, Label: CARDINAL\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: 9-7, Label: CARDINAL\n",
      "Entity: Spleen, Label: DATE\n",
      "Entity: CT, Label: ORG\n",
      "Entity: Brief Hospital Course, Label: ORG\n",
      "Entity: 60, Label: CARDINAL\n",
      "Entity: ED, Label: ORG\n",
      "Entity: 4 day, Label: DATE\n",
      "Entity: U/A, Label: ORG\n",
      "Entity: CT Abd, Label: PERSON\n",
      "Entity: Pyelonephritis, Label: NORP\n",
      "Entity: several\n",
      "days, Label: DATE\n",
      "Entity: GU, Label: ORG\n",
      "Entity: ICU, Label: ORG\n",
      "Entity: CT, Label: ORG\n",
      "Entity: ED, Label: ORG\n",
      "Entity: ICU, Label: ORG\n",
      "Entity: 70-90's, Label: DATE\n",
      "Entity: 80-90, Label: DATE\n",
      "Entity: 7L, Label: CARDINAL\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: 32, Label: DATE\n",
      "Entity: 500, Label: CARDINAL\n",
      "Entity: Q12, Label: ORG\n",
      "Entity: 14 day, Label: DATE\n",
      "Entity: E. Coli, Label: PERSON\n",
      "Entity: 90, Label: CARDINAL\n",
      "Entity: 1.1, Label: CARDINAL\n",
      "Entity: 1.0, Label: CARDINAL\n",
      "Entity: today, Label: DATE\n",
      "Entity: 0.7, Label: CARDINAL\n",
      "Entity: LFT, Label: ORG\n",
      "Entity: Lyme, Label: PERSON\n",
      "Entity: Bell, Label: ORG\n",
      "Entity: FEN, Label: PERSON\n",
      "Entity: Comm, Label: PERSON\n",
      "Entity: NI, Label: ORG\n",
      "Entity: 501, Label: CARDINAL\n",
      "Entity: NI, Label: ORG\n",
      "Entity: 496, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 502, Label: CARDINAL\n",
      "Entity: Dispo, Label: PERSON\n",
      "Entity: PCP, Label: ORG\n",
      "Entity: 503, Label: CARDINAL\n",
      "Entity: 9-10, Label: CARDINAL\n",
      "Entity: CBC, Label: ORG\n",
      "Entity: daily, Label: DATE\n",
      "Entity: un, Label: ORG\n",
      "Entity: 504**]-C, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 81, Label: CARDINAL\n",
      "Entity: Tablet, Label: ORG\n",
      "Entity: Chewable Sig, Label: PERSON\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Chewable\n",
      "PO DAILY, Label: ORG\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Multivitamin     Tablet Sig, Label: ORG\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Tablet PO, Label: ORG\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: 500, Label: CARDINAL\n",
      "Entity: Tablet, Label: ORG\n",
      "Entity: One, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Tablet PO Q12H, Label: ORG\n",
      "Entity: every 12 hours, Label: TIME\n",
      "Entity: 12 days, Label: DATE\n",
      "Entity: Tablet(s, Label: PERSON\n",
      "Entity: Discharge Disposition, Label: PERSON\n",
      "Entity: Osteopenia, Label: GPE\n",
      "Entity: Bell, Label: ORG\n",
      "Entity: Discharge Condition, Label: ORG\n",
      "Entity: O2, Label: ORG\n",
      "Entity: un, Label: ORG\n",
      "Entity: 505, Label: CARDINAL\n",
      "Entity: 18, Label: CARDINAL\n",
      "Entity: CT, Label: ORG\n",
      "Entity: ICU, Label: ORG\n",
      "Entity: PCP, Label: ORG\n",
      "Entity: ED, Label: ORG\n",
      "Entity: CBC, Label: ORG\n",
      "Entity: BP, Label: ORG\n",
      "Entity: tomorrow, Label: DATE\n",
      "Entity: ICU, Label: ORG\n",
      "Entity: E. Coli, Label: PERSON\n",
      "Entity: ICU, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 506, Label: CARDINAL\n",
      "Entity: CT, Label: ORG\n",
      "Entity: 14 day, Label: DATE\n",
      "Entity: Followup Instructions, Label: ORG\n",
      "Entity: Name11, Label: GPE\n",
      "Entity: 507, Label: CARDINAL\n",
      "Entity: 508, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 133, Label: CARDINAL\n",
      "Entity: 9-10, Label: CARDINAL\n",
      "Entity: Completed by:[**2189-, Label: PERSON\n",
      "****************************************************************************************************\n",
      "Idx: 2 Entities Found: 182\n",
      "Entity: Admission Date:  , Label: ORG\n",
      "Entity: 2194-7-24, Label: DATE\n",
      "Entity: 2194-8-3, Label: DATE\n",
      "Entity: 139, Label: CARDINAL\n",
      "Entity: 84-year-old, Label: DATE\n",
      "Entity: CREST, Label: ORG\n",
      "Entity: night, Label: TIME\n",
      "Entity: 130, Label: CARDINAL\n",
      "Entity: 72, Label: CARDINAL\n",
      "Entity: One hour, Label: TIME\n",
      "Entity: 119/39, Label: DATE\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: 16.6, Label: CARDINAL\n",
      "Entity: EGD, Label: ORG\n",
      "Entity: GI, Label: ORG\n",
      "Entity: Sjogren, Label: PERSON\n",
      "Entity: CREST, Label: ORG\n",
      "Entity: dysphagia, Label: GPE\n",
      "Entity: Patient, Label: PERSON\n",
      "Entity: Raynaud, Label: PERSON\n",
      "Entity: TAH, Label: ORG\n",
      "Entity: COPD, Label: ORG\n",
      "Entity: Sjogren, Label: PERSON\n",
      "Entity: 6-18, Label: CARDINAL\n",
      "Entity: Crohn, Label: ORG\n",
      "Entity: Crohn, Label: PRODUCT\n",
      "Entity: Penicillin, Label: GPE\n",
      "Entity: Bactrim and Sulfa, Label: PERSON\n",
      "Entity: Norvasc, Label: ORG\n",
      "Entity: Atenolol, Label: PERSON\n",
      "Entity: 50, Label: CARDINAL\n",
      "Entity: Levoxyl, Label: GPE\n",
      "Entity: 1.25, Label: CARDINAL\n",
      "Entity: Serax, Label: PERSON\n",
      "Entity: NSAIDs, Label: ORG\n",
      "Entity: Premarin, Label: GPE\n",
      "Entity: Aspirin, Label: PERSON\n",
      "Entity: 97, Label: CARDINAL\n",
      "Entity: 14, Label: CARDINAL\n",
      "Entity: 100%, Label: PERCENT\n",
      "Entity: two, Label: CARDINAL\n",
      "Entity: three, Label: CARDINAL\n",
      "Entity: Conjunctiva, Label: ORG\n",
      "Entity: S1, Label: PRODUCT\n",
      "Entity: S2, Label: GPE\n",
      "Entity: 2/6, Label: CARDINAL\n",
      "Entity: Fingers, Label: PERSON\n",
      "Entity: 1+, Label: DATE\n",
      "Entity: four, Label: CARDINAL\n",
      "Entity: Cranial, Label: PRODUCT\n",
      "Entity: XII, Label: ORG\n",
      "Entity: 5/5, Label: CARDINAL\n",
      "Entity: 2+, Label: DATE\n",
      "Entity: 12.8, Label: CARDINAL\n",
      "Entity: 16.6, Label: CARDINAL\n",
      "Entity: 282,000, Label: CARDINAL\n",
      "Entity: 89, Label: CARDINAL\n",
      "Entity: 140, Label: CARDINAL\n",
      "Entity: 4.8, Label: CARDINAL\n",
      "Entity: 105, Label: CARDINAL\n",
      "Entity: BUN, Label: ORG\n",
      "Entity: 10, Label: CARDINAL\n",
      "Entity: .9, Label: ORG\n",
      "Entity: 98, Label: CARDINAL\n",
      "Entity: 14, Label: CARDINAL\n",
      "Entity: 84, Label: DATE\n",
      "Entity: 313, Label: CARDINAL\n",
      "Entity: 469, Label: CARDINAL\n",
      "Entity: 199, Label: CARDINAL\n",
      "Entity: 6.4, Label: DATE\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: Gastrin, Label: PERSON\n",
      "Entity: 9-00, Label: DATE\n",
      "Entity: 92, Label: DATE\n",
      "Entity: EKG, Label: ORG\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: 184/74/422, Label: DATE\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: ST, Label: GPE\n",
      "Entity: 2193-7-21, Label: DATE\n",
      "Entity: CT, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: GI, Label: ORG\n",
      "Entity: Cardiovascular, Label: ORG\n",
      "Entity: 7-24, Label: CARDINAL\n",
      "Entity: epigastric pain, Label: PERSON\n",
      "Entity: three days, Label: DATE\n",
      "Entity: 15.6, Label: CARDINAL\n",
      "Entity: 43, Label: CARDINAL\n",
      "Entity: BUN, Label: ORG\n",
      "Entity: 53, Label: CARDINAL\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: Two, Label: CARDINAL\n",
      "Entity: Protonix, Label: PERSON\n",
      "Entity: EGD, Label: ORG\n",
      "Entity: AVM, Label: ORG\n",
      "Entity: EKG, Label: ORG\n",
      "Entity: ST, Label: GPE\n",
      "Entity: 7th, Label: ORDINAL\n",
      "Entity: 8th, Label: ORDINAL\n",
      "Entity: EGD, Label: ORG\n",
      "Entity: first, Label: ORDINAL\n",
      "Entity: IR, Label: ORG\n",
      "Entity: 11, Label: CARDINAL\n",
      "Entity: 8th, Label: ORDINAL\n",
      "Entity: the 10th, Label: DATE\n",
      "Entity: approximately\n",
      "40, Label: CARDINAL\n",
      "Entity: Vascular, Label: ORG\n",
      "Entity: 7-28, Label: CARDINAL\n",
      "Entity: only one, Label: CARDINAL\n",
      "Entity: PID, Label: ORG\n",
      "Entity: Groin, Label: NORP\n",
      "Entity: the 8th, Label: DATE\n",
      "Entity: 9th, Label: ORDINAL\n",
      "Entity: DNR, Label: ORG\n",
      "Entity: DNI, Label: ORG\n",
      "Entity: EGD, Label: ORG\n",
      "Entity: 7-29, Label: DATE\n",
      "Entity: Diarrhea, Label: PERSON\n",
      "Entity: C., Label: NORP\n",
      "Entity: melena, Label: ORG\n",
      "Entity: the 12th, Label: DATE\n",
      "Entity: 42, Label: CARDINAL\n",
      "Entity: 32.8, Label: CARDINAL\n",
      "Entity: EGD, Label: ORG\n",
      "Entity: the 15th, Label: DATE\n",
      "Entity: 33.5, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Fluids, Electrolytes & Nutrition, Label: ORG\n",
      "Entity: Lytes, Label: PERSON\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Synthroid, Label: PERSON\n",
      "Entity: 150, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Pulmonary, Label: PERSON\n",
      "Entity: PE, Label: ORG\n",
      "Entity: CT, Label: ORG\n",
      "Entity: the 12th, Label: DATE\n",
      "Entity: PE, Label: ORG\n",
      "Entity: EGD, Label: ORG\n",
      "Entity: Levofloxacin, Label: PERSON\n",
      "Entity: COPD, Label: ORG\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 1,000 to 100,000, Label: CARDINAL\n",
      "Entity: 7-31, Label: DATE\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: Patient, Label: PERSON\n",
      "Entity: CREST, Label: ORG\n",
      "Entity: Sjogren, Label: PERSON\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: Renal, Label: PERSON\n",
      "Entity: Patient, Label: PERSON\n",
      "Entity: more than 50, Label: CARDINAL\n",
      "Entity: 40, Label: CARDINAL\n",
      "Entity: 80-125, Label: CARDINAL\n",
      "Entity: Serax, Label: PERSON\n",
      "Entity: 10, Label: CARDINAL\n",
      "Entity: 25, Label: CARDINAL\n",
      "Entity: Metoprolol, Label: GPE\n",
      "Entity: 50, Label: CARDINAL\n",
      "Entity: Synthroid 150, Label: PERSON\n",
      "Entity: mcg q d, Label: PERSON\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: Magnesia, Label: PERSON\n",
      "Entity: Patient, Label: PERSON\n",
      "Entity: Levofloxacin\n",
      "500, Label: PERSON\n",
      "Entity: 2194-8-10, Label: DATE\n",
      "Entity: Flagyl 500, Label: NORP\n",
      "Entity: 2194-8-10, Label: DATE\n",
      "Entity: Stable, Label: PRODUCT\n",
      "Entity: 4427, Label: DATE\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: GI, Label: ORG\n",
      "Entity: AVM, Label: ORG\n",
      "Entity: DR.[**Last Name, Label: ORG\n",
      "Entity: First Name3 (LF, Label: ORG\n",
      "Entity: 4514, Label: DATE\n",
      "Entity: J. 12-424\n",
      "\n",
      "Dictated By:[**Last Name, Label: LAW\n",
      "Entity: 2194-8-4, Label: DATE\n",
      "Entity: 2194-8-7, Label: DATE\n",
      "Entity: 20:35, Label: CARDINAL\n",
      "****************************************************************************************************\n",
      "Idx: 3 Entities Found: 254\n",
      "Entity: Admission Date:  , Label: ORG\n",
      "Entity: 2195-6-17, Label: CARDINAL\n",
      "Entity: 2195-7-7, Label: DATE\n",
      "Entity: 84 year-old, Label: DATE\n",
      "Entity: CREST, Label: ORG\n",
      "Entity: GI, Label: ORG\n",
      "Entity: 7-19, Label: CARDINAL\n",
      "Entity: 16, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: two days, Label: DATE\n",
      "Entity: night, Label: TIME\n",
      "Entity: 99.5, Label: CARDINAL\n",
      "Entity: 143/53, Label: CARDINAL\n",
      "Entity: 86, Label: CARDINAL\n",
      "Entity: 16, Label: CARDINAL\n",
      "Entity: 98%, Label: PERCENT\n",
      "Entity: 200, Label: CARDINAL\n",
      "Entity: 250, Label: CARDINAL\n",
      "Entity: one liter, Label: QUANTITY\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Sjogren, Label: PERSON\n",
      "Entity: Sicca, Label: GPE\n",
      "Entity: CREST, Label: ORG\n",
      "Entity: dysphagia, Label: GPE\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Irritable, Label: ORG\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: Diverticula, Label: PERSON\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Cholecystectomy, Label: PERSON\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Three pack years, Label: DATE\n",
      "Entity: twenty\n",
      "years ago, Label: DATE\n",
      "Entity: Crohn, Label: ORG\n",
      "Entity: forty two\n",
      "years, Label: DATE\n",
      "Entity: Penicillin, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Atenolol, Label: PERSON\n",
      "Entity: 50, Label: CARDINAL\n",
      "Entity: q.d.  , Label: GPE\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Aldactone 25, Label: PRODUCT\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: q.d.  , Label: GPE\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Synthroid, Label: PERSON\n",
      "Entity: 175, Label: CARDINAL\n",
      "Entity: q.d., Label: GPE\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: 30, Label: CARDINAL\n",
      "Entity: q.d.  , Label: GPE\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: 50, Label: CARDINAL\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: Multivitamin, Label: NORP\n",
      "Entity: a\n",
      "day, Label: DATE\n",
      "Entity: Vital, Label: ORG\n",
      "Entity: 99.5, Label: CARDINAL\n",
      "Entity: 120/60, Label: CARDINAL\n",
      "Entity: 86, Label: CARDINAL\n",
      "Entity: Respiratory, Label: ORG\n",
      "Entity: 18, Label: CARDINAL\n",
      "Entity: Jugular, Label: PERSON\n",
      "Entity: S1, Label: ORG\n",
      "Entity: S2, Label: GPE\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: Fingers, Label: PERSON\n",
      "Entity: 2+, Label: DATE\n",
      "Entity: three, Label: CARDINAL\n",
      "Entity: Cranial, Label: PRODUCT\n",
      "Entity: XII, Label: ORG\n",
      "Entity: 11.1, Label: CARDINAL\n",
      "Entity: 10.3, Label: DATE\n",
      "Entity: 27.9, Label: CARDINAL\n",
      "Entity: 235, Label: CARDINAL\n",
      "Entity: 85, Label: DATE\n",
      "Entity: 29.3, Label: CARDINAL\n",
      "Entity: MCHC 34.4, Label: ORG\n",
      "Entity: 87.9%, Label: PERCENT\n",
      "Entity: 8%, Label: PERCENT\n",
      "Entity: 0, Label: CARDINAL\n",
      "Entity: 2.6%, Label: PERCENT\n",
      "Entity: 1.1%, Label: PERCENT\n",
      "Entity: 0.1%, Label: PERCENT\n",
      "Entity: 128, Label: CARDINAL\n",
      "Entity: 4.6, Label: CARDINAL\n",
      "Entity: 94, Label: CARDINAL\n",
      "Entity: 27, Label: CARDINAL\n",
      "Entity: BUN, Label: ORG\n",
      "Entity: 47, Label: DATE\n",
      "Entity: 1.1, Label: CARDINAL\n",
      "Entity: 122, Label: CARDINAL\n",
      "Entity: 8.5, Label: CARDINAL\n",
      "Entity: 1.8, Label: CARDINAL\n",
      "Entity: 2.8, Label: CARDINAL\n",
      "Entity: 30.1, Label: CARDINAL\n",
      "Entity: INR 1.3, Label: ORG\n",
      "Entity: Electrocardiogram, Label: PRODUCT\n",
      "Entity: 84, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 29.9, Label: CARDINAL\n",
      "Entity: melena, Label: ORG\n",
      "Entity: 6-18, Label: CARDINAL\n",
      "Entity: a year before, Label: DATE\n",
      "Entity: 6-25, Label: CARDINAL\n",
      "Entity: jejunum, Label: PERSON\n",
      "Entity: 6-29, Label: CARDINAL\n",
      "Entity: melena, Label: ORG\n",
      "Entity: 6-23, Label: CARDINAL\n",
      "Entity: 40, Label: CARDINAL\n",
      "Entity: Carafate, Label: ORG\n",
      "Entity: the evening, Label: TIME\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: fifteen, Label: CARDINAL\n",
      "Entity: 27.7, Label: CARDINAL\n",
      "Entity: 17.4, Label: CARDINAL\n",
      "Entity: 130s, Label: CARDINAL\n",
      "Entity: 420, Label: CARDINAL\n",
      "Entity: H20, Label: GPE\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: IR, Label: ORG\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: the evening, Label: TIME\n",
      "Entity: the Medicine Floor, Label: ORG\n",
      "Entity: 36.7, Label: CARDINAL\n",
      "Entity: one day, Label: DATE\n",
      "Entity: 24.1, Label: CARDINAL\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: twenty, Label: CARDINAL\n",
      "Entity: 26.4, Label: CARDINAL\n",
      "Entity: Two, Label: CARDINAL\n",
      "Entity: 30, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Hematology, Label: ORG\n",
      "Entity: 29.9, Label: CARDINAL\n",
      "Entity: 20, Label: CARDINAL\n",
      "Entity: GIC, Label: ORG\n",
      "Entity: 4516, Label: DATE\n",
      "Entity: Two, Label: CARDINAL\n",
      "Entity: five, Label: CARDINAL\n",
      "Entity: Desmopressin, Label: GPE\n",
      "Entity: two, Label: CARDINAL\n",
      "Entity: 6-24, Label: CARDINAL\n",
      "Entity: 6-27, Label: CARDINAL\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: PTT, Label: ORG\n",
      "Entity: Hematology, Label: ORG\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Atenolol, Label: ORG\n",
      "Entity: Aldactone, Label: ORG\n",
      "Entity: Lasix, Label: GPE\n",
      "Entity: 140s/80s, Label: DATE\n",
      "Entity: 80s, Label: DATE\n",
      "Entity: day five, Label: DATE\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: 130s, Label: CARDINAL\n",
      "Entity: 110s, Label: PRODUCT\n",
      "Entity: 100s, Label: DATE\n",
      "Entity: 120, Label: CARDINAL\n",
      "Entity: fifteen, Label: CARDINAL\n",
      "Entity: CK, Label: ORG\n",
      "Entity: 118, Label: CARDINAL\n",
      "Entity: 128, Label: CARDINAL\n",
      "Entity: 8 and, Label: PRODUCT\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: 0.9, Label: CARDINAL\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Pulmonary, Label: PERSON\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Lasix, Label: PERSON\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: five, Label: CARDINAL\n",
      "Entity: 101.5, Label: CARDINAL\n",
      "Entity: Urinalysis, Label: ORG\n",
      "Entity: 245, Label: CARDINAL\n",
      "Entity: Levofloxacin 500, Label: PERSON\n",
      "Entity: eight days, Label: DATE\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 19.9, Label: CARDINAL\n",
      "Entity: 12.3, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: IR, Label: ORG\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: FEN, Label: PERSON\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: Synthroid, Label: PERSON\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: CREST/Sjogren's, Label: ORG\n",
      "Entity: Evoxac, Label: ORG\n",
      "Entity: un, Label: ORG\n",
      "Entity: CVA, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 40, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Atenolol, Label: PERSON\n",
      "Entity: 20, Label: CARDINAL\n",
      "Entity: 110, Label: CARDINAL\n",
      "Entity: 60, Label: DATE\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Synthroid 175, Label: PERSON\n",
      "Entity: q.d., Label: GPE\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: Darvocet, Label: PERSON\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: 6 hours, Label: TIME\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: MSIR, Label: ORG\n",
      "Entity: 10 to 30, Label: CARDINAL\n",
      "Entity: 4 hours, Label: TIME\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: Colace, Label: ORG\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: 6 hours, Label: TIME\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: Zolpidem 5, Label: PERSON\n",
      "Entity: po, Label: GPE\n",
      "Entity: h.s., Label: GPE\n",
      "Entity: 10, Label: CARDINAL\n",
      "Entity: 30, Label: CARDINAL\n",
      "Entity: 11, Label: CARDINAL\n",
      "Entity: Multivitamin\n",
      "q.d., Label: ORG\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 4427, Label: DATE\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 2515, Label: DATE\n",
      "Entity: 4517, Label: DATE\n",
      "Entity: M.D., Label: GPE\n",
      "Entity: MD, Label: GPE\n",
      "Entity: 4518, Label: DATE\n",
      "Entity: Last Name, Label: PERSON\n",
      "Entity: 4519, Label: DATE\n",
      "Entity: 2195-7-6, Label: DATE\n",
      "Entity: 2195-7-7, Label: DATE\n",
      "Entity: 08:18, Label: CARDINAL\n",
      "****************************************************************************************************\n",
      "Idx: 4 Entities Found: 255\n",
      "Entity: Admission Date:  , Label: ORG\n",
      "Entity: 2195-6-17, Label: CARDINAL\n",
      "Entity: 2195-7-7, Label: DATE\n",
      "Entity: 84 year-old, Label: DATE\n",
      "Entity: CREST, Label: ORG\n",
      "Entity: GI, Label: ORG\n",
      "Entity: 7-19, Label: CARDINAL\n",
      "Entity: 16, Label: CARDINAL\n",
      "Entity: 11, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: two days, Label: DATE\n",
      "Entity: night, Label: TIME\n",
      "Entity: 99.5, Label: CARDINAL\n",
      "Entity: 143/53, Label: CARDINAL\n",
      "Entity: 86, Label: CARDINAL\n",
      "Entity: 16, Label: CARDINAL\n",
      "Entity: 98%, Label: PERCENT\n",
      "Entity: 200, Label: CARDINAL\n",
      "Entity: 250, Label: CARDINAL\n",
      "Entity: one liter, Label: QUANTITY\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Sjogren, Label: PERSON\n",
      "Entity: Sicca, Label: GPE\n",
      "Entity: CREST, Label: ORG\n",
      "Entity: dysphagia, Label: GPE\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Irritable, Label: ORG\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: Diverticula, Label: PERSON\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Cholecystectomy, Label: PERSON\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Three pack years, Label: DATE\n",
      "Entity: twenty\n",
      "years ago, Label: DATE\n",
      "Entity: Crohn, Label: ORG\n",
      "Entity: forty two\n",
      "years, Label: DATE\n",
      "Entity: Penicillin, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: Atenolol, Label: PERSON\n",
      "Entity: 50, Label: CARDINAL\n",
      "Entity: q.d.  , Label: GPE\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Aldactone 25, Label: PRODUCT\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: q.d.  , Label: GPE\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Synthroid, Label: PERSON\n",
      "Entity: 175, Label: CARDINAL\n",
      "Entity: q.d., Label: GPE\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: 30, Label: CARDINAL\n",
      "Entity: q.d.  , Label: GPE\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: 50, Label: CARDINAL\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: Multivitamin, Label: NORP\n",
      "Entity: a\n",
      "day, Label: DATE\n",
      "Entity: Vital, Label: ORG\n",
      "Entity: 99.5, Label: CARDINAL\n",
      "Entity: 120/60, Label: CARDINAL\n",
      "Entity: 86, Label: CARDINAL\n",
      "Entity: Respiratory, Label: ORG\n",
      "Entity: 18, Label: CARDINAL\n",
      "Entity: Jugular, Label: PERSON\n",
      "Entity: S1, Label: ORG\n",
      "Entity: S2, Label: GPE\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: Fingers, Label: PERSON\n",
      "Entity: 2+, Label: DATE\n",
      "Entity: three, Label: CARDINAL\n",
      "Entity: Cranial, Label: PRODUCT\n",
      "Entity: XII, Label: ORG\n",
      "Entity: 11.1, Label: CARDINAL\n",
      "Entity: 10.3, Label: DATE\n",
      "Entity: 27.9, Label: CARDINAL\n",
      "Entity: 235, Label: CARDINAL\n",
      "Entity: 85, Label: DATE\n",
      "Entity: 29.3, Label: CARDINAL\n",
      "Entity: MCHC 34.4, Label: ORG\n",
      "Entity: 87.9%, Label: PERCENT\n",
      "Entity: 8%, Label: PERCENT\n",
      "Entity: 0, Label: CARDINAL\n",
      "Entity: 2.6%, Label: PERCENT\n",
      "Entity: 1.1%, Label: PERCENT\n",
      "Entity: 0.1%, Label: PERCENT\n",
      "Entity: 128, Label: CARDINAL\n",
      "Entity: 4.6, Label: CARDINAL\n",
      "Entity: 94, Label: CARDINAL\n",
      "Entity: 27, Label: CARDINAL\n",
      "Entity: BUN, Label: ORG\n",
      "Entity: 47, Label: DATE\n",
      "Entity: 1.1, Label: CARDINAL\n",
      "Entity: 122, Label: CARDINAL\n",
      "Entity: 8.5, Label: CARDINAL\n",
      "Entity: 1.8, Label: CARDINAL\n",
      "Entity: 2.8, Label: CARDINAL\n",
      "Entity: 30.1, Label: CARDINAL\n",
      "Entity: INR 1.3, Label: ORG\n",
      "Entity: Electrocardiogram, Label: PRODUCT\n",
      "Entity: 84, Label: CARDINAL\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 29.9, Label: CARDINAL\n",
      "Entity: melena, Label: ORG\n",
      "Entity: 6-18, Label: CARDINAL\n",
      "Entity: a year before, Label: DATE\n",
      "Entity: 6-25, Label: CARDINAL\n",
      "Entity: jejunum, Label: PERSON\n",
      "Entity: 6-29, Label: CARDINAL\n",
      "Entity: melena, Label: ORG\n",
      "Entity: 6-23, Label: CARDINAL\n",
      "Entity: 40, Label: CARDINAL\n",
      "Entity: Carafate, Label: ORG\n",
      "Entity: the evening, Label: TIME\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: fifteen, Label: CARDINAL\n",
      "Entity: 27.7, Label: CARDINAL\n",
      "Entity: 17.4, Label: CARDINAL\n",
      "Entity: 130s, Label: CARDINAL\n",
      "Entity: 420, Label: CARDINAL\n",
      "Entity: H20, Label: GPE\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: IR, Label: ORG\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: the evening, Label: TIME\n",
      "Entity: the Medicine Floor, Label: ORG\n",
      "Entity: 36.7, Label: CARDINAL\n",
      "Entity: one day, Label: DATE\n",
      "Entity: 24.1, Label: CARDINAL\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: twenty, Label: CARDINAL\n",
      "Entity: 26.4, Label: CARDINAL\n",
      "Entity: Two, Label: CARDINAL\n",
      "Entity: 30, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Hematology, Label: ORG\n",
      "Entity: 29.9, Label: CARDINAL\n",
      "Entity: 20, Label: CARDINAL\n",
      "Entity: GIC, Label: ORG\n",
      "Entity: 4516, Label: DATE\n",
      "Entity: Two, Label: CARDINAL\n",
      "Entity: five, Label: CARDINAL\n",
      "Entity: Desmopressin, Label: GPE\n",
      "Entity: two, Label: CARDINAL\n",
      "Entity: 6-24, Label: CARDINAL\n",
      "Entity: 6-27, Label: CARDINAL\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: PTT, Label: ORG\n",
      "Entity: Hematology, Label: ORG\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Atenolol, Label: ORG\n",
      "Entity: Aldactone, Label: ORG\n",
      "Entity: Lasix, Label: GPE\n",
      "Entity: 140s/80s, Label: DATE\n",
      "Entity: 80s, Label: DATE\n",
      "Entity: day five, Label: DATE\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: 130s, Label: CARDINAL\n",
      "Entity: 110s, Label: PRODUCT\n",
      "Entity: 100s, Label: DATE\n",
      "Entity: 120, Label: CARDINAL\n",
      "Entity: fifteen, Label: CARDINAL\n",
      "Entity: CK, Label: ORG\n",
      "Entity: 118, Label: CARDINAL\n",
      "Entity: 128, Label: CARDINAL\n",
      "Entity: 8 and, Label: PRODUCT\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: 0.9, Label: CARDINAL\n",
      "Entity: CMO, Label: ORG\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: Pulmonary, Label: PERSON\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Lasix, Label: PERSON\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: five, Label: CARDINAL\n",
      "Entity: 101.5, Label: CARDINAL\n",
      "Entity: Urinalysis, Label: ORG\n",
      "Entity: 245, Label: CARDINAL\n",
      "Entity: Levofloxacin 500, Label: PERSON\n",
      "Entity: eight days, Label: DATE\n",
      "Entity: MICU, Label: ORG\n",
      "Entity: 19.9, Label: CARDINAL\n",
      "Entity: 12.3, Label: CARDINAL\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: IR, Label: ORG\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: FEN, Label: PERSON\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: Synthroid, Label: PERSON\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: CREST/Sjogren's, Label: ORG\n",
      "Entity: Evoxac, Label: ORG\n",
      "Entity: un, Label: ORG\n",
      "Entity: CVA, Label: ORG\n",
      "Entity: 1, Label: CARDINAL\n",
      "Entity: 40, Label: CARDINAL\n",
      "Entity: 2, Label: CARDINAL\n",
      "Entity: Atenolol, Label: PERSON\n",
      "Entity: 20, Label: CARDINAL\n",
      "Entity: 110, Label: CARDINAL\n",
      "Entity: 60, Label: DATE\n",
      "Entity: 3, Label: CARDINAL\n",
      "Entity: Synthroid 175, Label: PERSON\n",
      "Entity: q.d., Label: GPE\n",
      "Entity: 4, Label: CARDINAL\n",
      "Entity: 5, Label: CARDINAL\n",
      "Entity: Darvocet, Label: PERSON\n",
      "Entity: one, Label: CARDINAL\n",
      "Entity: 6 hours, Label: TIME\n",
      "Entity: 6, Label: CARDINAL\n",
      "Entity: MSIR, Label: ORG\n",
      "Entity: 10 to 30, Label: CARDINAL\n",
      "Entity: 4 hours, Label: TIME\n",
      "Entity: 7, Label: CARDINAL\n",
      "Entity: Colace, Label: ORG\n",
      "Entity: 100, Label: CARDINAL\n",
      "Entity: 8, Label: CARDINAL\n",
      "Entity: 6 hours, Label: TIME\n",
      "Entity: 9, Label: CARDINAL\n",
      "Entity: Zolpidem 5, Label: PERSON\n",
      "Entity: po, Label: GPE\n",
      "Entity: h.s., Label: GPE\n",
      "Entity: 10, Label: CARDINAL\n",
      "Entity: 30, Label: CARDINAL\n",
      "Entity: 11, Label: CARDINAL\n",
      "Entity: Multivitamin\n",
      "q.d., Label: ORG\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 4427, Label: DATE\n",
      "Entity: First, Label: ORDINAL\n",
      "Entity: 2515, Label: DATE\n",
      "Entity: 4517, Label: DATE\n",
      "Entity: M.D., Label: GPE\n",
      "Entity: MD, Label: GPE\n",
      "Entity: 4521, Label: DATE\n",
      "Entity: Last Name, Label: PERSON\n",
      "Entity: 4519, Label: DATE\n",
      "Entity: 2195-7-6, Label: DATE\n",
      "Entity: 2195-7-7, Label: DATE\n",
      "Entity: 08:18, Label: CARDINAL\n",
      "****************************************************************************************************\n"
     ]
    }
   ],
   "source": [
    "import spacy\n",
    "import pandas as pd\n",
    "\n",
    "df = pd.read_csv(\"liver_notes.csv\")[:5] # reduce to 5 for performance\n",
    "\n",
    "nlp = spacy.load(\"en_core_web_sm\")\n",
    "\n",
    "def extract_entities(text):\n",
    "    doc = nlp(text)\n",
    "    return [(ent.text, ent.label_) for ent in doc.ents], doc\n",
    "\n",
    "# Process and extract entities\n",
    "for idx, row in df.iterrows():\n",
    "    text = row['TEXT']\n",
    "    entities, doc = extract_entities(text)  # Now correctly returning two values\n",
    "    \n",
    "    if entities:  # Only display if there are entities\n",
    "        print(f\"Idx: {idx} Entities Found: {len(entities)}\")\n",
    "        for entity, label in entities:\n",
    "            print(f\"Entity: {entity}, Label: {label}\")\n",
    "        print('*' * 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from spacy import displacy\n",
    "\n",
    "for idx, row in df.iterrows():\n",
    "    text = row['TEXT']\n",
    "    entities, doc = extract_entities(text)  # Now correctly returning two values\n",
    "    \n",
    "    if entities:  # Only display if there are entities\n",
    "        displacy.render(doc, style=\"ent\", jupyter=True)\n",
    "        print('*' * 100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Scispacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/jesusminjares/Desktop/UT Austin MSAI/Courses/ AI395T AI in Healthcare/ai_healthcare/lib/python3.12/site-packages/spacy/util.py:910: UserWarning: [W095] Model 'en_core_sci_lg' (0.5.4) was trained with spaCy v3.7.4 and may not be 100% compatible with the current version (3.8.4). If you see errors or degraded performance, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n",
      "  warnings.warn(warn_msg)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Idx: 0 Entities Found: 663\n",
      "Entity: Admission, Label: ENTITY\n",
      "Entity: Date, Label: ENTITY\n",
      "Entity: Birth, Label: ENTITY\n",
      "Entity: Sex, Label: ENTITY\n",
      "Entity: Lisinopril, Label: ENTITY\n",
      "Entity: Name3, Label: ENTITY\n",
      "Entity: LF, Label: ENTITY\n",
      "Entity: Acute renal failure, Label: ENTITY\n",
      "Entity: Surgical, Label: ENTITY\n",
      "Entity: Invasive Procedure, Label: ENTITY\n",
      "Entity: yo, Label: ENTITY\n",
      "Entity: male, Label: ENTITY\n",
      "Entity: chronic kidney disease, Label: ENTITY\n",
      "Entity: cirrhosis, Label: ENTITY\n",
      "Entity: NASH, Label: ENTITY\n",
      "Entity: PSC, Label: ENTITY\n",
      "Entity: ascites, Label: ENTITY\n",
      "Entity: Grade II esophageal, Label: ENTITY\n",
      "Entity: varices, Label: ENTITY\n",
      "Entity: DM2, Label: ENTITY\n",
      "Entity: PSC, Label: ENTITY\n",
      "Entity: CAD, Label: ENTITY\n",
      "Entity: acute worsening, Label: ENTITY\n",
      "Entity: creatinine, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: chronic kidney disease, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: creatinine, Label: ENTITY\n",
      "Entity: elevated, Label: ENTITY\n",
      "Entity: potassium, Label: ENTITY\n",
      "Entity: CKD, Label: ENTITY\n",
      "Entity: HTN, Label: ENTITY\n",
      "Entity: DM2, Label: ENTITY\n",
      "Entity: therapeutic, Label: ENTITY\n",
      "Entity: paracentesis, Label: ENTITY\n",
      "Entity: removal, Label: ENTITY\n",
      "Entity: fluid, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: SBP, Label: ENTITY\n",
      "Entity: states, Label: ENTITY\n",
      "Entity: increasing, Label: ENTITY\n",
      "Entity: abdominal distension, Label: ENTITY\n",
      "Entity: fatigue, Label: ENTITY\n",
      "Entity: weeks, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: pruritus, Label: ENTITY\n",
      "Entity: confusion, Label: ENTITY\n",
      "Entity: delta MS, Label: ENTITY\n",
      "Entity: antibiotics, Label: ENTITY\n",
      "Entity: states, Label: ENTITY\n",
      "Entity: intake, Label: ENTITY\n",
      "Entity: poor, Label: ENTITY\n",
      "Entity: lack, Label: ENTITY\n",
      "Entity: urine, Label: ENTITY\n",
      "Entity: output, Label: ENTITY\n",
      "Entity: Denies, Label: ENTITY\n",
      "Entity: NSAIDS, Label: ENTITY\n",
      "Entity: walk long, Label: ENTITY\n",
      "Entity: LE swelling, Label: ENTITY\n",
      "Entity: Denies, Label: ENTITY\n",
      "Entity: Right Popliteal DVT, Label: ENTITY\n",
      "Entity: s/p IVC filter, Label: ENTITY\n",
      "Entity: DM type 2, Label: ENTITY\n",
      "Entity: Uncontrolled, Label: ENTITY\n",
      "Entity: Complications, Label: ENTITY\n",
      "Entity: Hypoglycemia, Label: ENTITY\n",
      "Entity: Cirrhosis, Label: ENTITY\n",
      "Entity: NASH, Label: ENTITY\n",
      "Entity: Grade 2 Esophageal Varices, Label: ENTITY\n",
      "Entity: Primary Sclerosing Cholangitis, Label: ENTITY\n",
      "Entity: Cholangiocarcinoma, Label: ENTITY\n",
      "Entity: CKD, Label: ENTITY\n",
      "Entity: Anemia, Label: ENTITY\n",
      "Entity: Thrombocytopenia, Label: ENTITY\n",
      "Entity: Splenomegaly, Label: ENTITY\n",
      "Entity: CAD-, Label: ENTITY\n",
      "Entity: MIB, Label: ENTITY\n",
      "Entity: ejection fraction, Label: ENTITY\n",
      "Entity: Hypoalbuminemia, Label: ENTITY\n",
      "Entity: Social History, Label: ENTITY\n",
      "Entity: Lives, Label: ENTITY\n",
      "Entity: wife, Label: ENTITY\n",
      "Entity: Retired, Label: ENTITY\n",
      "Entity: manager, Label: ENTITY\n",
      "Entity: No alcohol, Label: ENTITY\n",
      "Entity: smoking, Label: ENTITY\n",
      "Entity: drugs, Label: ENTITY\n",
      "Entity: Family History, Label: ENTITY\n",
      "Entity: Mother, Label: ENTITY\n",
      "Entity: died, Label: ENTITY\n",
      "Entity: MI, Label: ENTITY\n",
      "Entity: no renal dz, Label: ENTITY\n",
      "Entity: VS, Label: ENTITY\n",
      "Entity: HR, Label: ENTITY\n",
      "Entity: BP, Label: ENTITY\n",
      "Entity: RR, Label: ENTITY\n",
      "Entity: RA, Label: ENTITY\n",
      "Entity: AA male, Label: ENTITY\n",
      "Entity: cachectic, Label: ENTITY\n",
      "Entity: protruding, Label: ENTITY\n",
      "Entity: HEENT, Label: ENTITY\n",
      "Entity: PERRL, Label: ENTITY\n",
      "Entity: EOMI, Label: ENTITY\n",
      "Entity: left eye wandering, Label: ENTITY\n",
      "Entity: scleral icterus, Label: ENTITY\n",
      "Entity: Mucous membranes, Label: ENTITY\n",
      "Entity: dry, Label: ENTITY\n",
      "Entity: auscultation, Label: ENTITY\n",
      "Entity: percussion bilaterally, Label: ENTITY\n",
      "Entity: decreased, Label: ENTITY\n",
      "Entity: BS, Label: ENTITY\n",
      "Entity: CARDIAC, Label: ENTITY\n",
      "Entity: RRR, Label: ENTITY\n",
      "Entity: MRG, Label: ENTITY\n",
      "Entity: BS, Label: ENTITY\n",
      "Entity: distended abdomen, Label: ENTITY\n",
      "Entity: fluid wave, Label: ENTITY\n",
      "Entity: tympanic, Label: ENTITY\n",
      "Entity: umbilical hernia, Label: ENTITY\n",
      "Entity: Rectal, Label: ENTITY\n",
      "Entity: external hemorrhoids, Label: ENTITY\n",
      "Entity: Guaiac negative, Label: ENTITY\n",
      "Entity: [**2, Label: ENTITY\n",
      "Entity: pitting edema, Label: ENTITY\n",
      "Entity: midthigh, Label: ENTITY\n",
      "Entity: Skin excoriations, Label: ENTITY\n",
      "Entity: hyperpigmented macules, Label: ENTITY\n",
      "Entity: Neuro, Label: ENTITY\n",
      "Entity: Ca, Label: ENTITY\n",
      "Entity: Mg, Label: ENTITY\n",
      "Entity: N:73.1 Band:0 L:19.5 M:4.1, Label: ENTITY\n",
      "Entity: E:2.7, Label: ENTITY\n",
      "Entity: Bas:0.6, Label: ENTITY\n",
      "Entity: Anisocy, Label: ENTITY\n",
      "Entity: Poiklo, Label: ENTITY\n",
      "Entity: Macrocy, Label: ENTITY\n",
      "Entity: Spheroc, Label: ENTITY\n",
      "Entity: Target, Label: ENTITY\n",
      "Entity: Plt-Est, Label: ENTITY\n",
      "Entity: Low, Label: ENTITY\n",
      "Entity: PT, Label: ENTITY\n",
      "Entity: PTT, Label: ENTITY\n",
      "Entity: INR, Label: ENTITY\n",
      "Entity: NDICATION, Label: ENTITY\n",
      "Entity: Low-grade fever, Label: ENTITY\n",
      "Entity: cough, Label: ENTITY\n",
      "Entity: lung, Label: ENTITY\n",
      "Entity: volumes, Label: ENTITY\n",
      "Entity: low, Label: ENTITY\n",
      "Entity: factor, Label: ENTITY\n",
      "Entity: heart, Label: ENTITY\n",
      "Entity: size, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: left ventricular configuration, Label: ENTITY\n",
      "Entity: pulmonary vascularity, Label: ENTITY\n",
      "Entity: crowding, Label: ENTITY\n",
      "Entity: vessels, Label: ENTITY\n",
      "Entity: lower, Label: ENTITY\n",
      "Entity: lung, Label: ENTITY\n",
      "Entity: zones, Label: ENTITY\n",
      "Entity: low, Label: ENTITY\n",
      "Entity: lung, Label: ENTITY\n",
      "Entity: volumes, Label: ENTITY\n",
      "Entity: opacity, Label: ENTITY\n",
      "Entity: infrahilar region, Label: ENTITY\n",
      "Entity: lateral view, Label: ENTITY\n",
      "Entity: crowding, Label: ENTITY\n",
      "Entity: vascular structures, Label: ENTITY\n",
      "Entity: pleural effusions, Label: ENTITY\n",
      "Entity: identified, Label: ENTITY\n",
      "Entity: imaged, Label: ENTITY\n",
      "Entity: portion, Label: ENTITY\n",
      "Entity: upper abdomen, Label: ENTITY\n",
      "Entity: paucity, Label: ENTITY\n",
      "Entity: bowel gas, Label: ENTITY\n",
      "Entity: ascites, Label: ENTITY\n",
      "Entity: Low, Label: ENTITY\n",
      "Entity: lung volumes, Label: ENTITY\n",
      "Entity: pneumonia, Label: ENTITY\n",
      "Entity: study, Label: ENTITY\n",
      "Entity: basilar pneumonia, Label: ENTITY\n",
      "Entity: low, Label: ENTITY\n",
      "Entity: lung, Label: ENTITY\n",
      "Entity: volume radiograph, Label: ENTITY\n",
      "Entity: ascites, Label: ENTITY\n",
      "Entity: INDICATIONS, Label: ENTITY\n",
      "Entity: man, Label: ENTITY\n",
      "Entity: renal failure, Label: ENTITY\n",
      "Entity: cirrhosis, Label: ENTITY\n",
      "Entity: COMPARISONS, Label: ENTITY\n",
      "Entity: Ultrasound, Label: ENTITY\n",
      "Entity: TECHNIQUE, Label: ENTITY\n",
      "Entity: Renal ultrasound examination, Label: ENTITY\n",
      "Entity: FINDINGS, Label: ENTITY\n",
      "Entity: right kidney measures, Label: ENTITY\n",
      "Entity: length, Label: ENTITY\n",
      "Entity: left, Label: ENTITY\n",
      "Entity: kidneys, Label: ENTITY\n",
      "Entity: stones, Label: ENTITY\n",
      "Entity: masses, Label: ENTITY\n",
      "Entity: hydronephrosis, Label: ENTITY\n",
      "Entity: ascites, Label: ENTITY\n",
      "Entity: ultrasound, Label: ENTITY\n",
      "Entity: liver, Label: ENTITY\n",
      "Entity: coarse, Label: ENTITY\n",
      "Entity: nodular, Label: ENTITY\n",
      "Entity: consistent with, Label: ENTITY\n",
      "Entity: cirrhosis, Label: ENTITY\n",
      "Entity: evidence, Label: ENTITY\n",
      "Entity: hydronephrosis, Label: ENTITY\n",
      "Entity: ascites, Label: ENTITY\n",
      "Entity: Reason, Label: ENTITY\n",
      "Entity: temporary, Label: ENTITY\n",
      "Entity: IJ, Label: ENTITY\n",
      "Entity: dialysis catheter, Label: ENTITY\n",
      "Entity: year, Label: ENTITY\n",
      "Entity: old man, Label: ENTITY\n",
      "Entity: NASH cirrhosis, Label: ENTITY\n",
      "Entity: GI bleed, Label: ENTITY\n",
      "Entity: dialysis, Label: ENTITY\n",
      "Entity: REASON, Label: ENTITY\n",
      "Entity: temporary, Label: ENTITY\n",
      "Entity: IJ, Label: ENTITY\n",
      "Entity: dialysis catheter, Label: ENTITY\n",
      "Entity: CLINICAL INFORMATION, Label: ENTITY\n",
      "Entity: man, Label: ENTITY\n",
      "Entity: cirrhosis, Label: ENTITY\n",
      "Entity: liver, Label: ENTITY\n",
      "Entity: status post, Label: ENTITY\n",
      "Entity: GI bleed, Label: ENTITY\n",
      "Entity: renal failure, Label: ENTITY\n",
      "Entity: temporal, Label: ENTITY\n",
      "Entity: dialysis catheter, Label: ENTITY\n",
      "Entity: hemodialysis, Label: ENTITY\n",
      "Entity: PROCEDURE/FINDINGS, Label: ENTITY\n",
      "Entity: procedure, Label: ENTITY\n",
      "Entity: Dr. [**First Name (STitle) 379**] [**Name (STitle) **], Label: ENTITY\n",
      "Entity: Dr. [**Last Name (STitle) 380**]., Label: ENTITY\n",
      "Entity: attending, Label: ENTITY\n",
      "Entity: radiologist, Label: ENTITY\n",
      "Entity: present, Label: ENTITY\n",
      "Entity: supervising, Label: ENTITY\n",
      "Entity: procedure, Label: ENTITY\n",
      "Entity: risks, Label: ENTITY\n",
      "Entity: benefits, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: supine, Label: ENTITY\n",
      "Entity: angiographic table, Label: ENTITY\n",
      "Entity: right neck, Label: ENTITY\n",
      "Entity: prepped, Label: ENTITY\n",
      "Entity: standard, Label: ENTITY\n",
      "Entity: sterile fashion, Label: ENTITY\n",
      "Entity: Ultrasound, Label: ENTITY\n",
      "Entity: patent, Label: ENTITY\n",
      "Entity: compressible, Label: ENTITY\n",
      "Entity: preprocedure, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: site, Label: ENTITY\n",
      "Entity: lidocaine, Label: ENTITY\n",
      "Entity: local anesthesia, Label: ENTITY\n",
      "Entity: ultrasonographic, Label: ENTITY\n",
      "Entity: guidance, Label: ENTITY\n",
      "Entity: 21-gauge\n",
      "needle, Label: ENTITY\n",
      "Entity: access, Label: ENTITY\n",
      "Entity: right internal jugular vein, Label: ENTITY\n",
      "Entity: wire, Label: ENTITY\n",
      "Entity: needle, Label: ENTITY\n",
      "Entity: fluoroscopic guidance, Label: ENTITY\n",
      "Entity: tip, Label: ENTITY\n",
      "Entity: superior vena cava, Label: ENTITY\n",
      "Entity: needle, Label: ENTITY\n",
      "Entity: 4-French micropuncture sheath, Label: ENTITY\n",
      "Entity: wire, Label: ENTITY\n",
      "Entity: wire, Label: ENTITY\n",
      "Entity: fluoroscopic, Label: ENTITY\n",
      "Entity: tip, Label: ENTITY\n",
      "Entity: inferior vena cava, Label: ENTITY\n",
      "Entity: micropuncture sheath, Label: ENTITY\n",
      "Entity: removed, Label: ENTITY\n",
      "Entity: venous access, Label: ENTITY\n",
      "Entity: dilated, Label: ENTITY\n",
      "Entity: dilators, Label: ENTITY\n",
      "Entity: hemodialysis, Label: ENTITY\n",
      "Entity: catheter, Label: ENTITY\n",
      "Entity: wire, Label: ENTITY\n",
      "Entity: tip, Label: ENTITY\n",
      "Entity: right\n",
      "atrium, Label: ENTITY\n",
      "Entity: wire, Label: ENTITY\n",
      "Entity: removed, Label: ENTITY\n",
      "Entity: lumens, Label: ENTITY\n",
      "Entity: flushed, Label: ENTITY\n",
      "Entity: catheter, Label: ENTITY\n",
      "Entity: skin, Label: ENTITY\n",
      "Entity: sutures, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: tolerated, Label: ENTITY\n",
      "Entity: procedure, Label: ENTITY\n",
      "Entity: immediate, Label: ENTITY\n",
      "Entity: complications, Label: ENTITY\n",
      "Entity: procedure, Label: ENTITY\n",
      "Entity: ultrasound films, Label: ENTITY\n",
      "Entity: placement, Label: ENTITY\n",
      "Entity: temporal, Label: ENTITY\n",
      "Entity: right internal jugular vein, Label: ENTITY\n",
      "Entity: tip, Label: ENTITY\n",
      "Entity: right atrium, Label: ENTITY\n",
      "Entity: catheter, Label: ENTITY\n",
      "Entity: PERITONEAL FLUID\n",
      "\n",
      "                            **FINAL REPORT [**2137, Label: ENTITY\n",
      "Entity: NO, Label: ENTITY\n",
      "Entity: LEUKOCYTES SEEN, Label: ENTITY\n",
      "Entity: NO, Label: ENTITY\n",
      "Entity: NO, Label: ENTITY\n",
      "Entity: NO, Label: ENTITY\n",
      "Entity: GROWTH, Label: ENTITY\n",
      "Entity: Brief Hospital Course, Label: ENTITY\n",
      "Entity: yo, Label: ENTITY\n",
      "Entity: male, Label: ENTITY\n",
      "Entity: DM2, Label: ENTITY\n",
      "Entity: HTN, Label: ENTITY\n",
      "Entity: CKD, Label: ENTITY\n",
      "Entity: cirrhosis, Label: ENTITY\n",
      "Entity: NASH, Label: ENTITY\n",
      "Entity: PSC, Label: ENTITY\n",
      "Entity: acute, Label: ENTITY\n",
      "Entity: chronic renal failure, Label: ENTITY\n",
      "Entity: complicated, Label: ENTITY\n",
      "Entity: UGIB, Label: ENTITY\n",
      "Entity: esophageal, Label: ENTITY\n",
      "Entity: varices, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: transferred, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: [**2137, Label: ENTITY\n",
      "Entity: banding, Label: ENTITY\n",
      "Entity: esophageal varices, Label: ENTITY\n",
      "Entity: transfusion, Label: ENTITY\n",
      "Entity: pRBC, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: s/p placement, Label: ENTITY\n",
      "Entity: hemodialysis catheter, Label: ENTITY\n",
      "Entity: dialysis, Label: ENTITY\n",
      "Entity: intiiated, Label: ENTITY\n",
      "Entity: volume paracentesis, Label: ENTITY\n",
      "Entity: removal, Label: ENTITY\n",
      "Entity: clinical status, Label: ENTITY\n",
      "Entity: deteriorated, Label: ENTITY\n",
      "Entity: worsening, Label: ENTITY\n",
      "Entity: cirrhosis, Label: ENTITY\n",
      "Entity: renal failure, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: hospice, Label: ENTITY\n",
      "Entity: Acute, Label: ENTITY\n",
      "Entity: chronic renal failure, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: ARF, Label: ENTITY\n",
      "Entity: hepatorenal syndrome, Label: ENTITY\n",
      "Entity: intravascular, Label: ENTITY\n",
      "Entity: volume, Label: ENTITY\n",
      "Entity: depletion, Label: ENTITY\n",
      "Entity: volume paracentesis, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: contribution, Label: ENTITY\n",
      "Entity: UGIB, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: Renal ultrasound, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: obstruction, Label: ENTITY\n",
      "Entity: urine, Label: ENTITY\n",
      "Entity: electrolytes, Label: ENTITY\n",
      "Entity: Location, Label: ENTITY\n",
      "Entity: HRS, Label: ENTITY\n",
      "Entity: urine sediment bland, Label: ENTITY\n",
      "Entity: Urine eosinophils, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: ATN, Label: ENTITY\n",
      "Entity: cause, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: NS, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: improvement, Label: ENTITY\n",
      "Entity: renal function, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: hemodialysis, Label: ENTITY\n",
      "Entity: sessions, Label: ENTITY\n",
      "Entity: minimal, Label: ENTITY\n",
      "Entity: improvement, Label: ENTITY\n",
      "Entity: renal function, Label: ENTITY\n",
      "Entity: nephrocaps, Label: ENTITY\n",
      "Entity: octreotide, Label: ENTITY\n",
      "Entity: midodrine, Label: ENTITY\n",
      "Entity: treatment, Label: ENTITY\n",
      "Entity: HRS, Label: ENTITY\n",
      "Entity: albumin, Label: ENTITY\n",
      "Entity: twice daily, Label: ENTITY\n",
      "Entity: diuretics, Label: ENTITY\n",
      "Entity: GI bleeding, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: episode, Label: ENTITY\n",
      "Entity: coffee, Label: ENTITY\n",
      "Entity: grounds, Label: ENTITY\n",
      "Entity: emesis, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: Grade II esophageal varices, Label: ENTITY\n",
      "Entity: episode, Label: ENTITY\n",
      "Entity: upper GI bleeding, Label: ENTITY\n",
      "Entity: floor, Label: ENTITY\n",
      "Entity: transferred, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: gastric banding, Label: ENTITY\n",
      "Entity: variceal bleeds, Label: ENTITY\n",
      "Entity: octreotide gtt, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: started, Label: ENTITY\n",
      "Entity: carafate, Label: ENTITY\n",
      "Entity: banding, Label: ENTITY\n",
      "Entity: hematemasis, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: hct, Label: ENTITY\n",
      "Entity: drop, Label: ENTITY\n",
      "Entity: liquid diet, Label: ENTITY\n",
      "Entity: transferred, Label: ENTITY\n",
      "Entity: floor, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: active, Label: ENTITY\n",
      "Entity: T&S, Label: ENTITY\n",
      "Entity: protonix, Label: ENTITY\n",
      "Entity: carafate, Label: ENTITY\n",
      "Entity: scheduled, Label: ENTITY\n",
      "Entity: endoscopy, Label: ENTITY\n",
      "Entity: weeks, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: discharge, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: guaiac positive material, Label: ENTITY\n",
      "Entity: KUB, Label: ENTITY\n",
      "Entity: ileus, Label: ENTITY\n",
      "Entity: vomiting, Label: ENTITY\n",
      "Entity: feculent material, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: indication, Label: ENTITY\n",
      "Entity: active bleeding, Label: ENTITY\n",
      "Entity: Scrotal edema, Label: ENTITY\n",
      "Entity: Patient c/o pain, Label: ENTITY\n",
      "Entity: tenderness, Label: ENTITY\n",
      "Entity: Foley, Label: ENTITY\n",
      "Entity: insertion site, Label: ENTITY\n",
      "Entity: foley, Label: ENTITY\n",
      "Entity: discontinued, Label: ENTITY\n",
      "Entity: urine output, Label: ENTITY\n",
      "Entity: intermittent, Label: ENTITY\n",
      "Entity: catheterizations, Label: ENTITY\n",
      "Entity: minimal, Label: ENTITY\n",
      "Entity: urine output, Label: ENTITY\n",
      "Entity: discontinued, Label: ENTITY\n",
      "Entity: patient discomfort, Label: ENTITY\n",
      "Entity: Bladder scan, Label: ENTITY\n",
      "Entity: urine, Label: ENTITY\n",
      "Entity: bladder, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: ascites, Label: ENTITY\n",
      "Entity: Patient's pain, Label: ENTITY\n",
      "Entity: controlled, Label: ENTITY\n",
      "Entity: morphine, Label: ENTITY\n",
      "Entity: viscous lidocaine, Label: ENTITY\n",
      "Entity: scrotal elevation, Label: ENTITY\n",
      "Entity: warm packs, Label: ENTITY\n",
      "Entity: Cirrhosis, Label: ENTITY\n",
      "Entity: PSC, Label: ENTITY\n",
      "Entity: MELD score, Label: ENTITY\n",
      "Entity: calculated, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: diagnostic paracentesis, Label: ENTITY\n",
      "Entity: SBP, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: no growth, Label: ENTITY\n",
      "Entity: SBP, Label: ENTITY\n",
      "Entity: prophylaxis, Label: ENTITY\n",
      "Entity: levofloxacin, Label: ENTITY\n",
      "Entity: volume, Label: ENTITY\n",
      "Entity: paracentesis, Label: ENTITY\n",
      "Entity: removal, Label: ENTITY\n",
      "Entity: nadolol, Label: ENTITY\n",
      "Entity: fluid, Label: ENTITY\n",
      "Entity: restriction, Label: ENTITY\n",
      "Entity: lactulose, Label: ENTITY\n",
      "Entity: hepatic encephalopathy, Label: ENTITY\n",
      "Entity: spironolactone, Label: ENTITY\n",
      "Entity: furosemide, Label: ENTITY\n",
      "Entity: concerns, Label: ENTITY\n",
      "Entity: hypotension, Label: ENTITY\n",
      "Entity: ursodiol, Label: ENTITY\n",
      "Entity: Liver consult, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: hospital stay, Label: ENTITY\n",
      "Entity: Vit K, Label: ENTITY\n",
      "Entity: SC, Label: ENTITY\n",
      "Entity: coagulopathy, Label: ENTITY\n",
      "Entity: Hyperkalemia, Label: ENTITY\n",
      "Entity: ARF, Label: ENTITY\n",
      "Entity: hyperkalemia, Label: ENTITY\n",
      "Entity: resolved, Label: ENTITY\n",
      "Entity: kayexelate, Label: ENTITY\n",
      "Entity: dialysis, Label: ENTITY\n",
      "Entity: Diabetes type 2, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: home insulin, Label: ENTITY\n",
      "Entity: regimen, Label: ENTITY\n",
      "Entity: decision, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: PPx, Label: ENTITY\n",
      "Entity: Incentive spirometer, Label: ENTITY\n",
      "Entity: Senna/colace, Label: ENTITY\n",
      "Entity: PPI, Label: ENTITY\n",
      "Entity: Code status, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: palliative care, Label: ENTITY\n",
      "Entity: consult, Label: ENTITY\n",
      "Entity: fentanyl, Label: ENTITY\n",
      "Entity: patch, Label: ENTITY\n",
      "Entity: morphine, Label: ENTITY\n",
      "Entity: elixir, Label: ENTITY\n",
      "Entity: pain, Label: ENTITY\n",
      "Entity: ativan, Label: ENTITY\n",
      "Entity: dolasetron, Label: ENTITY\n",
      "Entity: discharged to, Label: ENTITY\n",
      "Entity: hospice, Label: ENTITY\n",
      "Entity: Communication, Label: ENTITY\n",
      "Entity: NI, Label: ENTITY\n",
      "Entity: Known lastname 384**], Label: ENTITY\n",
      "Entity: Medications, Label: ENTITY\n",
      "Entity: Admission, Label: ENTITY\n",
      "Entity: CIPRO, Label: ENTITY\n",
      "Entity: mouth, Label: ENTITY\n",
      "Entity: twice daily, Label: ENTITY\n",
      "Entity: FERGON, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: NamePattern1, Label: ENTITY\n",
      "Entity: HUMALOG, Label: ENTITY\n",
      "Entity: Sliding scale, Label: ENTITY\n",
      "Entity: INSULIN, Label: ENTITY\n",
      "Entity: LANCETS, Label: ENTITY\n",
      "Entity: glucometer, Label: ENTITY\n",
      "Entity: monitoring, Label: ENTITY\n",
      "Entity: LANTUS, Label: ENTITY\n",
      "Entity: U/ML--16 units, Label: ENTITY\n",
      "Entity: bedtime, Label: ENTITY\n",
      "Entity: LASIX 40MG--[**12, Label: ENTITY\n",
      "Entity: mouth, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: NADOLOL, Label: ENTITY\n",
      "Entity: mouth, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: ONE TOUCH GLUCOMETER STRIPS, Label: ENTITY\n",
      "Entity: PROCRIT, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: week, Label: ENTITY\n",
      "Entity: mouth, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: SYRINGE, Label: ENTITY\n",
      "Entity: DISPOSABLE, Label: ENTITY\n",
      "Entity: procrit, Label: ENTITY\n",
      "Entity: TEDS, Label: ENTITY\n",
      "Entity: HOSE, Label: ENTITY\n",
      "Entity: KNEE, Label: ENTITY\n",
      "Entity: PAIR, Label: ENTITY\n",
      "Entity: Wear, Label: ENTITY\n",
      "Entity: FORTE, Label: ENTITY\n",
      "Entity: mouth, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: liver unit, Label: ENTITY\n",
      "Entity: Lidocaine HCl, Label: ENTITY\n",
      "Entity: Gel Sig, Label: ENTITY\n",
      "Entity: Mucous membrane, Label: ENTITY\n",
      "Entity: PRN, Label: ENTITY\n",
      "Entity: foley manipulation, Label: ENTITY\n",
      "Entity: Fentanyl, Label: ENTITY\n",
      "Entity: Patch 72HR Sig, Label: ENTITY\n",
      "Entity: Patch, Label: ENTITY\n",
      "Entity: Transdermal Q72H, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: Patch, Label: ENTITY\n",
      "Entity: Refills:*2, Label: ENTITY\n",
      "Entity: Lactulose 10 g/15 mL Syrup Sig, Label: ENTITY\n",
      "Entity: ML, Label: ENTITY\n",
      "Entity: PO, Label: ENTITY\n",
      "Entity: TID, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: Morphine, Label: ENTITY\n",
      "Entity: Concentrate 20 mg/mL, Label: ENTITY\n",
      "Entity: Solution Sig, Label: ENTITY\n",
      "Entity: PO, Label: ENTITY\n",
      "Entity: Q3H, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: Disp:*150 cc*, Label: ENTITY\n",
      "Entity: Refills:*2, Label: ENTITY\n",
      "Entity: Morphine, Label: ENTITY\n",
      "Entity: Concentrate 20 mg/mL, Label: ENTITY\n",
      "Entity: Solution Sig, Label: ENTITY\n",
      "Entity: PO, Label: ENTITY\n",
      "Entity: Morphine, Label: ENTITY\n",
      "Entity: Concentrate 20 mg/mL, Label: ENTITY\n",
      "Entity: Solution Sig, Label: ENTITY\n",
      "Entity: PO, Label: ENTITY\n",
      "Entity: q3h, Label: ENTITY\n",
      "Entity: dyspnea, Label: ENTITY\n",
      "Entity: pain, Label: ENTITY\n",
      "Entity: Disp:*150 cc* Refills:*0, Label: ENTITY\n",
      "Entity: Ativan 5, Label: ENTITY\n",
      "Entity: tongue q4, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: anxiety, Label: ENTITY\n",
      "Entity: nausea, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: Disp, Label: ENTITY\n",
      "Entity: Scopolamine Base 1.5 mg, Label: ENTITY\n",
      "Entity: Patch, Label: ENTITY\n",
      "Entity: Transdermal, Label: ENTITY\n",
      "Entity: seventy-two, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: secretions, Label: ENTITY\n",
      "Entity: Disp:*1 box* Refills:*0*\n",
      "\n",
      "\n",
      "Discharge Disposition, Label: ENTITY\n",
      "Entity: Extended Care\n",
      "\n",
      "Facility, Label: ENTITY\n",
      "Entity: Discharge Diagnosis, Label: ENTITY\n",
      "Entity: Hepatorenal syndrome, Label: ENTITY\n",
      "Entity: Acute renal failure, Label: ENTITY\n",
      "Entity: dialysis, Label: ENTITY\n",
      "Entity: Upper GI bleeding, Label: ENTITY\n",
      "Entity: esophageal varices, Label: ENTITY\n",
      "Entity: Cirrhosis, Label: ENTITY\n",
      "Entity: ascites, Label: ENTITY\n",
      "Entity: Scrotal edema, Label: ENTITY\n",
      "Entity: Ileus, Label: ENTITY\n",
      "Entity: Hyperkalemia, Label: ENTITY\n",
      "Entity: Diabetes mellitus type 2, Label: ENTITY\n",
      "Entity: Thrombocytopenia, Label: ENTITY\n",
      "Entity: Poor\n",
      "\n",
      "\n",
      "Discharge, Label: ENTITY\n",
      "Entity: Instructions, Label: ENTITY\n",
      "Entity: inpatient, Label: ENTITY\n",
      "Entity: hospice center, Label: ENTITY\n",
      "Entity: pain, Label: ENTITY\n",
      "Entity: controlled, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: trouble breathing, Label: ENTITY\n",
      "Entity: nausea, Label: ENTITY\n",
      "Entity: pain, Label: ENTITY\n",
      "Entity: doctors, Label: ENTITY\n",
      "Entity: Followup, Label: ENTITY\n",
      "Entity: Instructions, Label: ENTITY\n",
      "Entity: Provider, Label: ENTITY\n",
      "Entity: MD, Label: ENTITY\n",
      "Entity: Provider, Label: ENTITY\n",
      "Entity: Pattern1, Label: ENTITY\n",
      "Entity: MD, Label: ENTITY\n",
      "****************************************************************************************************\n",
      "Idx: 1 Entities Found: 533\n",
      "Entity: Admission, Label: ENTITY\n",
      "Entity: Date, Label: ENTITY\n",
      "Entity: Birth, Label: ENTITY\n",
      "Entity: Sex, Label: ENTITY\n",
      "Entity: Lomotil, Label: ENTITY\n",
      "Entity: NamePattern1, Label: ENTITY\n",
      "Entity: Pyelonephritis, Label: ENTITY\n",
      "Entity: Surgical, Label: ENTITY\n",
      "Entity: Invasive Procedure, Label: ENTITY\n",
      "Entity: History of Present Illness, Label: ENTITY\n",
      "Entity: chronic hepatitis C, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: dysuria, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: chills, Label: ENTITY\n",
      "Entity: nausea, Label: ENTITY\n",
      "Entity: vomiting, Label: ENTITY\n",
      "Entity: hematuria, Label: ENTITY\n",
      "Entity: Saturday, Label: ENTITY\n",
      "Entity: dysuria, Label: ENTITY\n",
      "Entity: urinary frequency, Label: ENTITY\n",
      "Entity: urgency, Label: ENTITY\n",
      "Entity: incontinence, Label: ENTITY\n",
      "Entity: anorexia, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: N/V, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: Denies back pain, Label: ENTITY\n",
      "Entity: mild, Label: ENTITY\n",
      "Entity: abdominal discomfort, Label: ENTITY\n",
      "Entity: temperature, Label: ENTITY\n",
      "Entity: home, Label: ENTITY\n",
      "Entity: hospitalizations, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: visit, Label: ENTITY\n",
      "Entity: Bell's palsy, Label: ENTITY\n",
      "Entity: Lyme disease, Label: ENTITY\n",
      "Entity: urinary tract infection, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: initial, Label: ENTITY\n",
      "Entity: vitals, Label: ENTITY\n",
      "Entity: HR, Label: ENTITY\n",
      "Entity: BP, Label: ENTITY\n",
      "Entity: RR, Label: ENTITY\n",
      "Entity: O2, Label: ENTITY\n",
      "Entity: RA, Label: ENTITY\n",
      "Entity: fever, Label: ENTITY\n",
      "Entity: BP, Label: ENTITY\n",
      "Entity: asymptomatic, Label: ENTITY\n",
      "Entity: grossly positive, Label: ENTITY\n",
      "Entity: U/A, Label: ENTITY\n",
      "Entity: CT, Label: ENTITY\n",
      "Entity: evidence, Label: ENTITY\n",
      "Entity: bilateral, Label: ENTITY\n",
      "Entity: pyelonephritis, Label: ENTITY\n",
      "Entity: 5L, Label: ENTITY\n",
      "Entity: IVFs, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: urine output, Label: ENTITY\n",
      "Entity: ROS, Label: ENTITY\n",
      "Entity: headache, Label: ENTITY\n",
      "Entity: CP, Label: ENTITY\n",
      "Entity: SOB, Label: ENTITY\n",
      "Entity: dysphagia, Label: ENTITY\n",
      "Entity: weight change, Label: ENTITY\n",
      "Entity: constipation, Label: ENTITY\n",
      "Entity: no cough, Label: ENTITY\n",
      "Entity: muscle weakness, Label: ENTITY\n",
      "Entity: Hepatitis C infection, Label: ENTITY\n",
      "Entity: Liver biopsy, Label: ENTITY\n",
      "Entity: grade, Label: ENTITY\n",
      "Entity: inflammation, Label: ENTITY\n",
      "Entity: stage, Label: ENTITY\n",
      "Entity: fibrosis, Label: ENTITY\n",
      "Entity: needlestick injury, Label: ENTITY\n",
      "Entity: Osteopenia, Label: ENTITY\n",
      "Entity: Herpes zoster, Label: ENTITY\n",
      "Entity: right middle, Label: ENTITY\n",
      "Entity: years, Label: ENTITY\n",
      "Entity: age, Label: ENTITY\n",
      "Entity: Psoriasis, Label: ENTITY\n",
      "Entity: Lyme, Label: ENTITY\n",
      "Entity: disease/Bell's, Label: ENTITY\n",
      "Entity: palsy, Label: ENTITY\n",
      "Entity: Thyroid nodule, Label: ENTITY\n",
      "Entity: Social History, Label: ENTITY\n",
      "Entity: sociologist, Label: ENTITY\n",
      "Entity: single, Label: ENTITY\n",
      "Entity: lives, Label: ENTITY\n",
      "Entity: alcohol use, Label: ENTITY\n",
      "Entity: [**2164**], Label: ENTITY\n",
      "Entity: drink, Label: ENTITY\n",
      "Entity: socially, Label: ENTITY\n",
      "Entity: Denies, Label: ENTITY\n",
      "Entity: smoking, Label: ENTITY\n",
      "Entity: drug use, Label: ENTITY\n",
      "Entity: Family History, Label: ENTITY\n",
      "Entity: Mother, Label: ENTITY\n",
      "Entity: arthritis, Label: ENTITY\n",
      "Entity: health, Label: ENTITY\n",
      "Entity: Father, Label: ENTITY\n",
      "Entity: mental decline, Label: ENTITY\n",
      "Entity: diagnosis, Label: ENTITY\n",
      "Entity: sister, Label: ENTITY\n",
      "Entity: health, Label: ENTITY\n",
      "Entity: brothers, Label: ENTITY\n",
      "Entity: hepatitis C., Label: ENTITY\n",
      "Entity: Paternal, Label: ENTITY\n",
      "Entity: grandfather, Label: ENTITY\n",
      "Entity: NI, Label: ENTITY\n",
      "Entity: Paternal grandmother, Label: ENTITY\n",
      "Entity: lung, Label: ENTITY\n",
      "Entity: Paternal aunts, Label: ENTITY\n",
      "Entity: breast cancer, Label: ENTITY\n",
      "Entity: paternal uncle, Label: ENTITY\n",
      "Entity: NI, Label: ENTITY\n",
      "Entity: Tmax, Label: ENTITY\n",
      "Entity: C, Label: ENTITY\n",
      "Entity: F, Label: ENTITY\n",
      "Entity: Tcurrent, Label: ENTITY\n",
      "Entity: C, Label: ENTITY\n",
      "Entity: F, Label: ENTITY\n",
      "Entity: HR, Label: ENTITY\n",
      "Entity: BP, Label: ENTITY\n",
      "Entity: mmHg, Label: ENTITY\n",
      "Entity: RR, Label: ENTITY\n",
      "Entity: SpO2, Label: ENTITY\n",
      "Entity: RA, Label: ENTITY\n",
      "Entity: Heart rhythm, Label: ENTITY\n",
      "Entity: SR, Label: ENTITY\n",
      "Entity: Sinus Rhythm, Label: ENTITY\n",
      "Entity: Height, Label: ENTITY\n",
      "Entity: NAD, Label: ENTITY\n",
      "Entity: pleasant, Label: ENTITY\n",
      "Entity: conversive, Label: ENTITY\n",
      "Entity: HEENT, Label: ENTITY\n",
      "Entity: PERRL, Label: ENTITY\n",
      "Entity: MMM, Label: ENTITY\n",
      "Entity: OP lesions, Label: ENTITY\n",
      "Entity: EOMI, Label: ENTITY\n",
      "Entity: Supple, Label: ENTITY\n",
      "Entity: LAD, Label: ENTITY\n",
      "Entity: no bruit, Label: ENTITY\n",
      "Entity: LVD, Label: ENTITY\n",
      "Entity: RRR, Label: ENTITY\n",
      "Entity: S3/4, Label: ENTITY\n",
      "Entity: murmurs, Label: ENTITY\n",
      "Entity: Lungs, Label: ENTITY\n",
      "Entity: CTA, Label: ENTITY\n",
      "Entity: Abd, Label: ENTITY\n",
      "Entity: Soft, NT/ND, Label: ENTITY\n",
      "Entity: BS, Label: ENTITY\n",
      "Entity: no guarding, Label: ENTITY\n",
      "Entity: rebound tenderness, Label: ENTITY\n",
      "Entity: normoactive bowel sounds, Label: ENTITY\n",
      "Entity: CVA, Label: ENTITY\n",
      "Entity: tenderness, Label: ENTITY\n",
      "Entity: R, Label: ENTITY\n",
      "Entity: L, Label: ENTITY\n",
      "Entity: Extrem, Label: ENTITY\n",
      "Entity: edema, Label: ENTITY\n",
      "Entity: cyanosis, Label: ENTITY\n",
      "Entity: clubbing, Label: ENTITY\n",
      "Entity: Skin, Label: ENTITY\n",
      "Entity: no rashes, Label: ENTITY\n",
      "Entity: Neuro, Label: ENTITY\n",
      "Entity: A+Ox3, Label: ENTITY\n",
      "Entity: muscle strength, Label: ENTITY\n",
      "Entity: sensation, Label: ENTITY\n",
      "Entity: WBC-7.3 RBC-3.16* Hgb-10.9* Hct-29.8*, Label: ENTITY\n",
      "Entity: Cl-113* HCO3, Label: ENTITY\n",
      "Entity: TSH-0.43, Label: ENTITY\n",
      "Entity: LE, Label: ENTITY\n",
      "Entity: Lg blood, Label: ENTITY\n",
      "Entity: Nitr negative, Label: ENTITY\n",
      "Entity: trace protein, Label: ENTITY\n",
      "Entity: WBC, Label: ENTITY\n",
      "Entity: Bacteria, Label: ENTITY\n",
      "Entity: Epi [**1-21**], Label: ENTITY\n",
      "Entity: Urine cx, Label: ENTITY\n",
      "Entity: [**9, Label: ENTITY\n",
      "Entity: 7**]-, Label: ENTITY\n",
      "Entity: E.Coli, Label: ENTITY\n",
      "Entity: sensitivities, Label: ENTITY\n",
      "Entity: PENDING, Label: ENTITY\n",
      "Entity: Blood cx, Label: ENTITY\n",
      "Entity: [**9, Label: ENTITY\n",
      "Entity: CT SCAN, Label: ENTITY\n",
      "Entity: CT, Label: ENTITY\n",
      "Entity: Dependent atelectases, Label: ENTITY\n",
      "Entity: lung bases, Label: ENTITY\n",
      "Entity: bilaterally, Label: ENTITY\n",
      "Entity: pleural effusion, Label: ENTITY\n",
      "Entity: Visualized heart, Label: ENTITY\n",
      "Entity: pericardium, Label: ENTITY\n",
      "Entity: unremarkable, Label: ENTITY\n",
      "Entity: striated, Label: ENTITY\n",
      "Entity: appearance, Label: ENTITY\n",
      "Entity: bilateral kidneys, Label: ENTITY\n",
      "Entity: peripheral, Label: ENTITY\n",
      "Entity: hypodensities, Label: ENTITY\n",
      "Entity: bilaterally, Label: ENTITY\n",
      "Entity: hypodensities, Label: ENTITY\n",
      "Entity: upper pole, Label: ENTITY\n",
      "Entity: left kidney, Label: ENTITY\n",
      "Entity: associated marked, Label: ENTITY\n",
      "Entity: inflammatory, Label: ENTITY\n",
      "Entity: kidneys, Label: ENTITY\n",
      "Entity: excrete, Label: ENTITY\n",
      "Entity: kidneys, Label: ENTITY\n",
      "Entity: circumferential wall, Label: ENTITY\n",
      "Entity: thickening, Label: ENTITY\n",
      "Entity: ureters, Label: ENTITY\n",
      "Entity: course, Label: ENTITY\n",
      "Entity: findings, Label: ENTITY\n",
      "Entity: bilateral pyelonephritis, Label: ENTITY\n",
      "Entity: associated ureteritis, Label: ENTITY\n",
      "Entity: abscess, Label: ENTITY\n",
      "Entity: identified, Label: ENTITY\n",
      "Entity: hypodensity, Label: ENTITY\n",
      "Entity: upper pole, Label: ENTITY\n",
      "Entity: left\n",
      "kidney, Label: ENTITY\n",
      "Entity: risk, Label: ENTITY\n",
      "Entity: internal abscess, Label: ENTITY\n",
      "Entity: liver, Label: ENTITY\n",
      "Entity: gallbladder, Label: ENTITY\n",
      "Entity: normal limits, Label: ENTITY\n",
      "Entity: focal, Label: ENTITY\n",
      "Entity: hypodensity, Label: ENTITY\n",
      "Entity: adjacent, Label: ENTITY\n",
      "Entity: gallbladder, Label: ENTITY\n",
      "Entity: area, Label: ENTITY\n",
      "Entity: focal fat, Label: ENTITY\n",
      "Entity: Spleen, Label: ENTITY\n",
      "Entity: pancreas, Label: ENTITY\n",
      "Entity: adrenal glands, Label: ENTITY\n",
      "Entity: unremarkable, Label: ENTITY\n",
      "Entity: stomach, Label: ENTITY\n",
      "Entity: small bowel, Label: ENTITY\n",
      "Entity: large bowel, Label: ENTITY\n",
      "Entity: unremarkable, Label: ENTITY\n",
      "Entity: appendix, Label: ENTITY\n",
      "Entity: visualized, Label: ENTITY\n",
      "Entity: findings, Label: ENTITY\n",
      "Entity: acute appendicitis, Label: ENTITY\n",
      "Entity: free air, Label: ENTITY\n",
      "Entity: retroperitoneal, Label: ENTITY\n",
      "Entity: nodes, Label: ENTITY\n",
      "Entity: CT, Label: ENTITY\n",
      "Entity: criteria, Label: ENTITY\n",
      "Entity: pathologic, Label: ENTITY\n",
      "Entity: enlargement, Label: ENTITY\n",
      "Entity: Urinary bladder, Label: ENTITY\n",
      "Entity: rectum, Label: ENTITY\n",
      "Entity: unremarkable, Label: ENTITY\n",
      "Entity: lymphadenopathy, Label: ENTITY\n",
      "Entity: free fluid, Label: ENTITY\n",
      "Entity: Findings, Label: ENTITY\n",
      "Entity: bilateral pyelonephritis, Label: ENTITY\n",
      "Entity: ureteritis, Label: ENTITY\n",
      "Entity: abscess, Label: ENTITY\n",
      "Entity: identified, Label: ENTITY\n",
      "Entity: hypodensity, Label: ENTITY\n",
      "Entity: left, Label: ENTITY\n",
      "Entity: upper pole, Label: ENTITY\n",
      "Entity: risk, Label: ENTITY\n",
      "Entity: abscess, Label: ENTITY\n",
      "Entity: Close interval, Label: ENTITY\n",
      "Entity: followup, Label: ENTITY\n",
      "Entity: Brief Hospital Course, Label: ENTITY\n",
      "Entity: female, Label: ENTITY\n",
      "Entity: chronic hepatitis C infection, Label: ENTITY\n",
      "Entity: cirrhosis, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: dysuria, Label: ENTITY\n",
      "Entity: chills, Label: ENTITY\n",
      "Entity: grossly positive, Label: ENTITY\n",
      "Entity: U/A, Label: ENTITY\n",
      "Entity: evidence, Label: ENTITY\n",
      "Entity: bilateral pyelonephritis, Label: ENTITY\n",
      "Entity: CT, Label: ENTITY\n",
      "Entity: Abd/pelvis, Label: ENTITY\n",
      "Entity: hypotensive, Label: ENTITY\n",
      "Entity: Pyelonephritis/Sepsis, Label: ENTITY\n",
      "Entity: Pt w/, Label: ENTITY\n",
      "Entity: signs, Label: ENTITY\n",
      "Entity: UTI, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: GU infection, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: UTIs, Label: ENTITY\n",
      "Entity: resistent, Label: ENTITY\n",
      "Entity: organisms, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: ICU, Label: ENTITY\n",
      "Entity: stable condition, Label: ENTITY\n",
      "Entity: CT scan, Label: ENTITY\n",
      "Entity: performed, Label: ENTITY\n",
      "Entity: consistent with, Label: ENTITY\n",
      "Entity: pyelonephritis w/, Label: ENTITY\n",
      "Entity: abscess, Label: ENTITY\n",
      "Entity: hypodensity, Label: ENTITY\n",
      "Entity: abscess, Label: ENTITY\n",
      "Entity: left upper pole, Label: ENTITY\n",
      "Entity: cipro, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: ICU, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: cultures, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: blood pressures, Label: ENTITY\n",
      "Entity: range, Label: ENTITY\n",
      "Entity: SBP, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: good mentation, Label: ENTITY\n",
      "Entity: urine output, Label: ENTITY\n",
      "Entity: peripheral perfusion, Label: ENTITY\n",
      "Entity: compliants, Label: ENTITY\n",
      "Entity: indication, Label: ENTITY\n",
      "Entity: adequate, Label: ENTITY\n",
      "Entity: organ perfusion, Label: ENTITY\n",
      "Entity: Pt, Label: ENTITY\n",
      "Entity: hypotensive, Label: ENTITY\n",
      "Entity: SBP, Label: ENTITY\n",
      "Entity: IVFs, Label: ENTITY\n",
      "Entity: presentation, Label: ENTITY\n",
      "Entity: insensible losses, Label: ENTITY\n",
      "Entity: fever, Label: ENTITY\n",
      "Entity: Pt, Label: ENTITY\n",
      "Entity: reports, Label: ENTITY\n",
      "Entity: low, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: dose, Label: ENTITY\n",
      "Entity: stress dose, Label: ENTITY\n",
      "Entity: steriods, Label: ENTITY\n",
      "Entity: discontinued, Label: ENTITY\n",
      "Entity: AM, Label: ENTITY\n",
      "Entity: random cortisol, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: IV ciprofloxacin, Label: ENTITY\n",
      "Entity: cipro, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: course, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: urine, Label: ENTITY\n",
      "Entity: E. Coli, Label: ENTITY\n",
      "Entity: sensitivities, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: SBP, Label: ENTITY\n",
      "Entity: discharge, Label: ENTITY\n",
      "Entity: Pt, Label: ENTITY\n",
      "Entity: afebrile, Label: ENTITY\n",
      "Entity: ambulating, Label: ENTITY\n",
      "Entity: eating, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: Acute renal failure, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: initial, Label: ENTITY\n",
      "Entity: creatine, Label: ENTITY\n",
      "Entity: stablized, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: prerenal w/, Label: ENTITY\n",
      "Entity: combination, Label: ENTITY\n",
      "Entity: poor, Label: ENTITY\n",
      "Entity: intake, Label: ENTITY\n",
      "Entity: vomiting, Label: ENTITY\n",
      "Entity: fever, Label: ENTITY\n",
      "Entity: Chronic hepatitis C infection, Label: ENTITY\n",
      "Entity: Stable, Label: ENTITY\n",
      "Entity: treatment, Label: ENTITY\n",
      "Entity: LFT's, Label: ENTITY\n",
      "Entity: Lyme, Label: ENTITY\n",
      "Entity: disease/Bell's, Label: ENTITY\n",
      "Entity: palsy, Label: ENTITY\n",
      "Entity: resolving, Label: ENTITY\n",
      "Entity: FEN, Label: ENTITY\n",
      "Entity: regular diet, Label: ENTITY\n",
      "Entity: lytes, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: PPx, Label: ENTITY\n",
      "Entity: heparin, Label: ENTITY\n",
      "Entity: bowel regimen, Label: ENTITY\n",
      "Entity: Access, Label: ENTITY\n",
      "Entity: PIV, Label: ENTITY\n",
      "Entity: Code, Label: ENTITY\n",
      "Entity: confirmed w/, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: ICU, Label: ENTITY\n",
      "Entity: consent, Label: ENTITY\n",
      "Entity: Comm, Label: ENTITY\n",
      "Entity: Dispo, Label: ENTITY\n",
      "Entity: Pt, Label: ENTITY\n",
      "Entity: discharged, Label: ENTITY\n",
      "Entity: follow-up, Label: ENTITY\n",
      "Entity: PCP, Label: ENTITY\n",
      "Entity: PRE, Label: ENTITY\n",
      "Entity: vitals, Label: ENTITY\n",
      "Entity: CBC, Label: ENTITY\n",
      "Entity: Medications, Label: ENTITY\n",
      "Entity: Admission, Label: ENTITY\n",
      "Entity: ASA, Label: ENTITY\n",
      "Entity: daily, Label: ENTITY\n",
      "Entity: [**, Label: ENTITY\n",
      "Entity: Vitamin D, Label: ENTITY\n",
      "Entity: MVI, Label: ENTITY\n",
      "Entity: multiple, Label: ENTITY\n",
      "Entity: herbal supplements, Label: ENTITY\n",
      "Entity: Discharge Medications, Label: ENTITY\n",
      "Entity: Aspirin, Label: ENTITY\n",
      "Entity: Tablet, Label: ENTITY\n",
      "Entity: Chewable Sig, Label: ENTITY\n",
      "Entity: Tablet, Label: ENTITY\n",
      "Entity: Chewable, Label: ENTITY\n",
      "Entity: PO, Label: ENTITY\n",
      "Entity: Daily, Label: ENTITY\n",
      "Entity: Multivitamin     , Label: ENTITY\n",
      "Entity: Tablet Sig, Label: ENTITY\n",
      "Entity: Tablet, Label: ENTITY\n",
      "Entity: PO, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: Vitamin D, Label: ENTITY\n",
      "Entity: Oral, Label: ENTITY\n",
      "Entity: Ciprofloxacin, Label: ENTITY\n",
      "Entity: Tablet Sig, Label: ENTITY\n",
      "Entity: Tablet PO Q12H, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: Disp:*24 Tablet(s)* Refills:*0*\n",
      "\n",
      "\n",
      "Discharge Disposition, Label: ENTITY\n",
      "Entity: Home\n",
      "\n",
      "Discharge, Label: ENTITY\n",
      "Entity: Diagnosis, Label: ENTITY\n",
      "Entity: Primary, Label: ENTITY\n",
      "Entity: Pyelonephritis, Label: ENTITY\n",
      "Entity: Hypotension, Label: ENTITY\n",
      "Entity: Secondary, Label: ENTITY\n",
      "Entity: Hepatitis C infection, Label: ENTITY\n",
      "Entity: Osteopenia, Label: ENTITY\n",
      "Entity: Herpes zoster, Label: ENTITY\n",
      "Entity: Psoriasis, Label: ENTITY\n",
      "Entity: Lyme disease/Bell's, Label: ENTITY\n",
      "Entity: palsy, Label: ENTITY\n",
      "Entity: Thyroid nodule, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: normotensive, Label: ENTITY\n",
      "Entity: ambulating, Label: ENTITY\n",
      "Entity: normal diet, Label: ENTITY\n",
      "Entity: O2, Label: ENTITY\n",
      "Entity: room air, Label: ENTITY\n",
      "Entity: Instructions, Label: ENTITY\n",
      "Entity: pleasure [**Last Name, Label: ENTITY\n",
      "Entity: hospital, Label: ENTITY\n",
      "Entity: admitted, Label: ENTITY\n",
      "Entity: infection, Label: ENTITY\n",
      "Entity: kidney, Label: ENTITY\n",
      "Entity: CT scan, Label: ENTITY\n",
      "Entity: kidney, Label: ENTITY\n",
      "Entity: consistent with, Label: ENTITY\n",
      "Entity: kidney infection, Label: ENTITY\n",
      "Entity: ICU, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: low, Label: ENTITY\n",
      "Entity: fluids, Label: ENTITY\n",
      "Entity: treated with, Label: ENTITY\n",
      "Entity: antibiotics, Label: ENTITY\n",
      "Entity: infection, Label: ENTITY\n",
      "Entity: improved, Label: ENTITY\n",
      "Entity: treatments, Label: ENTITY\n",
      "Entity: home, Label: ENTITY\n",
      "Entity: oral antibiotics, Label: ENTITY\n",
      "Entity: medications prescibed, Label: ENTITY\n",
      "Entity: appoints, Label: ENTITY\n",
      "Entity: PCP, Label: ENTITY\n",
      "Entity: ED, Label: ENTITY\n",
      "Entity: experience, Label: ENTITY\n",
      "Entity: worsening, Label: ENTITY\n",
      "Entity: fevers, Label: ENTITY\n",
      "Entity: chills, Label: ENTITY\n",
      "Entity: pain with, Label: ENTITY\n",
      "Entity: urination, Label: ENTITY\n",
      "Entity: nausea, Label: ENTITY\n",
      "Entity: vomiting, Label: ENTITY\n",
      "Entity: chest\n",
      "pain, Label: ENTITY\n",
      "Entity: shortness of breath, Label: ENTITY\n",
      "Entity: back pain, Label: ENTITY\n",
      "Entity: worsening, Label: ENTITY\n",
      "Entity: symptoms, Label: ENTITY\n",
      "Entity: PCP, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: CBC, Label: ENTITY\n",
      "Entity: BP, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: hypotensive, Label: ENTITY\n",
      "Entity: ICU, Label: ENTITY\n",
      "Entity: pressor, Label: ENTITY\n",
      "Entity: dependent, Label: ENTITY\n",
      "Entity: baseline blood pressure, Label: ENTITY\n",
      "Entity: discharge, Label: ENTITY\n",
      "Entity: afebrile, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: urine culture, Label: ENTITY\n",
      "Entity: E. Coli, Label: ENTITY\n",
      "Entity: sensitivities, Label: ENTITY\n",
      "Entity: ICU, Label: ENTITY\n",
      "Entity: follow-up, Label: ENTITY\n",
      "Entity: sensitivies, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: CT, Label: ENTITY\n",
      "Entity: hypodensity, Label: ENTITY\n",
      "Entity: left upper pole, Label: ENTITY\n",
      "Entity: risk, Label: ENTITY\n",
      "Entity: abscess, Label: ENTITY\n",
      "Entity: Close interval, Label: ENTITY\n",
      "Entity: followup, Label: ENTITY\n",
      "Entity: Imaging, Label: ENTITY\n",
      "Entity: symptoms, Label: ENTITY\n",
      "Entity: worsen, Label: ENTITY\n",
      "Entity: recurrs, Label: ENTITY\n",
      "Entity: treatment, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: course, Label: ENTITY\n",
      "Entity: antibiotics, Label: ENTITY\n",
      "Entity: Followup, Label: ENTITY\n",
      "Entity: Instructions, Label: ENTITY\n",
      "Entity: PCP, Label: ENTITY\n",
      "Entity: NameIs, Label: ENTITY\n",
      "Entity: NameIs, Label: ENTITY\n",
      "Entity: Appointment, Label: ENTITY\n",
      "Entity: Completed by:[**2189, Label: ENTITY\n",
      "****************************************************************************************************\n",
      "Idx: 2 Entities Found: 447\n",
      "Entity: Admission, Label: ENTITY\n",
      "Entity: Date, Label: ENTITY\n",
      "Entity: Discharge Date, Label: ENTITY\n",
      "Entity: Medicine, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: female, Label: ENTITY\n",
      "Entity: history of diverticula, Label: ENTITY\n",
      "Entity: CREST, Label: ENTITY\n",
      "Entity: irritable bowel syndrome, Label: ENTITY\n",
      "Entity: Emergency Room, Label: ENTITY\n",
      "Entity: chief complaint, Label: ENTITY\n",
      "Entity: epigastric pain, Label: ENTITY\n",
      "Entity: lightheadedness, Label: ENTITY\n",
      "Entity: nausea, Label: ENTITY\n",
      "Entity: emesis, Label: ENTITY\n",
      "Entity: chest pain, Label: ENTITY\n",
      "Entity: shortness of breath, Label: ENTITY\n",
      "Entity: fevers, Label: ENTITY\n",
      "Entity: chills, Label: ENTITY\n",
      "Entity: night sweats, Label: ENTITY\n",
      "Entity: Emergency, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: hour, Label: ENTITY\n",
      "Entity: pulse, Label: ENTITY\n",
      "Entity: heme positive, Label: ENTITY\n",
      "Entity: stool, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: emergent, Label: ENTITY\n",
      "Entity: EGD, Label: ENTITY\n",
      "Entity: GI unit, Label: ENTITY\n",
      "Entity: No, Label: ENTITY\n",
      "Entity: nasogastric lavage, Label: ENTITY\n",
      "Entity: PAST MEDICAL HISTORY, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: Sjogren's, Label: ENTITY\n",
      "Entity: sicca, Label: ENTITY\n",
      "Entity: CREST, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: dysphagia, Label: ENTITY\n",
      "Entity: dyspepsia, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: primary gastroenterologist, Label: ENTITY\n",
      "Entity: Patient, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: hypertension, Label: ENTITY\n",
      "Entity: hypothyroidism, Label: ENTITY\n",
      "Entity: irritable bowel syndrome, Label: ENTITY\n",
      "Entity: chronic, Label: ENTITY\n",
      "Entity: Raynaud's, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: TAH, Label: ENTITY\n",
      "Entity: cholecystectomy, Label: ENTITY\n",
      "Entity: pericholecystectomy hernia repair, Label: ENTITY\n",
      "Entity: COPD, Label: ENTITY\n",
      "Entity: bronchiectasis, Label: ENTITY\n",
      "Entity: right bronchial sclerosis, Label: ENTITY\n",
      "Entity: Sjogren's, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: bladder, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: MRCP, Label: ENTITY\n",
      "Entity: liver cysts, Label: ENTITY\n",
      "Entity: colonoscopy, Label: ENTITY\n",
      "Entity: Crohn's, Label: ENTITY\n",
      "Entity: patient smoked, Label: ENTITY\n",
      "Entity: tobacco, Label: ENTITY\n",
      "Entity: drinks, Label: ENTITY\n",
      "Entity: no alcohol, Label: ENTITY\n",
      "Entity: FAMILY HISTORY, Label: ENTITY\n",
      "Entity: Crohn's disease, Label: ENTITY\n",
      "Entity: Penicillin, Label: ENTITY\n",
      "Entity: Bactrim, Label: ENTITY\n",
      "Entity: Sulfa, Label: ENTITY\n",
      "Entity: Norvasc, Label: ENTITY\n",
      "Entity: Atenolol, Label: ENTITY\n",
      "Entity: Levoxyl, Label: ENTITY\n",
      "Entity: Dyazide, Label: ENTITY\n",
      "Entity: Serax prn, Label: ENTITY\n",
      "Entity: NSAIDs, Label: ENTITY\n",
      "Entity: Premarin, Label: ENTITY\n",
      "Entity: Aspirin, Label: ENTITY\n",
      "Entity: Temperature 97, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: respiratory rate, Label: ENTITY\n",
      "Entity: liters, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: oriented times, Label: ENTITY\n",
      "Entity: conversant, Label: ENTITY\n",
      "Entity: awake, Label: ENTITY\n",
      "Entity: interactive, Label: ENTITY\n",
      "Entity: appropriate, Label: ENTITY\n",
      "Entity: acute, Label: ENTITY\n",
      "Entity: Conjunctiva, Label: ENTITY\n",
      "Entity: pale, Label: ENTITY\n",
      "Entity: dry mucus, Label: ENTITY\n",
      "Entity: membranes, Label: ENTITY\n",
      "Entity: normocephalic, Label: ENTITY\n",
      "Entity: atraumatic, Label: ENTITY\n",
      "Entity: extraocular, Label: ENTITY\n",
      "Entity: movements, Label: ENTITY\n",
      "Entity: intact, Label: ENTITY\n",
      "Entity: pupils, Label: ENTITY\n",
      "Entity: round, Label: ENTITY\n",
      "Entity: reactive, Label: ENTITY\n",
      "Entity: JVD, Label: ENTITY\n",
      "Entity: Neck, Label: ENTITY\n",
      "Entity: supple, Label: ENTITY\n",
      "Entity: TMs, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: lymphadenopathy, Label: ENTITY\n",
      "Entity: neck, Label: ENTITY\n",
      "Entity: faint bibasilar, Label: ENTITY\n",
      "Entity: lung exam, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: normal S1, Label: ENTITY\n",
      "Entity: S2, Label: ENTITY\n",
      "Entity: systolic, Label: ENTITY\n",
      "Entity: axilla, Label: ENTITY\n",
      "Entity: Abdomen, Label: ENTITY\n",
      "Entity: soft\n",
      ", Label: ENTITY\n",
      "Entity: non, Label: ENTITY\n",
      "Entity: distended with, Label: ENTITY\n",
      "Entity: normal bowel sounds, Label: ENTITY\n",
      "Entity: mildly tender, Label: ENTITY\n",
      "Entity: deep palpation, Label: ENTITY\n",
      "Entity: Extremities, Label: ENTITY\n",
      "Entity: clubbing, Label: ENTITY\n",
      "Entity: cyanosis, Label: ENTITY\n",
      "Entity: edema, Label: ENTITY\n",
      "Entity: Fingers, Label: ENTITY\n",
      "Entity: cool, Label: ENTITY\n",
      "Entity: toes, Label: ENTITY\n",
      "Entity: pulses, Label: ENTITY\n",
      "Entity: Cranial nerves II, Label: ENTITY\n",
      "Entity: XII, Label: ENTITY\n",
      "Entity: intact, Label: ENTITY\n",
      "Entity: Motor, Label: ENTITY\n",
      "Entity: symmetric, Label: ENTITY\n",
      "Entity: Deep\n",
      "tendon reflexes, Label: ENTITY\n",
      "Entity: globally, Label: ENTITY\n",
      "Entity: symmetric, Label: ENTITY\n",
      "Entity: White count, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: platelet\n",
      "count, Label: ENTITY\n",
      "Entity: MCV, Label: ENTITY\n",
      "Entity: Chem 7, Label: ENTITY\n",
      "Entity: sodium 140, Label: ENTITY\n",
      "Entity: potassium, Label: ENTITY\n",
      "Entity: CO2, Label: ENTITY\n",
      "Entity: BUN, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: creatinine, Label: ENTITY\n",
      "Entity: glucose 98, Label: ENTITY\n",
      "Entity: anion, Label: ENTITY\n",
      "Entity: ESR, Label: ENTITY\n",
      "Entity: ALT, Label: ENTITY\n",
      "Entity: AST, Label: ENTITY\n",
      "Entity: alkaline phosphatase 313, Label: ENTITY\n",
      "Entity: thyroid peroxidase antibody, Label: ENTITY\n",
      "Entity: endomesial antibodies, Label: ENTITY\n",
      "Entity: positive, Label: ENTITY\n",
      "Entity: Note, Label: ENTITY\n",
      "Entity: alkaline phosphatase, Label: ENTITY\n",
      "Entity: elevations, Label: ENTITY\n",
      "Entity: GGT, Label: ENTITY\n",
      "Entity: lipase, Label: ENTITY\n",
      "Entity: TSH, Label: ENTITY\n",
      "Entity: positive, Label: ENTITY\n",
      "Entity: Gastrin, Label: ENTITY\n",
      "Entity: EKG, Label: ENTITY\n",
      "Entity: left axis deviation, Label: ENTITY\n",
      "Entity: intervals, Label: ENTITY\n",
      "Entity: T wave inversion, Label: ENTITY\n",
      "Entity: AVL, Label: ENTITY\n",
      "Entity: left anterior, Label: ENTITY\n",
      "Entity: fascicular block, Label: ENTITY\n",
      "Entity: ST, Label: ENTITY\n",
      "Entity: deviation, Label: ENTITY\n",
      "Entity: [**2193, Label: ENTITY\n",
      "Entity: CT, Label: ENTITY\n",
      "Entity: abdominal pain, Label: ENTITY\n",
      "Entity: emphysema, Label: ENTITY\n",
      "Entity: hypoattenuation, Label: ENTITY\n",
      "Entity: liver, Label: ENTITY\n",
      "Entity: fibrotic, Label: ENTITY\n",
      "Entity: lung, Label: ENTITY\n",
      "Entity: changes, Label: ENTITY\n",
      "Entity: GI, Label: ENTITY\n",
      "Entity: Cardiovascular, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: epigastric pain, Label: ENTITY\n",
      "Entity: nausea, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: lightheadedness, Label: ENTITY\n",
      "Entity: black stools, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: BUN, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: admitted, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: peripheral, Label: ENTITY\n",
      "Entity: IVs, Label: ENTITY\n",
      "Entity: fluids, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: Protonix, Label: ENTITY\n",
      "Entity: IV, Label: ENTITY\n",
      "Entity: EGD, Label: ENTITY\n",
      "Entity: stomach, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: AVM, Label: ENTITY\n",
      "Entity: treated with, Label: ENTITY\n",
      "Entity: electrocautery, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: MI, Label: ENTITY\n",
      "Entity: inferolateral, Label: ENTITY\n",
      "Entity: EKG, Label: ENTITY\n",
      "Entity: changes, Label: ENTITY\n",
      "Entity: ST, Label: ENTITY\n",
      "Entity: depression, Label: ENTITY\n",
      "Entity: resolved, Label: ENTITY\n",
      "Entity: blood transfusion, Label: ENTITY\n",
      "Entity: hypotension, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: hypertension, Label: ENTITY\n",
      "Entity: evaluated, Label: ENTITY\n",
      "Entity: surgery, Label: ENTITY\n",
      "Entity: operation, Label: ENTITY\n",
      "Entity: bleed, Label: ENTITY\n",
      "Entity: risk, Label: ENTITY\n",
      "Entity: morbidity, Label: ENTITY\n",
      "Entity: partial gastrectomy, Label: ENTITY\n",
      "Entity: declined, Label: ENTITY\n",
      "Entity: operation, Label: ENTITY\n",
      "Entity: groin line, Label: ENTITY\n",
      "Entity: EGD, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: interventional, Label: ENTITY\n",
      "Entity: radiology, Label: ENTITY\n",
      "Entity: left gastric artery, Label: ENTITY\n",
      "Entity: embolized, Label: ENTITY\n",
      "Entity: IR options, Label: ENTITY\n",
      "Entity: procedure, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: hematocrits, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: Vascular access, Label: ENTITY\n",
      "Entity: floor [**7, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: PID, Label: ENTITY\n",
      "Entity: Groin line, Label: ENTITY\n",
      "Entity: fever, Label: ENTITY\n",
      "Entity: stool, Label: ENTITY\n",
      "Entity: contamination, Label: ENTITY\n",
      "Entity: triple lumen, Label: ENTITY\n",
      "Entity: removed, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: options, Label: ENTITY\n",
      "Entity: massive bleed, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: DNR, Label: ENTITY\n",
      "Entity: DNI, Label: ENTITY\n",
      "Entity: request, Label: ENTITY\n",
      "Entity: plans, Label: ENTITY\n",
      "Entity: comfort care, Label: ENTITY\n",
      "Entity: recurrent bleed, Label: ENTITY\n",
      "Entity: short-term, Label: ENTITY\n",
      "Entity: central line, Label: ENTITY\n",
      "Entity: acceptable, Label: ENTITY\n",
      "Entity: floor, Label: ENTITY\n",
      "Entity: issues, Label: ENTITY\n",
      "Entity: mild, Label: ENTITY\n",
      "Entity: sinus tachycardia, Label: ENTITY\n",
      "Entity: beta blocker, Label: ENTITY\n",
      "Entity: withdrawal, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: volume, Label: ENTITY\n",
      "Entity: repletion, Label: ENTITY\n",
      "Entity: EGD, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: lesion, Label: ENTITY\n",
      "Entity: blood, Label: ENTITY\n",
      "Entity: stomach, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: friability, Label: ENTITY\n",
      "Entity: findings, Label: ENTITY\n",
      "Entity: duodenum, Label: ENTITY\n",
      "Entity: Beta blocker, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: treat, Label: ENTITY\n",
      "Entity: hypertension, Label: ENTITY\n",
      "Entity: tachycardia, Label: ENTITY\n",
      "Entity: risk, Label: ENTITY\n",
      "Entity: rebleed, Label: ENTITY\n",
      "Entity: Diarrhea, Label: ENTITY\n",
      "Entity: C. diff, Label: ENTITY\n",
      "Entity: fecal, Label: ENTITY\n",
      "Entity: checked, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: melena, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: decreased, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: declined, Label: ENTITY\n",
      "Entity: apparent, Label: ENTITY\n",
      "Entity: rebleed, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: melena, Label: ENTITY\n",
      "Entity: EGD, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: Simethicone, Label: ENTITY\n",
      "Entity: gassy distension, Label: ENTITY\n",
      "Entity: ambulation, Label: ENTITY\n",
      "Entity: decrease, Label: ENTITY\n",
      "Entity: Fluids, Label: ENTITY\n",
      "Entity: Electrolytes & Nutrition, Label: ENTITY\n",
      "Entity: Lytes, Label: ENTITY\n",
      "Entity: potassium, Label: ENTITY\n",
      "Entity: phosphorus, Label: ENTITY\n",
      "Entity: repleted, Label: ENTITY\n",
      "Entity: Endocrine, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: hypothyroidism, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: TSH, Label: ENTITY\n",
      "Entity: TSH, Label: ENTITY\n",
      "Entity: Pulmonary, Label: ENTITY\n",
      "Entity: persistent tachycardia, Label: ENTITY\n",
      "Entity: BVL, Label: ENTITY\n",
      "Entity: PE, Label: ENTITY\n",
      "Entity: rose, Label: ENTITY\n",
      "Entity: chest x-ray, Label: ENTITY\n",
      "Entity: right upper lobe process, Label: ENTITY\n",
      "Entity: pneumonia, Label: ENTITY\n",
      "Entity: CT angio, Label: ENTITY\n",
      "Entity: PE, Label: ENTITY\n",
      "Entity: left upper lobe, Label: ENTITY\n",
      "Entity: left lower lobe consolidations, Label: ENTITY\n",
      "Entity: adjacent, Label: ENTITY\n",
      "Entity: effusion, Label: ENTITY\n",
      "Entity: treated, Label: ENTITY\n",
      "Entity: multifocal, Label: ENTITY\n",
      "Entity: aspiration, Label: ENTITY\n",
      "Entity: EGD, Label: ENTITY\n",
      "Entity: Levofloxacin, Label: ENTITY\n",
      "Entity: Flagyl, Label: ENTITY\n",
      "Entity: decrease, Label: ENTITY\n",
      "Entity: white blood count, Label: ENTITY\n",
      "Entity: Nebs, Label: ENTITY\n",
      "Entity: wheezing, Label: ENTITY\n",
      "Entity: COPD, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: aspiration, Label: ENTITY\n",
      "Entity: meds, Label: ENTITY\n",
      "Entity: crushed, Label: ENTITY\n",
      "Entity: administered, Label: ENTITY\n",
      "Entity: apple, Label: ENTITY\n",
      "Entity: sauce, Label: ENTITY\n",
      "Entity: soft moist solids, Label: ENTITY\n",
      "Entity: liquids, Label: ENTITY\n",
      "Entity: aspiration, Label: ENTITY\n",
      "Entity: risk, Label: ENTITY\n",
      "Entity: ID, Label: ENTITY\n",
      "Entity: pulmonary, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: positive, Label: ENTITY\n",
      "Entity: culture, Label: ENTITY\n",
      "Entity: proteus, Label: ENTITY\n",
      "Entity: pseudomonas, Label: ENTITY\n",
      "Entity: floor, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: complained, Label: ENTITY\n",
      "Entity: urinary discomfort, Label: ENTITY\n",
      "Entity: treated, Label: ENTITY\n",
      "Entity: UTI, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: physical therapy, Label: ENTITY\n",
      "Entity: assisted with, Label: ENTITY\n",
      "Entity: ambulation, Label: ENTITY\n",
      "Entity: Patient's CREST, Label: ENTITY\n",
      "Entity: Sjogren's, Label: ENTITY\n",
      "Entity: treated with, Label: ENTITY\n",
      "Entity: solutions, Label: ENTITY\n",
      "Entity: mouth, Label: ENTITY\n",
      "Entity: eyes, Label: ENTITY\n",
      "Entity: routine, Label: ENTITY\n",
      "Entity: Calcium channel, Label: ENTITY\n",
      "Entity: blocker, Label: ENTITY\n",
      "Entity: question esophageal spasm, Label: ENTITY\n",
      "Entity: risk, Label: ENTITY\n",
      "Entity: re-bleed, Label: ENTITY\n",
      "Entity: hypotension, Label: ENTITY\n",
      "Entity: Renal, Label: ENTITY\n",
      "Entity: Patient's, Label: ENTITY\n",
      "Entity: creatinine, Label: ENTITY\n",
      "Entity: clearance, Label: ENTITY\n",
      "Entity: estimated, Label: ENTITY\n",
      "Entity: minute, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: DISCHARGE MEDICATIONS, Label: ENTITY\n",
      "Entity: Protonix 40 mg [**Hospital1 **], Label: ENTITY\n",
      "Entity: Simethicone, Label: ENTITY\n",
      "Entity: qid, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: Serax 10 mg po prn, Label: ENTITY\n",
      "Entity: Trazodone, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: insomnia, Label: ENTITY\n",
      "Entity: Metoprolol, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: Colace 100 mg po, Label: ENTITY\n",
      "Entity: bid, Label: ENTITY\n",
      "Entity: Milk, Label: ENTITY\n",
      "Entity: Magnesia, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: Patient's, Label: ENTITY\n",
      "Entity: mouth, Label: ENTITY\n",
      "Entity: rinses, Label: ENTITY\n",
      "Entity: eyedrops, Label: ENTITY\n",
      "Entity: sicca syndrome, Label: ENTITY\n",
      "Entity: Levofloxacin, Label: ENTITY\n",
      "Entity: Flagyl, Label: ENTITY\n",
      "Entity: DISCHARGE CONDITION, Label: ENTITY\n",
      "Entity: Stable, Label: ENTITY\n",
      "Entity: FOLLOW-UP, Label: ENTITY\n",
      "Entity: Dr. [**Last Name (STitle) 1940**] of, Label: ENTITY\n",
      "Entity: gastroenterology, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: primary care physician, Label: ENTITY\n",
      "Entity: DISCHARGE DIAGNOSIS, Label: ENTITY\n",
      "Entity: HPI, Label: ENTITY\n",
      "Entity: GI bleed, Label: ENTITY\n",
      "Entity: secondary to, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: AVM, Label: ENTITY\n",
      "Entity: arteriovenous\n",
      "malformation, Label: ENTITY\n",
      "Entity: LF, Label: ENTITY\n",
      "Entity: Dictated, Label: ENTITY\n",
      "Entity: T, Label: ENTITY\n",
      "Entity: JOB, Label: ENTITY\n",
      "****************************************************************************************************\n",
      "Idx: 3 Entities Found: 518\n",
      "Entity: Admission, Label: ENTITY\n",
      "Entity: Date, Label: ENTITY\n",
      "Entity: year-old, Label: ENTITY\n",
      "Entity: female, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: CREST, Label: ENTITY\n",
      "Entity: diverticular disease, Label: ENTITY\n",
      "Entity: irritable, Label: ENTITY\n",
      "Entity: upper, Label: ENTITY\n",
      "Entity: GI bleed, Label: ENTITY\n",
      "Entity: AVM, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: UGIB, Label: ENTITY\n",
      "Entity: hospitalization, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: stay, Label: ENTITY\n",
      "Entity: fresh, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: esophagogastroduodenoscopy, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: cauterization, Label: ENTITY\n",
      "Entity: gastric AVM, Label: ENTITY\n",
      "Entity: angiography, Label: ENTITY\n",
      "Entity: embolization, Label: ENTITY\n",
      "Entity: left gastric artery, Label: ENTITY\n",
      "Entity: Emergency Room, Label: ENTITY\n",
      "Entity: chief, Label: ENTITY\n",
      "Entity: complaint, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: dark stools, Label: ENTITY\n",
      "Entity: left lower, Label: ENTITY\n",
      "Entity: abdominal, Label: ENTITY\n",
      "Entity: lightheadedness, Label: ENTITY\n",
      "Entity: fevers, Label: ENTITY\n",
      "Entity: chills, Label: ENTITY\n",
      "Entity: night sweats, Label: ENTITY\n",
      "Entity: No bright red, Label: ENTITY\n",
      "Entity: rectum, Label: ENTITY\n",
      "Entity: no hematemesis, Label: ENTITY\n",
      "Entity: Emergency Room, Label: ENTITY\n",
      "Entity: acute distress, Label: ENTITY\n",
      "Entity: temperature, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: pulse, Label: ENTITY\n",
      "Entity: respirations, Label: ENTITY\n",
      "Entity: room air, Label: ENTITY\n",
      "Entity: Nasogastric suction, Label: ENTITY\n",
      "Entity: coffee, Label: ENTITY\n",
      "Entity: grounds, Label: ENTITY\n",
      "Entity: lavage, Label: ENTITY\n",
      "Entity: coffee, Label: ENTITY\n",
      "Entity: grounds, Label: ENTITY\n",
      "Entity: bright red tinge, Label: ENTITY\n",
      "Entity: lavage, Label: ENTITY\n",
      "Entity: stopped, Label: ENTITY\n",
      "Entity: patient discomfort, Label: ENTITY\n",
      "Entity: Central line, Label: ENTITY\n",
      "Entity: femoral vein, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: saline, Label: ENTITY\n",
      "Entity: PAST MEDICAL HISTORY, Label: ENTITY\n",
      "Entity: Sjogren's, Label: ENTITY\n",
      "Entity: Sicca syndrome, Label: ENTITY\n",
      "Entity: CREST, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: dysphagia, Label: ENTITY\n",
      "Entity: dyspepsia, Label: ENTITY\n",
      "Entity: gastroenterologist Dr., Label: ENTITY\n",
      "Entity: Hypertension, Label: ENTITY\n",
      "Entity: Hypothyroidism, Label: ENTITY\n",
      "Entity: Irritable bowel syndrome, Label: ENTITY\n",
      "Entity: chronic diarrhea, Label: ENTITY\n",
      "Entity: constipation, Label: ENTITY\n",
      "Entity: abdominal pain, Label: ENTITY\n",
      "Entity: Diverticula, Label: ENTITY\n",
      "Entity: colonoscopy, Label: ENTITY\n",
      "Entity: Chronic, Label: ENTITY\n",
      "Entity: bronchiectasis, Label: ENTITY\n",
      "Entity: right, Label: ENTITY\n",
      "Entity: bronchial sclerosis, Label: ENTITY\n",
      "Entity: History, Label: ENTITY\n",
      "Entity: bladder stretching, Label: ENTITY\n",
      "Entity: PAST SURGICAL HISTORY, Label: ENTITY\n",
      "Entity: Cholecystectomy, Label: ENTITY\n",
      "Entity: Pericholecystectomy hernia repair, Label: ENTITY\n",
      "Entity: Hysterectomy, Label: ENTITY\n",
      "Entity: smoking, Label: ENTITY\n",
      "Entity: quit, Label: ENTITY\n",
      "Entity: years, Label: ENTITY\n",
      "Entity: no alcohol, Label: ENTITY\n",
      "Entity: FAMILY HISTORY, Label: ENTITY\n",
      "Entity: Crohn's disease, Label: ENTITY\n",
      "Entity: years, Label: ENTITY\n",
      "Entity: Penicillin, Label: ENTITY\n",
      "Entity: sulfa, Label: ENTITY\n",
      "Entity: ON ADMISSION, Label: ENTITY\n",
      "Entity: Atenolol, Label: ENTITY\n",
      "Entity: Aldactone, Label: ENTITY\n",
      "Entity: Lasix 20 mg, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: Prevacid, Label: ENTITY\n",
      "Entity: Evoxac, Label: ENTITY\n",
      "Entity: Serax 50 mg b.i.d, Label: ENTITY\n",
      "Entity: Multivitamin, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: General, Label: ENTITY\n",
      "Entity: elderly, Label: ENTITY\n",
      "Entity: woman, Label: ENTITY\n",
      "Entity: acute distress, Label: ENTITY\n",
      "Entity: Vital signs, Label: ENTITY\n",
      "Entity: temperature, Label: ENTITY\n",
      "Entity: Blood\n",
      "pressure, Label: ENTITY\n",
      "Entity: Pulse 86, Label: ENTITY\n",
      "Entity: Respiratory rate, Label: ENTITY\n",
      "Entity: Skin, Label: ENTITY\n",
      "Entity: telangiectasias, Label: ENTITY\n",
      "Entity: HEENT right ptosis, Label: ENTITY\n",
      "Entity: No scleral icterus, Label: ENTITY\n",
      "Entity: Pupils, Label: ENTITY\n",
      "Entity: round, Label: ENTITY\n",
      "Entity: reactive to light, Label: ENTITY\n",
      "Entity: Extraocular, Label: ENTITY\n",
      "Entity: movements, Label: ENTITY\n",
      "Entity: intact, Label: ENTITY\n",
      "Entity: Mucous membranes, Label: ENTITY\n",
      "Entity: dry, Label: ENTITY\n",
      "Entity: No lower dentition, Label: ENTITY\n",
      "Entity: Neck supple, Label: ENTITY\n",
      "Entity: lymphadenopathy, Label: ENTITY\n",
      "Entity: Jugular veins flat, Label: ENTITY\n",
      "Entity: Chest, Label: ENTITY\n",
      "Entity: auscultation, Label: ENTITY\n",
      "Entity: bilaterally, Label: ENTITY\n",
      "Entity: Cardiovascular regular rate, Label: ENTITY\n",
      "Entity: rhythm, Label: ENTITY\n",
      "Entity: S1, Label: ENTITY\n",
      "Entity: S2, Label: ENTITY\n",
      "Entity: systolic, Label: ENTITY\n",
      "Entity: right upper sternal border, Label: ENTITY\n",
      "Entity: No gallops, Label: ENTITY\n",
      "Entity: rubs, Label: ENTITY\n",
      "Entity: Abdomen, Label: ENTITY\n",
      "Entity: Scar, Label: ENTITY\n",
      "Entity: right abdomen, Label: ENTITY\n",
      "Entity: Positive bowel sounds, Label: ENTITY\n",
      "Entity: nondistended, Label: ENTITY\n",
      "Entity: No tenderness, Label: ENTITY\n",
      "Entity: palpation, Label: ENTITY\n",
      "Entity: hepatosplenomegaly, Label: ENTITY\n",
      "Entity: no clubbing, Label: ENTITY\n",
      "Entity: cyanosis, Label: ENTITY\n",
      "Entity: edema, Label: ENTITY\n",
      "Entity: Fingers, Label: ENTITY\n",
      "Entity: toes cool, Label: ENTITY\n",
      "Entity: touch, Label: ENTITY\n",
      "Entity: radial, Label: ENTITY\n",
      "Entity: dorsalis pedis pulses, Label: ENTITY\n",
      "Entity: Rectal guaiac positive, Label: ENTITY\n",
      "Entity: Emergency Department, Label: ENTITY\n",
      "Entity: Neurological alert, Label: ENTITY\n",
      "Entity: Pleasant, Label: ENTITY\n",
      "Entity: Cranial nerves II, Label: ENTITY\n",
      "Entity: XII, Label: ENTITY\n",
      "Entity: intact, Label: ENTITY\n",
      "Entity: No asterixics, Label: ENTITY\n",
      "Entity: STUDIES, Label: ENTITY\n",
      "Entity: White blood cell, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: MCV, Label: ENTITY\n",
      "Entity: MCH, Label: ENTITY\n",
      "Entity: MCHC, Label: ENTITY\n",
      "Entity: neutrophils, Label: ENTITY\n",
      "Entity: lymphocytes, Label: ENTITY\n",
      "Entity: monocytes, Label: ENTITY\n",
      "Entity: eosinophils, Label: ENTITY\n",
      "Entity: basophils, Label: ENTITY\n",
      "Entity: sodium, Label: ENTITY\n",
      "Entity: potassium, Label: ENTITY\n",
      "Entity: chloride 94, Label: ENTITY\n",
      "Entity: bicarbonate, Label: ENTITY\n",
      "Entity: BUN, Label: ENTITY\n",
      "Entity: creatinine, Label: ENTITY\n",
      "Entity: glucose, Label: ENTITY\n",
      "Entity: calcium, Label: ENTITY\n",
      "Entity: magnesium, Label: ENTITY\n",
      "Entity: PT, Label: ENTITY\n",
      "Entity: PTT, Label: ENTITY\n",
      "Entity: INR, Label: ENTITY\n",
      "Entity: Urinalysis, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: Electrocardiogram heart rate, Label: ENTITY\n",
      "Entity: beats, Label: ENTITY\n",
      "Entity: left axis deviation, Label: ENTITY\n",
      "Entity: No acute ischemic, Label: ENTITY\n",
      "Entity: changes, Label: ENTITY\n",
      "Entity: Gastrointestinal, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: upper gastrointestinal bleed, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: melena left lower quadrant pain, Label: ENTITY\n",
      "Entity: coffee, Label: ENTITY\n",
      "Entity: grounds, Label: ENTITY\n",
      "Entity: red tinge, Label: ENTITY\n",
      "Entity: nasogastric lavage, Label: ENTITY\n",
      "Entity: source, Label: ENTITY\n",
      "Entity: bleed, Label: ENTITY\n",
      "Entity: procedures, Label: ENTITY\n",
      "Entity: esophagogastroduodenoscopy, Label: ENTITY\n",
      "Entity: [**6, Label: ENTITY\n",
      "Entity: diffuse gastritis, Label: ENTITY\n",
      "Entity: normal duodenum, Label: ENTITY\n",
      "Entity: consistent with, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: year, Label: ENTITY\n",
      "Entity: enteroscopy, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: normal duodenum, Label: ENTITY\n",
      "Entity: jejunum, Label: ENTITY\n",
      "Entity: Colonoscopy, Label: ENTITY\n",
      "Entity: melena, Label: ENTITY\n",
      "Entity: multiple, Label: ENTITY\n",
      "Entity: nonbleeding diverticula, Label: ENTITY\n",
      "Entity: bleeding, Label: ENTITY\n",
      "Entity: tagged, Label: ENTITY\n",
      "Entity: red cell scan, Label: ENTITY\n",
      "Entity: source, Label: ENTITY\n",
      "Entity: gastrointestinal bleeding, Label: ENTITY\n",
      "Entity: H-pylori antibody test, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: supportive therapy, Label: ENTITY\n",
      "Entity: Protonix, Label: ENTITY\n",
      "Entity: Carafate, Label: ENTITY\n",
      "Entity: continuous, Label: ENTITY\n",
      "Entity: gastrointestinal, Label: ENTITY\n",
      "Entity: guaiac positive stools, Label: ENTITY\n",
      "Entity: melena, Label: ENTITY\n",
      "Entity: bloody stool, Label: ENTITY\n",
      "Entity: unstable, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: stay, Label: ENTITY\n",
      "Entity: evening, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: dramatic gastric bleed, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: drop, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: tachycardic, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: maintained, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: Nasogastric, Label: ENTITY\n",
      "Entity: bright red, Label: ENTITY\n",
      "Entity: clots, Label: ENTITY\n",
      "Entity: transferred, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: packed red, Label: ENTITY\n",
      "Entity: fresh, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: IR, Label: ENTITY\n",
      "Entity: next morning, Label: ENTITY\n",
      "Entity: left gastroduodenal, Label: ENTITY\n",
      "Entity: embolized, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: blood product, Label: ENTITY\n",
      "Entity: transfusions, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: evening, Label: ENTITY\n",
      "Entity: hospital, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: transferred, Label: ENTITY\n",
      "Entity: Medicine Floor, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: transfer, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: bloody diarrhea, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: reexpressed, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: laboratory tests, Label: ENTITY\n",
      "Entity: blood product, Label: ENTITY\n",
      "Entity: transfusions, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: stable tachycardia, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: gastrointestinal bleeding, Label: ENTITY\n",
      "Entity: slowed, Label: ENTITY\n",
      "Entity: stopped, Label: ENTITY\n",
      "Entity: discussion, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: family, Label: ENTITY\n",
      "Entity: hematocrit check, Label: ENTITY\n",
      "Entity: stopped, Label: ENTITY\n",
      "Entity: bleeding, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: red blood, Label: ENTITY\n",
      "Entity: transfused, Label: ENTITY\n",
      "Entity: increase, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: Hematology, Label: ENTITY\n",
      "Entity: presentation, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: packed red blood cells, Label: ENTITY\n",
      "Entity: hematologic workup, Label: ENTITY\n",
      "Entity: bleed, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: GIC, Label: ENTITY\n",
      "Entity: hemolysis, Label: ENTITY\n",
      "Entity: Prefixes, Label: ENTITY\n",
      "Entity: studies, Label: ENTITY\n",
      "Entity: epinephrine, Label: ENTITY\n",
      "Entity: arachidonic acid, Label: ENTITY\n",
      "Entity: platelet aggregation, Label: ENTITY\n",
      "Entity: abnormal, Label: ENTITY\n",
      "Entity: Desmopressin, Label: ENTITY\n",
      "Entity: intravenous times, Label: ENTITY\n",
      "Entity: doses, Label: ENTITY\n",
      "Entity: bag, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: stabilize, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: fresh frozen, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: multiple red, Label: ENTITY\n",
      "Entity: diluted, Label: ENTITY\n",
      "Entity: concentration, Label: ENTITY\n",
      "Entity: clotting, Label: ENTITY\n",
      "Entity: coagulopathy, Label: ENTITY\n",
      "Entity: PTT, Label: ENTITY\n",
      "Entity: value, Label: ENTITY\n",
      "Entity: Hematology/oncology, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: platelet, Label: ENTITY\n",
      "Entity: aggregation abnormalities, Label: ENTITY\n",
      "Entity: coagulopathy, Label: ENTITY\n",
      "Entity: Cardiovascular, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: antihypertensive, Label: ENTITY\n",
      "Entity: medications, Label: ENTITY\n",
      "Entity: Atenolol, Label: ENTITY\n",
      "Entity: Aldactone, Label: ENTITY\n",
      "Entity: Lasix, Label: ENTITY\n",
      "Entity: stop bleeding briskly, Label: ENTITY\n",
      "Entity: sympathetic system, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: vital signs, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: blood\n",
      "pressure, Label: ENTITY\n",
      "Entity: 140s/80s, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: hospital, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: sinus tachycardic 100, Label: ENTITY\n",
      "Entity: time, Label: ENTITY\n",
      "Entity: urinary tract, Label: ENTITY\n",
      "Entity: tachycardia, Label: ENTITY\n",
      "Entity: infection, Label: ENTITY\n",
      "Entity: dehydration, Label: ENTITY\n",
      "Entity: normal saline, Label: ENTITY\n",
      "Entity: intravenous, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: hospital course, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: elevated, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: symptomatic, Label: ENTITY\n",
      "Entity: palpitations, Label: ENTITY\n",
      "Entity: administration, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: saline intravenous, Label: ENTITY\n",
      "Entity: tachycardia, Label: ENTITY\n",
      "Entity: precipitous, Label: ENTITY\n",
      "Entity: hospital, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: cardiac enzymes, Label: ENTITY\n",
      "Entity: checked, Label: ENTITY\n",
      "Entity: mild, Label: ENTITY\n",
      "Entity: enzyme leak, Label: ENTITY\n",
      "Entity: CK, Label: ENTITY\n",
      "Entity: troponin, Label: ENTITY\n",
      "Entity: enzyme cycling, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: measures, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: systolic murmur, Label: ENTITY\n",
      "Entity: loudest, Label: ENTITY\n",
      "Entity: right upper sternal border, Label: ENTITY\n",
      "Entity: subclavian arteries, Label: ENTITY\n",
      "Entity: outpatient workup, Label: ENTITY\n",
      "Entity: Pulmonary, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: packed red blood cells, Label: ENTITY\n",
      "Entity: fresh frozen, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: dyspnea, Label: ENTITY\n",
      "Entity: bilateral, Label: ENTITY\n",
      "Entity: pleural, Label: ENTITY\n",
      "Entity: effusion, Label: ENTITY\n",
      "Entity: doses, Label: ENTITY\n",
      "Entity: Lasix 20 mg, Label: ENTITY\n",
      "Entity: intravenous, Label: ENTITY\n",
      "Entity: dyspnea, Label: ENTITY\n",
      "Entity: improved, Label: ENTITY\n",
      "Entity: Infectious disease, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: spiked, Label: ENTITY\n",
      "Entity: temperature, Label: ENTITY\n",
      "Entity: Urinalysis, Label: ENTITY\n",
      "Entity: white, Label: ENTITY\n",
      "Entity: blood cells, Label: ENTITY\n",
      "Entity: blood culture, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: treated, Label: ENTITY\n",
      "Entity: Levofloxacin, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: white blood cells, Label: ENTITY\n",
      "Entity: spiked, Label: ENTITY\n",
      "Entity: afebrile, Label: ENTITY\n",
      "Entity: infection, Label: ENTITY\n",
      "Entity: pneumonia, Label: ENTITY\n",
      "Entity: chest x-ray, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: urine culture, Label: ENTITY\n",
      "Entity: white\n",
      ", Label: ENTITY\n",
      "Entity: blood cells, Label: ENTITY\n",
      "Entity: medicine, Label: ENTITY\n",
      "Entity: floor, Label: ENTITY\n",
      "Entity: Access, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: maintain, Label: ENTITY\n",
      "Entity: Access, Label: ENTITY\n",
      "Entity: femoral central\n",
      "line, Label: ENTITY\n",
      "Entity: peripheral line, Label: ENTITY\n",
      "Entity: left IJ central line by, Label: ENTITY\n",
      "Entity: IR, Label: ENTITY\n",
      "Entity: FEN, Label: ENTITY\n",
      "Entity: Potassium, Label: ENTITY\n",
      "Entity: calcium, Label: ENTITY\n",
      "Entity: magnesium, Label: ENTITY\n",
      "Entity: phosphate, Label: ENTITY\n",
      "Entity: repleted, Label: ENTITY\n",
      "Entity: Endocrine, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: hypothyroidism, Label: ENTITY\n",
      "Entity: CREST/Sjogren's, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: Evoxac, Label: ENTITY\n",
      "Entity: home, Label: ENTITY\n",
      "Entity: hospitalization, Label: ENTITY\n",
      "Entity: cholinergic, Label: ENTITY\n",
      "Entity: agonist, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: gastric, Label: ENTITY\n",
      "Entity: CVA, Label: ENTITY\n",
      "Entity: response, Label: ENTITY\n",
      "Entity: hypotension, Label: ENTITY\n",
      "Entity: DISCHARGE CONDITION, Label: ENTITY\n",
      "Entity: Stable, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: rehab, Label: ENTITY\n",
      "Entity: instructions, Label: ENTITY\n",
      "Entity: cared, Label: ENTITY\n",
      "Entity: recurrent, Label: ENTITY\n",
      "Entity: gastrointestinal bleed, Label: ENTITY\n",
      "Entity: DISCHARGE MEDICATIONS, Label: ENTITY\n",
      "Entity: Protonix 40 mg b.i.d, Label: ENTITY\n",
      "Entity: Atenolol 20 mg, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: systolic blood pressure, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: Ativan 0.5 mg po b.i.d, Label: ENTITY\n",
      "Entity: Darvocet, Label: ENTITY\n",
      "Entity: tab, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: MSIR, Label: ENTITY\n",
      "Entity: oral solution, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: Colace 100 mg, Label: ENTITY\n",
      "Entity: diarrhea, Label: ENTITY\n",
      "Entity: Imodium 2, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: Zolpidem, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: Multivitamin, Label: ENTITY\n",
      "Entity: UP, Label: ENTITY\n",
      "Entity: Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1940**], Label: ENTITY\n",
      "Entity: gastroenterology, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: primary care physician, Label: ENTITY\n",
      "Entity: DISCHARGE DIAGNOSIS, Label: ENTITY\n",
      "Entity: Upper gastrointestinal bleed, Label: ENTITY\n",
      "Entity: secondary to, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: Pattern1, Label: ENTITY\n",
      "Entity: M.D.  [**MD Number(1) 4518**]\n",
      "\n",
      ", Label: ENTITY\n",
      "Entity: Dictated By:[**Doctor Last Name 4519**], Label: ENTITY\n",
      "Entity: JOB, Label: ENTITY\n",
      "****************************************************************************************************\n",
      "Idx: 4 Entities Found: 524\n",
      "Entity: Admission, Label: ENTITY\n",
      "Entity: Date, Label: ENTITY\n",
      "Entity: year-old, Label: ENTITY\n",
      "Entity: female, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: CREST, Label: ENTITY\n",
      "Entity: diverticular disease, Label: ENTITY\n",
      "Entity: irritable, Label: ENTITY\n",
      "Entity: upper, Label: ENTITY\n",
      "Entity: GI bleed, Label: ENTITY\n",
      "Entity: AVM, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: UGIB, Label: ENTITY\n",
      "Entity: hospitalization, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: packed red blood cells, Label: ENTITY\n",
      "Entity: transfusion, Label: ENTITY\n",
      "Entity: stay, Label: ENTITY\n",
      "Entity: fresh, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: esophagogastroduodenoscopy, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: cauterization, Label: ENTITY\n",
      "Entity: gastric AVM, Label: ENTITY\n",
      "Entity: angiography, Label: ENTITY\n",
      "Entity: embolization, Label: ENTITY\n",
      "Entity: left gastric artery, Label: ENTITY\n",
      "Entity: Emergency Room, Label: ENTITY\n",
      "Entity: chief, Label: ENTITY\n",
      "Entity: complaint, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: dark stools, Label: ENTITY\n",
      "Entity: left lower, Label: ENTITY\n",
      "Entity: abdominal, Label: ENTITY\n",
      "Entity: weakness, Label: ENTITY\n",
      "Entity: chest pain, Label: ENTITY\n",
      "Entity: shortness, Label: ENTITY\n",
      "Entity: lightheadedness, Label: ENTITY\n",
      "Entity: fevers, Label: ENTITY\n",
      "Entity: chills, Label: ENTITY\n",
      "Entity: night sweats, Label: ENTITY\n",
      "Entity: No bright red, Label: ENTITY\n",
      "Entity: rectum, Label: ENTITY\n",
      "Entity: no hematemesis, Label: ENTITY\n",
      "Entity: Emergency Room, Label: ENTITY\n",
      "Entity: acute distress, Label: ENTITY\n",
      "Entity: temperature, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: pulse, Label: ENTITY\n",
      "Entity: respirations, Label: ENTITY\n",
      "Entity: room air, Label: ENTITY\n",
      "Entity: Nasogastric suction, Label: ENTITY\n",
      "Entity: coffee, Label: ENTITY\n",
      "Entity: grounds, Label: ENTITY\n",
      "Entity: lavage, Label: ENTITY\n",
      "Entity: coffee, Label: ENTITY\n",
      "Entity: grounds, Label: ENTITY\n",
      "Entity: bright red tinge, Label: ENTITY\n",
      "Entity: lavage, Label: ENTITY\n",
      "Entity: stopped, Label: ENTITY\n",
      "Entity: patient discomfort, Label: ENTITY\n",
      "Entity: Central line, Label: ENTITY\n",
      "Entity: femoral vein, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: saline, Label: ENTITY\n",
      "Entity: PAST MEDICAL HISTORY, Label: ENTITY\n",
      "Entity: Sjogren's, Label: ENTITY\n",
      "Entity: Sicca syndrome, Label: ENTITY\n",
      "Entity: CREST, Label: ENTITY\n",
      "Entity: history, Label: ENTITY\n",
      "Entity: dysphagia, Label: ENTITY\n",
      "Entity: dyspepsia, Label: ENTITY\n",
      "Entity: gastroenterologist Dr., Label: ENTITY\n",
      "Entity: Hypertension, Label: ENTITY\n",
      "Entity: Hypothyroidism, Label: ENTITY\n",
      "Entity: Irritable bowel syndrome, Label: ENTITY\n",
      "Entity: chronic diarrhea, Label: ENTITY\n",
      "Entity: constipation, Label: ENTITY\n",
      "Entity: abdominal pain, Label: ENTITY\n",
      "Entity: Diverticula, Label: ENTITY\n",
      "Entity: colonoscopy, Label: ENTITY\n",
      "Entity: Chronic, Label: ENTITY\n",
      "Entity: bronchiectasis, Label: ENTITY\n",
      "Entity: right, Label: ENTITY\n",
      "Entity: bronchial sclerosis, Label: ENTITY\n",
      "Entity: History, Label: ENTITY\n",
      "Entity: bladder stretching, Label: ENTITY\n",
      "Entity: PAST SURGICAL HISTORY, Label: ENTITY\n",
      "Entity: Cholecystectomy, Label: ENTITY\n",
      "Entity: Pericholecystectomy hernia repair, Label: ENTITY\n",
      "Entity: Hysterectomy, Label: ENTITY\n",
      "Entity: smoking, Label: ENTITY\n",
      "Entity: quit, Label: ENTITY\n",
      "Entity: years, Label: ENTITY\n",
      "Entity: no alcohol, Label: ENTITY\n",
      "Entity: FAMILY HISTORY, Label: ENTITY\n",
      "Entity: Crohn's disease, Label: ENTITY\n",
      "Entity: years, Label: ENTITY\n",
      "Entity: Penicillin, Label: ENTITY\n",
      "Entity: sulfa, Label: ENTITY\n",
      "Entity: ON ADMISSION, Label: ENTITY\n",
      "Entity: Atenolol, Label: ENTITY\n",
      "Entity: Aldactone, Label: ENTITY\n",
      "Entity: Lasix 20 mg, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: Prevacid, Label: ENTITY\n",
      "Entity: Evoxac, Label: ENTITY\n",
      "Entity: Serax 50 mg b.i.d, Label: ENTITY\n",
      "Entity: Multivitamin, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: General, Label: ENTITY\n",
      "Entity: elderly, Label: ENTITY\n",
      "Entity: woman, Label: ENTITY\n",
      "Entity: acute distress, Label: ENTITY\n",
      "Entity: Vital signs, Label: ENTITY\n",
      "Entity: temperature, Label: ENTITY\n",
      "Entity: Blood\n",
      "pressure, Label: ENTITY\n",
      "Entity: Pulse 86, Label: ENTITY\n",
      "Entity: Respiratory rate, Label: ENTITY\n",
      "Entity: Skin, Label: ENTITY\n",
      "Entity: telangiectasias, Label: ENTITY\n",
      "Entity: HEENT right ptosis, Label: ENTITY\n",
      "Entity: No scleral icterus, Label: ENTITY\n",
      "Entity: Pupils, Label: ENTITY\n",
      "Entity: round, Label: ENTITY\n",
      "Entity: reactive to light, Label: ENTITY\n",
      "Entity: Extraocular, Label: ENTITY\n",
      "Entity: movements, Label: ENTITY\n",
      "Entity: intact, Label: ENTITY\n",
      "Entity: Mucous membranes, Label: ENTITY\n",
      "Entity: dry, Label: ENTITY\n",
      "Entity: No lower dentition, Label: ENTITY\n",
      "Entity: Neck supple, Label: ENTITY\n",
      "Entity: lymphadenopathy, Label: ENTITY\n",
      "Entity: Jugular veins flat, Label: ENTITY\n",
      "Entity: Chest, Label: ENTITY\n",
      "Entity: auscultation, Label: ENTITY\n",
      "Entity: bilaterally, Label: ENTITY\n",
      "Entity: Cardiovascular regular rate, Label: ENTITY\n",
      "Entity: rhythm, Label: ENTITY\n",
      "Entity: S1, Label: ENTITY\n",
      "Entity: S2, Label: ENTITY\n",
      "Entity: systolic, Label: ENTITY\n",
      "Entity: right upper sternal border, Label: ENTITY\n",
      "Entity: No gallops, Label: ENTITY\n",
      "Entity: rubs, Label: ENTITY\n",
      "Entity: Abdomen, Label: ENTITY\n",
      "Entity: Scar, Label: ENTITY\n",
      "Entity: right abdomen, Label: ENTITY\n",
      "Entity: Positive bowel sounds, Label: ENTITY\n",
      "Entity: nondistended, Label: ENTITY\n",
      "Entity: No tenderness, Label: ENTITY\n",
      "Entity: palpation, Label: ENTITY\n",
      "Entity: hepatosplenomegaly, Label: ENTITY\n",
      "Entity: no clubbing, Label: ENTITY\n",
      "Entity: cyanosis, Label: ENTITY\n",
      "Entity: edema, Label: ENTITY\n",
      "Entity: Fingers, Label: ENTITY\n",
      "Entity: toes cool, Label: ENTITY\n",
      "Entity: touch, Label: ENTITY\n",
      "Entity: radial, Label: ENTITY\n",
      "Entity: dorsalis pedis pulses, Label: ENTITY\n",
      "Entity: Rectal guaiac positive, Label: ENTITY\n",
      "Entity: Emergency Department, Label: ENTITY\n",
      "Entity: Neurological alert, Label: ENTITY\n",
      "Entity: Pleasant, Label: ENTITY\n",
      "Entity: Cranial nerves II, Label: ENTITY\n",
      "Entity: XII, Label: ENTITY\n",
      "Entity: intact, Label: ENTITY\n",
      "Entity: No asterixics, Label: ENTITY\n",
      "Entity: STUDIES, Label: ENTITY\n",
      "Entity: White blood cell, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: MCV, Label: ENTITY\n",
      "Entity: MCH, Label: ENTITY\n",
      "Entity: MCHC, Label: ENTITY\n",
      "Entity: neutrophils, Label: ENTITY\n",
      "Entity: lymphocytes, Label: ENTITY\n",
      "Entity: monocytes, Label: ENTITY\n",
      "Entity: eosinophils, Label: ENTITY\n",
      "Entity: basophils, Label: ENTITY\n",
      "Entity: sodium, Label: ENTITY\n",
      "Entity: potassium, Label: ENTITY\n",
      "Entity: chloride 94, Label: ENTITY\n",
      "Entity: bicarbonate, Label: ENTITY\n",
      "Entity: BUN, Label: ENTITY\n",
      "Entity: creatinine, Label: ENTITY\n",
      "Entity: glucose, Label: ENTITY\n",
      "Entity: calcium, Label: ENTITY\n",
      "Entity: magnesium, Label: ENTITY\n",
      "Entity: PT, Label: ENTITY\n",
      "Entity: PTT, Label: ENTITY\n",
      "Entity: INR, Label: ENTITY\n",
      "Entity: Urinalysis, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: Electrocardiogram heart rate, Label: ENTITY\n",
      "Entity: beats, Label: ENTITY\n",
      "Entity: left axis deviation, Label: ENTITY\n",
      "Entity: No acute ischemic, Label: ENTITY\n",
      "Entity: changes, Label: ENTITY\n",
      "Entity: Gastrointestinal, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: upper gastrointestinal bleed, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: melena left lower quadrant pain, Label: ENTITY\n",
      "Entity: coffee, Label: ENTITY\n",
      "Entity: grounds, Label: ENTITY\n",
      "Entity: red tinge, Label: ENTITY\n",
      "Entity: nasogastric lavage, Label: ENTITY\n",
      "Entity: source, Label: ENTITY\n",
      "Entity: bleed, Label: ENTITY\n",
      "Entity: procedures, Label: ENTITY\n",
      "Entity: esophagogastroduodenoscopy, Label: ENTITY\n",
      "Entity: [**6, Label: ENTITY\n",
      "Entity: diffuse gastritis, Label: ENTITY\n",
      "Entity: normal duodenum, Label: ENTITY\n",
      "Entity: consistent with, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: year, Label: ENTITY\n",
      "Entity: enteroscopy, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: normal duodenum, Label: ENTITY\n",
      "Entity: jejunum, Label: ENTITY\n",
      "Entity: Colonoscopy, Label: ENTITY\n",
      "Entity: melena, Label: ENTITY\n",
      "Entity: multiple, Label: ENTITY\n",
      "Entity: nonbleeding diverticula, Label: ENTITY\n",
      "Entity: bleeding, Label: ENTITY\n",
      "Entity: tagged, Label: ENTITY\n",
      "Entity: red cell scan, Label: ENTITY\n",
      "Entity: source, Label: ENTITY\n",
      "Entity: gastrointestinal bleeding, Label: ENTITY\n",
      "Entity: H-pylori antibody test, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: supportive therapy, Label: ENTITY\n",
      "Entity: Protonix, Label: ENTITY\n",
      "Entity: Carafate, Label: ENTITY\n",
      "Entity: continuous, Label: ENTITY\n",
      "Entity: gastrointestinal, Label: ENTITY\n",
      "Entity: guaiac positive stools, Label: ENTITY\n",
      "Entity: melena, Label: ENTITY\n",
      "Entity: bloody stool, Label: ENTITY\n",
      "Entity: unstable, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: stay, Label: ENTITY\n",
      "Entity: evening, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: dramatic gastric bleed, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: drop, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: tachycardic, Label: ENTITY\n",
      "Entity: baseline, Label: ENTITY\n",
      "Entity: maintained, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: Nasogastric, Label: ENTITY\n",
      "Entity: bright red, Label: ENTITY\n",
      "Entity: clots, Label: ENTITY\n",
      "Entity: transferred, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: packed red, Label: ENTITY\n",
      "Entity: fresh, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: IR, Label: ENTITY\n",
      "Entity: next morning, Label: ENTITY\n",
      "Entity: left gastroduodenal, Label: ENTITY\n",
      "Entity: embolized, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: blood product, Label: ENTITY\n",
      "Entity: transfusions, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: evening, Label: ENTITY\n",
      "Entity: hospital, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: transferred, Label: ENTITY\n",
      "Entity: Medicine Floor, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: transfer, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: bloody diarrhea, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: reexpressed, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: laboratory tests, Label: ENTITY\n",
      "Entity: blood product, Label: ENTITY\n",
      "Entity: transfusions, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: stable tachycardia, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: gastrointestinal bleeding, Label: ENTITY\n",
      "Entity: slowed, Label: ENTITY\n",
      "Entity: stopped, Label: ENTITY\n",
      "Entity: discussion, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: family, Label: ENTITY\n",
      "Entity: hematocrit check, Label: ENTITY\n",
      "Entity: stopped, Label: ENTITY\n",
      "Entity: bleeding, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: red blood, Label: ENTITY\n",
      "Entity: transfused, Label: ENTITY\n",
      "Entity: increase, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: Hematology, Label: ENTITY\n",
      "Entity: presentation, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: admission, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: packed red blood cells, Label: ENTITY\n",
      "Entity: hematologic workup, Label: ENTITY\n",
      "Entity: bleed, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: GIC, Label: ENTITY\n",
      "Entity: hemolysis, Label: ENTITY\n",
      "Entity: Prefixes, Label: ENTITY\n",
      "Entity: studies, Label: ENTITY\n",
      "Entity: epinephrine, Label: ENTITY\n",
      "Entity: arachidonic acid, Label: ENTITY\n",
      "Entity: platelet aggregation, Label: ENTITY\n",
      "Entity: abnormal, Label: ENTITY\n",
      "Entity: Desmopressin, Label: ENTITY\n",
      "Entity: intravenous times, Label: ENTITY\n",
      "Entity: doses, Label: ENTITY\n",
      "Entity: bag, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: stabilize, Label: ENTITY\n",
      "Entity: hematocrit, Label: ENTITY\n",
      "Entity: units, Label: ENTITY\n",
      "Entity: fresh frozen, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: multiple red, Label: ENTITY\n",
      "Entity: diluted, Label: ENTITY\n",
      "Entity: concentration, Label: ENTITY\n",
      "Entity: clotting, Label: ENTITY\n",
      "Entity: coagulopathy, Label: ENTITY\n",
      "Entity: PTT, Label: ENTITY\n",
      "Entity: value, Label: ENTITY\n",
      "Entity: Hematology/oncology, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: platelet, Label: ENTITY\n",
      "Entity: aggregation abnormalities, Label: ENTITY\n",
      "Entity: coagulopathy, Label: ENTITY\n",
      "Entity: Cardiovascular, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: antihypertensive, Label: ENTITY\n",
      "Entity: medications, Label: ENTITY\n",
      "Entity: Atenolol, Label: ENTITY\n",
      "Entity: Aldactone, Label: ENTITY\n",
      "Entity: Lasix, Label: ENTITY\n",
      "Entity: stop bleeding briskly, Label: ENTITY\n",
      "Entity: sympathetic system, Label: ENTITY\n",
      "Entity: blood pressure, Label: ENTITY\n",
      "Entity: vital signs, Label: ENTITY\n",
      "Entity: stable, Label: ENTITY\n",
      "Entity: blood\n",
      "pressure, Label: ENTITY\n",
      "Entity: 140s/80s, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: hospital, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: sinus tachycardic 100, Label: ENTITY\n",
      "Entity: time, Label: ENTITY\n",
      "Entity: urinary tract, Label: ENTITY\n",
      "Entity: tachycardia, Label: ENTITY\n",
      "Entity: infection, Label: ENTITY\n",
      "Entity: dehydration, Label: ENTITY\n",
      "Entity: normal saline, Label: ENTITY\n",
      "Entity: intravenous, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: hospital course, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: elevated, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: symptomatic, Label: ENTITY\n",
      "Entity: palpitations, Label: ENTITY\n",
      "Entity: administration, Label: ENTITY\n",
      "Entity: normal, Label: ENTITY\n",
      "Entity: saline intravenous, Label: ENTITY\n",
      "Entity: tachycardia, Label: ENTITY\n",
      "Entity: precipitous, Label: ENTITY\n",
      "Entity: hospital, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: cardiac enzymes, Label: ENTITY\n",
      "Entity: checked, Label: ENTITY\n",
      "Entity: mild, Label: ENTITY\n",
      "Entity: enzyme leak, Label: ENTITY\n",
      "Entity: CK, Label: ENTITY\n",
      "Entity: troponin, Label: ENTITY\n",
      "Entity: enzyme cycling, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: CMO, Label: ENTITY\n",
      "Entity: measures, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: systolic murmur, Label: ENTITY\n",
      "Entity: loudest, Label: ENTITY\n",
      "Entity: right upper sternal border, Label: ENTITY\n",
      "Entity: subclavian arteries, Label: ENTITY\n",
      "Entity: outpatient workup, Label: ENTITY\n",
      "Entity: Pulmonary, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: packed red blood cells, Label: ENTITY\n",
      "Entity: fresh frozen, Label: ENTITY\n",
      "Entity: platelets, Label: ENTITY\n",
      "Entity: dyspnea, Label: ENTITY\n",
      "Entity: bilateral, Label: ENTITY\n",
      "Entity: pleural, Label: ENTITY\n",
      "Entity: effusion, Label: ENTITY\n",
      "Entity: doses, Label: ENTITY\n",
      "Entity: Lasix 20 mg, Label: ENTITY\n",
      "Entity: intravenous, Label: ENTITY\n",
      "Entity: dyspnea, Label: ENTITY\n",
      "Entity: improved, Label: ENTITY\n",
      "Entity: Infectious disease, Label: ENTITY\n",
      "Entity: hospital day, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: spiked, Label: ENTITY\n",
      "Entity: temperature, Label: ENTITY\n",
      "Entity: Urinalysis, Label: ENTITY\n",
      "Entity: white, Label: ENTITY\n",
      "Entity: blood cells, Label: ENTITY\n",
      "Entity: blood culture, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: treated, Label: ENTITY\n",
      "Entity: Levofloxacin, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: days, Label: ENTITY\n",
      "Entity: MICU, Label: ENTITY\n",
      "Entity: white blood cells, Label: ENTITY\n",
      "Entity: spiked, Label: ENTITY\n",
      "Entity: afebrile, Label: ENTITY\n",
      "Entity: infection, Label: ENTITY\n",
      "Entity: pneumonia, Label: ENTITY\n",
      "Entity: chest x-ray, Label: ENTITY\n",
      "Entity: negative, Label: ENTITY\n",
      "Entity: urine culture, Label: ENTITY\n",
      "Entity: white\n",
      ", Label: ENTITY\n",
      "Entity: blood cells, Label: ENTITY\n",
      "Entity: medicine, Label: ENTITY\n",
      "Entity: floor, Label: ENTITY\n",
      "Entity: Access, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: maintain, Label: ENTITY\n",
      "Entity: Access, Label: ENTITY\n",
      "Entity: femoral central\n",
      "line, Label: ENTITY\n",
      "Entity: peripheral line, Label: ENTITY\n",
      "Entity: left IJ central line by, Label: ENTITY\n",
      "Entity: IR, Label: ENTITY\n",
      "Entity: FEN, Label: ENTITY\n",
      "Entity: Potassium, Label: ENTITY\n",
      "Entity: calcium, Label: ENTITY\n",
      "Entity: magnesium, Label: ENTITY\n",
      "Entity: phosphate, Label: ENTITY\n",
      "Entity: repleted, Label: ENTITY\n",
      "Entity: Endocrine, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: hypothyroidism, Label: ENTITY\n",
      "Entity: CREST/Sjogren's, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: Evoxac, Label: ENTITY\n",
      "Entity: home, Label: ENTITY\n",
      "Entity: hospitalization, Label: ENTITY\n",
      "Entity: cholinergic, Label: ENTITY\n",
      "Entity: agonist, Label: ENTITY\n",
      "Entity: increased, Label: ENTITY\n",
      "Entity: gastric, Label: ENTITY\n",
      "Entity: CVA, Label: ENTITY\n",
      "Entity: response, Label: ENTITY\n",
      "Entity: hypotension, Label: ENTITY\n",
      "Entity: DISCHARGE CONDITION, Label: ENTITY\n",
      "Entity: Stable, Label: ENTITY\n",
      "Entity: patient, Label: ENTITY\n",
      "Entity: rehab, Label: ENTITY\n",
      "Entity: instructions, Label: ENTITY\n",
      "Entity: cared, Label: ENTITY\n",
      "Entity: recurrent, Label: ENTITY\n",
      "Entity: gastrointestinal bleed, Label: ENTITY\n",
      "Entity: DISCHARGE MEDICATIONS, Label: ENTITY\n",
      "Entity: Protonix 40 mg b.i.d, Label: ENTITY\n",
      "Entity: Atenolol 20 mg, Label: ENTITY\n",
      "Entity: day, Label: ENTITY\n",
      "Entity: systolic blood pressure, Label: ENTITY\n",
      "Entity: heart rate, Label: ENTITY\n",
      "Entity: Synthroid, Label: ENTITY\n",
      "Entity: Ativan 0.5 mg po b.i.d, Label: ENTITY\n",
      "Entity: Darvocet, Label: ENTITY\n",
      "Entity: tab, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: MSIR, Label: ENTITY\n",
      "Entity: oral solution, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: Colace 100 mg, Label: ENTITY\n",
      "Entity: diarrhea, Label: ENTITY\n",
      "Entity: Imodium 2, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: hours, Label: ENTITY\n",
      "Entity: Zolpidem, Label: ENTITY\n",
      "Entity: prn, Label: ENTITY\n",
      "Entity: Multivitamin, Label: ENTITY\n",
      "Entity: UP, Label: ENTITY\n",
      "Entity: Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1940**], Label: ENTITY\n",
      "Entity: gastroenterology, Label: ENTITY\n",
      "Entity: patient's, Label: ENTITY\n",
      "Entity: primary care physician, Label: ENTITY\n",
      "Entity: DISCHARGE DIAGNOSIS, Label: ENTITY\n",
      "Entity: Upper gastrointestinal bleed, Label: ENTITY\n",
      "Entity: secondary to, Label: ENTITY\n",
      "Entity: gastritis, Label: ENTITY\n",
      "Entity: Pattern1, Label: ENTITY\n",
      "Entity: M.D.  [**MD Number(1) 4521**]\n",
      "\n",
      ", Label: ENTITY\n",
      "Entity: Dictated By:[**Doctor Last Name 4519**], Label: ENTITY\n",
      "Entity: JOB, Label: ENTITY\n",
      "****************************************************************************************************\n"
     ]
    }
   ],
   "source": [
    "import scispacy\n",
    "import pandas as pd\n",
    "import en_core_sci_lg\n",
    "\n",
    "df = pd.read_csv(\"liver_notes.csv\")[:5] # only use the 5 for performance\n",
    "nlp = en_core_sci_lg.load()\n",
    "\n",
    "# Function to extract named entities using SciSpaCy\n",
    "def extract_entities(text):\n",
    "    doc = nlp(text)\n",
    "    return [(ent.text, ent.label_) for ent in doc.ents], doc\n",
    "\n",
    "# Process and extract entities\n",
    "for idx, row in df.iterrows():\n",
    "    text = row['TEXT']\n",
    "    entities, doc = extract_entities(text)  # Now correctly returning two values\n",
    "    \n",
    "    if entities:  # Only display if there are entities\n",
    "        print(f\"Idx: {idx} Entities Found: {len(entities)}\")\n",
    "        for entity, label in entities:\n",
    "            print(f\"Entity: {entity}, Label: {label}\")\n",
    "        print('*' * 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Process and extract entities\n",
    "for idx, row in df.iterrows():\n",
    "    text = row['TEXT']\n",
    "    entities, doc = extract_entities(text)  # Now correctly returning two values\n",
    "    \n",
    "    if entities:  # Only display if there are entities\n",
    "        displacy.render(doc, style=\"ent\", jupyter=True)\n",
    "        print('*' * 100)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Scispacy with en_ner_bc5cdr_md model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/jesusminjares/Desktop/UT Austin MSAI/Courses/ AI395T AI in Healthcare/ai_healthcare/lib/python3.12/site-packages/spacy/util.py:910: UserWarning: [W095] Model 'en_ner_bc5cdr_md' (0.5.4) was trained with spaCy v3.7.4 and may not be 100% compatible with the current version (3.8.4). If you see errors or degraded performance, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n",
      "  warnings.warn(warn_msg)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Admission Date:  [**2137-3-7**]              Discharge Date:   [**2137-3-16**]<br><br>Date of Birth:  [**2060-10-8**]             Sex:   M<br><br>Service: MEDICINE<br><br>Allergies:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lisinopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br><br>Attending:[**First Name3 (LF) 348**]<br>Chief Complaint:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Acute renal failure\n",
       "\n",
       "\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "Major Surgical or Invasive Procedure:<br>None<br><br>History of Present Illness:<br> 76 yo male w/PMHx sx for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " [**1-31**]<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NASH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " vs. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PSC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with resultant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and Grade II esophageal<br>varices, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DM2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PSC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " who presents with acute worsening of<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Patient has \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with baseline<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " of 1.8, now elevated to 4.8 with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 5.8. His<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CKD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is thought [**1-31**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HTN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DM2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". He recently received therapeutic<br>paracentesis with removal of 3.5L of fluid, negative for SBP. He<br>states that he has noticed increasing abdominal distension and<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " over the past several weeks. He has not noticed<br>increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pruritus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    confusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", delta MS.<br>.<br>He has taken recent antibiotics, and states that his po intake<br>has been poor due to lack of appetite. He says that his urine<br>output has been about the same as prior. Denies use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NSAIDS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " at<br>home. He has not been able to walk long distances because of his<br>LE \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    swelling\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Denies CP/SOB/DOE/F/C/N/V/BRBPR/melena.<br><br><br>Past Medical History:<br>1) Right \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Popliteal DVT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  (s/p IVC filter)<br>2) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DM type 2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; Uncontrolled with Complications:  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypoglycemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br>1) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " ??????\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NASH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>2) Grade 2 Esophageal Varices<br>3) Possible \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Primary Sclerosing Cholangitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " ?????? (Rule Out diffuse<br>   \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cholangiocarcinoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ")<br>4) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CKD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>5) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>6) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thrombocytopenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>7) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Splenomegaly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>8) CAD- known mild reversible \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior defect\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (MIB [**1-3**]),<br>preserved ejection fraction<br>9) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypoalbuminemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br><br>Social History:<br>Lives at home with his wife. Retired [**Company 378**] manager. No \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ",<br>smoking, or drugs.<br><br>Family History:<br>Mother died from MI @ 75, no renal dz, no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DM\n",
       "\n",
       "\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "Physical Exam:<br>VS: 97.0 HR 67 BP 106/54 RR 16 O2sat 95% RA<br>GENERAL: AA male, appears mildly cachectic with protruding<br>abdomen<br>HEENT: PERRL, EOMI, left eye wandering. No scleral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    icterus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>Mucous membranes dry.<br>LUNGS: Clear to auscultation and percussion bilaterally. No<br>decreased BS.<br>CARDIAC: RRR w/o MRG<br>ABDOMEN: +BS, distended abdomen, +fluid wave, tympanic,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    umbilical hernia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Rectal: external \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemorrhoids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Guaiac negative.<br><br>EXTREMITIES: [**2-1**]+ pitting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the midthigh.<br>SKIN: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Skin excoriations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and hyperpigmented macules.<br>Neuro: no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    asterixis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br><br>Pertinent Results:<br>132 100 94 / 211 AGap=20<br>-------------<br>5.8 18 4.7 \\<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ca\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": 8.0 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mg\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": 2.8 P: 6.9<br>.<br>97<br>6.6 \\ 11.5 / 115<br>-------<br>35.3<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    N:73.1 Band:0\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " L:19.5 M:4.1 E:2.7 Bas:0.6<br>Anisocy: 2+ Poiklo: 1+ Macrocy: 3+ Spheroc: 1+ Target: 1+<br>Plt-Est: Low<br>PT: 15.0 PTT: 24.6 INR: 1.3<br>NDICATION: Low-grade \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>The lung volumes are low. Allowing for this factor, the heart<br>size is normal, but demonstrates left ventricular configuration.<br>The pulmonary vascularity is normal. There is some crowding of<br>vessels in the lower lung zones likely related to the low lung<br>volumes. A slightly more patchy area of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    opacity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is seen in the<br>infrahilar region on the lateral view likely due to crowding of<br>vascular structures. No \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pleural effusions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are identified.<br><br>Within the imaged portion of the upper abdomen, there is a<br>paucity of bowel gas suggesting underlying \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>IMPRESSION:<br>1. Low lung volumes. No definite \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pneumonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but repeat study may<br>be helpful to fully exclude \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    basilar pneumonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on this low lung<br>volume radiograph.<br>2. Probable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>.<br>INDICATIONS: 76-year-old man with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>COMPARISONS: Ultrasound from [**2137-2-28**].<br><br>TECHNIQUE: Renal ultrasound examination.<br><br>FINDINGS: The right kidney measures 10.5 cm in length, the left<br>10.9 cm. Both kidneys appear normal without stones, masses, or<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hydronephrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". There is a large amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", as seen on<br>the recent ultrasound as well. The liver is coarse and nodular<br>consistent with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>IMPRESSION: No evidence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hydronephrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Large amount of<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>.<br>Reason: Please place temporary IJ dialysis catheter on [**2137-3-11**]<br><br>[**Hospital 93**] MEDICAL CONDITION:<br>76 year old man with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NASH cirrhosis s/p GI bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " now requires<br>dialysis<br>REASON FOR THIS EXAMINATION:<br>Please place temporary IJ dialysis catheter on [**2137-3-11**]<br>CLINICAL INFORMATION: 76-year-old man with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cirrhosis of the\n",
       "liver, status post GI bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", needs temporal<br>dialysis catheter placement for hemodialysis.<br><br>PROCEDURE/FINDINGS: The procedure was performed by Dr. [**First Name (STitle) 379**] [**Name (STitle) **]<br>and Dr. [**Last Name (STitle) 380**]. Dr. [**Last Name (STitle) 380**], the attending radiologist, was<br>present and supervising throughout the procedure.<br><br>After the risks and benefits were explained to the patient,<br>written informed consent was obtained. The patient was placed<br>supine on the angiographic table. The right neck was prepped and<br>draped in the standard sterile fashion. Ultrasound confirmed the<br>right internal jugular vein was patent and compressible. A<br>preprocedure timeout was obtained to confirm the patient's name,<br>procedure, and the site. 5 cc of 1% \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lidocaine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was applied for<br>local anesthesia. Under ultrasonographic guidance, a 21-gauge<br>needle was used to access the right internal jugular vein. A<br>0.018 guide wire was placed through the needle under<br>fluoroscopic guidance with the tip in the superior vena cava.<br>The needle was exchanged for a 4-French micropuncture sheath.<br>The wire was exchanged for a 0.035 guide wire under fluoroscopic<br>guidance with the tip in the inferior vena cava. The<br>micropuncture sheath was removed. The venous access was dilated<br>by using 12- and 14-French dilators. A 20-cm hemodialysis<br>catheter was placed over the wire with the tip in the right<br>atrium. The wire was removed. Two lumens were flushed, and the<br>catheter was secured with skin with sutures.<br><br>The patient tolerated the procedure well, and there were no<br>immediate complications.<br><br>During the procedure, two ultrasound films were taken.<br><br>IMPRESSION: Successful placement of a 20-cm, temporal<br>hemodialysis catheter through right internal jugular vein with<br>the tip in the right atrium. The catheter is ready to use.<br>.<br>[**2137-3-8**] 5:26 pm PERITONEAL FLUID<br><br>                            **FINAL REPORT [**2137-3-14**]**<br><br>   GRAM STAIN (Final [**2137-3-8**]):<br>      \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " POLYMORPHONUCLEAR LEUKOCYTES SEEN.<br>      \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " MICROORGANISMS SEEN.<br><br>   FLUID CULTURE (Final [**2137-3-11**]):    \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " GROWTH.<br><br>   ANAEROBIC CULTURE (Final [**2137-3-14**]):    \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " GROWTH.<br><br><br>Brief Hospital Course:<br>76 yo male w/PMHx sx for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DM2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HTN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CKD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " [**1-31**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NASH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " vs.<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PSC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " who presented with acute on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", thought<br>[**1-31**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatorenal syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", complicated by an UGIB from esophageal<br>varices. Patient was transferred to the MICU on [**2137-3-8**], with<br>banding of esophageal varices and transfusion of 4u pRBC, now<br>stable and s/p placement of hemodialysis catheter and has<br>dialysis intiiated, also received large volume paracentesis with<br>removal of 1.1 L. His clinical status deteriorated due to<br>worsening \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cirrhosis and renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and he was made \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " prior<br>to transfer to hospice.<br>.<br>#. Acute on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Patient likely had \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatorenal syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", triggered by intravascular volume<br>depletion from large volume paracentesis done several days prior<br>to admission, with contribution from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    UGIB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " during his admission.<br>Renal ultrasound has been negative for obstruction, urine<br>electrolytes [**Location (un) 381**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " c/w HRS, and urine sediment bland.<br>Urine eosinophils negative, less concerning for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as cause.<br>Patient received 500cc NS challenge on day of admission, with no<br>improvement in his renal function.  Patient was initiated on<br>hemodialysis and received three sessions with minimal<br>improvement in renal function. He was placed on nephrocaps, and<br>given \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    octreotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    midodrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for treatment of HRS. He was<br>given albumin 12.5 mg twice daily. His diuretics were held.<br>.<br>#. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GI bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Patient had an episode of coffee grounds \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    emesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>in the ED, with hx Grade II esophageal varices. He again had an<br>episode of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    upper GI bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " while on the floor, and was<br>transferred to the MICU.<br>In the MICU, the patient received 2 units of blood and underwent<br>gastric banding for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    variceal bleeds\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  He was continued on<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    octreotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " gtt for 5 days and started on carafate. After the<br>banding, pt did not develop any further \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hematemasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", however, pt<br>received two more units for hct drop.  He was started on full<br>liquid diet. He was then transferred to the floor, where he was<br>stable for the next several days. He had an active T&amp;S, and was<br>on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    protonix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and carafate, scheduled for repeat endoscopy two<br>weeks later. On day prior to discharge, patient again started<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vomiting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " up guaiac positive material. KUB showed an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ileus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", with<br>likely \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vomiting of feculent\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " material mixed with blood. There was<br>no indication of active \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>#. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Scrotal edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Patient c/o \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tenderness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at Foley<br>insertion site, and his foley was discontinued. He was not<br>having any urine output and received intermittent straight<br>catheterizations with minimal urine output. These were<br>discontinued as well due to patient discomfort. Bladder scan was<br>not reliable for urine in bladder due to increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>Patient's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was controlled with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    morphine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", viscous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lidocaine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ",<br>and scrotal elevation with warm packs.<br>.<br>#. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " [**1-31**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NASH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " vs. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PSC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". MELD score calculated at 32.<br>Patient received diagnostic paracentesis for SBP which was<br>negative, with final cx showing no growth, and was placed on SBP<br>prophylaxis with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    levofloxacin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". He also received a large volume<br>paracentesis wtih removal of 1.1L . His \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nadolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was held. He had<br>a fluid restriction of 1500cc/day and his I/Os were monitored<br>closely. He was given \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lactulose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatic encephalopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". His<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    furosemide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were held due to concerns over<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". He was continued on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ursodiol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Liver consult<br>followed the patient throughout his hospital stay. He was given<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Vit K\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " SC for his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coagulopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>#. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Likely [**1-31**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". His \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " resolved with<br>kayexelate and dialysis.<br>.<br>#. Diabetes type 2. Patient was continued on home insulin<br>regimen until decision was made to make patient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>.<br>#. PPx. Incentive spirometer. Senna/colace. PPI.<br>.<br>#. Code status: Patient was made \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A palliative care consult<br>was obtained. He was given a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fentanyl\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " patch with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    morphine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " elixir<br>for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and given \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ativan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dolasetron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as well. He was<br>discharged to hospice.<br>.<br>#. Communication: Wife [**Name (NI) 382**]- [**Name (NI) 383**] [**Known lastname 384**] (h)-[**Telephone/Fax (1) 385**] and<br>(w)-[**Telephone/Fax (1) 386**]<br><br><br>Medications on Admission:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CIPRO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 250 mg--1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tablet(s\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") by mouth twice daily<br>FERGON 240MG--One twice a day [**First Name8 (NamePattern2) **] [**Last Name (un) 387**]. dr [**First Name4 (NamePattern1) 388**] [**Last Name (NamePattern1) **]<br>HUMALOG 100 U/ML--Sliding scale [**First Name8 (NamePattern2) **] [**Last Name (un) 387**]<br>INSULIN SYRINGE 30GX0.312&quot;--Use as directed<br>INSULIN SYRINGE 30GX0.375&quot;--Use as directed<br>LANCETS --As directed for glucometer monitoring<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LANTUS 100 U/ML--16\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " units at bedtime<br>LASIX 40MG--[**12-31**] by mouth twice a day<br>NADOLOL 20MG--One by mouth every day<br>ONE TOUCH GLUCOMETER STRIPS --As directed.<br>PROCRIT [**Numeric Identifier 389**] U/ML--Take one ml (20,000 units) every week<br>SPIRONOLACTONE 25MG--[**12-31**] by mouth every day<br>SYRINGE,DISPOSABLE --Use one ml syringe for the procrit<br>TEDS HOSE - KNEE HIGH 2 PAIR--Wear daily<br>[**Last Name (un) 390**] FORTE 500MG--one \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tablet(s\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") by mouth three times a day per<br>liver unit<br><br>Discharge Medications:<br>1. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lidocaine HCl\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 2 % Gel Sig: One (1) Appl Mucous membrane  PRN<br>(as needed) as needed for foley manipulation.<br>2. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fentanyl\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 50 mcg/hr Patch 72HR Sig: One (1) Patch 72HR<br>Transdermal Q72H (every 72 hours).<br>Disp:*10 Patch 72HR(s)* Refills:*2*<br>3. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lactulose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 10 g/15 mL Syrup Sig: Thirty (30) ML PO TID (3<br>times a day).<br>4. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Morphine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Concentrate 20 mg/mL Solution Sig: Ten (10) mg PO<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Q3H\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (every 3 hours).<br>Disp:*150 cc* Refills:*2*<br>5. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Morphine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Concentrate 20 mg/mL Solution Sig: 5-10 mg PO Q1-2H<br>() as needed.<br>6. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Morphine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Concentrate 20 mg/mL Solution Sig: Five (5) mg PO<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q3h\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as needed for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspnea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>Disp:*150 cc* Refills:*0*<br>7. Other<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ativan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 5 mg/ml<br>0.25 to 2 mg under the tongue q4-6h prn \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anxiety\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>Not to exceed 8 mg/25 hours<br>Disp: 30 ml<br>8. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Scopolamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Base 1.5 mg Patch 72HR Sig: One (1)  Transdermal<br>every seventy-two (72) hours as needed for increased secretions.<br>Disp:*1 box* Refills:*0*<br><br><br>Discharge Disposition:<br>Extended Care<br><br>Facility:<br>[**Doctor First Name 391**] Bay - [**Hospital1 392**]<br><br>Discharge Diagnosis:<br>1. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hepatorenal syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>2. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Acute renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " requiring dialysis<br>3. Upper GI bleeding from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    esophageal varices\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>4. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascites\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>5. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Scrotal edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>6. Ileus<br>7. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>8. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " type 2<br>9. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thrombocytopenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>10. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    External hemorrhoids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br><br>Discharge Condition:<br>Poor<br><br><br>Discharge Instructions:<br>You will be going to an inpatient hospice center where your \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>will be controlled. If you develop increased trouble breathing,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", please let your doctors [**Name5 (PTitle) 393**].<br><br>Followup Instructions:<br>Provider: [**Name Initial (NameIs) 394**]/[**Name8 (MD) 395**] M.D. Date/Time:[**2137-3-28**] 11:15<br>Provider: [**First Name11 (Name Pattern1) 396**] [**Last Name (NamePattern4) 397**], MD Phone:[**Telephone/Fax (1) 22**]<br>Date/Time:[**2137-4-9**] 11:00<br><br><br><br></div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "****************************************************************************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Admission Date:  [**2189-9-7**]              Discharge Date:   [**2189-9-9**]<br><br>Date of Birth:  [**2129-3-28**]             Sex:   F<br><br>Service: MEDICINE<br><br>Allergies:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lomotil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br><br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Attending:[**Last\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Name (NamePattern1) 495**]<br>Chief Complaint:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pyelonephritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br>Major Surgical or Invasive Procedure:<br>none<br><br><br>History of Present Illness:<br>Ms. [**Known lastname 496**] is a 60 yo F with hx of chronic hepatitis C who<br>presents to the ED with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysuria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " x 4 days, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chills\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vomiting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". She first noted \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hematuria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on Saturday, then developed<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysuria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", urinary frequency, urgency and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    incontinence\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". +\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anorexia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>x 3 days and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    N/V\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on the day prior to admission. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Denies back pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>but did have mild abdominal discomfort. She did not take her<br>temperature at home. She has no recent hospitalizations except<br>for an ED visit for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bell's palsy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which was felt to be related to<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lyme disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". She denies ever having a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    urinary tract infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>.<br>In the ED her initial vitals were: T 99.0, HR 102, BP 103/59, RR<br>16, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    O2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 98% on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", however shortly afterwards developed a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>to 104F and BP 80/30 (asymptomatic). She had a grossly positive<br>U/A, and CT Abd/Pelvis showed evidence of bilateral<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pyelonephritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". She received approx 5L IVFs in the ED with 1L of<br>urine output.<br>.<br>ROS: +\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    headache\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SOB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysphagia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". denies weight change.<br>+\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    constipation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br><br>Past Medical History:<br>- Hepatitis C infection (Liver biopsy in [**2185-2-17**] --&gt; grade<br>1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and stage 0 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fibrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; followed Dr. [**Last Name (STitle) 497**] -<br>contracted from needlestick injury<br>- \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Osteopenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>- \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Herpes zoster\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the right middle of the back and the side<br>when she was 14 years of age,<br>- \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Psoriasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>- \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lyme\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " disease/Bell's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palsy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>- Thyroid nodule<br><br><br>Social History:<br>She is a sociologist at [**Hospital1 498**].  She is single and lives alone.<br>She stopped \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " use in [**2164**].  Prior to that, she used to<br>drink mostly socially, occasionally heavily. Denies ever \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>or drug use.<br><br><br>Family History:<br>Mother is 85 and has \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arthritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " but is otherwise in good health.<br>Father is 83 and appears to have some &quot;mental decline&quot; the exact<br>diagnosis is not certain.  She has one sister who is 55 in good<br>health.  Three brothers, one with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " C. Paternal<br>grandfather with [**Name2 (NI) 499**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Paternal grandmother with lung<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Paternal aunts with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and paternal uncle<br>with [**Name2 (NI) 500**] \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br><br>Physical Exam:<br>Tmax: 37.8 ??????C (100 ??????F)<br>Tcurrent: 37.7 ??????C (99.8 ??????F)<br>HR: 89 (77 - 109) bpm<br>BP: 104/61(72) {76/34(50) - 106/74(80)} mmHg<br>RR: 11 (11 - 30) insp/min<br>SpO2: 98% RA<br>Heart rhythm: SR (Sinus Rhythm)<br>Height: 66 Inch<br><br>Gen: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NAD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", pleasant, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    conversive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>HEENT: PERRL, MMM, no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    OP lesions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", EOMI<br>Neck: Supple, no LAD, no bruit, no LVD<br>Heart: RRR, nl S1/2, nl S3/4, no murmurs<br>Lungs: CTA b/l, no w/r/r<br>Abd: Soft, NT/ND, +BS, no guarding or rebound \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tenderness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ",<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    normoactive bowel sounds\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", +\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CVA tenderness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", R &gt; L<br>Extrem: no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cyanosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    clubbing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", 2+ dp pulses b/l<br>Skin: no rashes<br>Neuro: A+Ox3, nl muscle strength, nl sensation<br><br>Pertinent Results:<br>[**2189-9-9**] 05:32AM BLOOD WBC-7.3 RBC-3.16* Hgb-10.9* Hct-29.8*<br>MCV-95 MCH-34.5* MCHC-36.5* RDW-13.6 Plt Ct-161<br>[**2189-9-9**] 05:32AM BLOOD Glucose-108* UreaN-11 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Creat-1.0 Na-140\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>K-3.9 Cl-113* HCO3-24 AnGap-7*<br>[**2189-9-8**] 04:59AM BLOOD ALT-28 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AST-23\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " TotBili-0.8<br>[**2189-9-7**] 02:30PM BLOOD TSH-0.43<br>[**2189-9-7**] 02:30PM BLOOD Cortsol-32.2*<br>[**2189-9-7**] 09:25PM BLOOD Lactate-0.9<br><br>U/A: Mod LE, Lg blood, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitr\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " negative, trace protein, &gt;50 WBC,<br>Bacteria - many, Epi [**1-21**].<br>.<br>Urine cx [**9-7**]- \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    E.Coli\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", sensitivities PENDING<br>Blood cx [**9-8**]- pending<br><br>IMAGING:<br>CT SCAN [**9-7**]<br>CT OF THE ABDOMEN WITH IV CONTRAST: Dependent atelectases are<br>present within<br>the lung bases bilaterally. There is no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pleural effusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>Visualized heart<br>and pericardium are unremarkable.<br><br>There is a striated appearance of bilateral kidneys, with<br>peripheral wedge- shaped hypodensities bilaterally. The largest<br>of these \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypodensities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is in the upper pole of the left kidney.<br>There is associated marked inflammatory stranding surrounding<br>both kidneys. Additionally, contrast is seen to excrete normally<br>from both kidneys. However, there is circumferential wall<br>thickening involving both ureters throughout its course. These<br>findings are overall suggestive of bilateral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pyelonephritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ",<br>with associated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ureteritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Although no discrete \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abscess\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is<br>identified, the hypodensity in the upper pole of the left<br>kidney, is likely at risk for developing an internal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abscess\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>The liver and gallbladder are within normal limits, with a focal<br>hypodensity adjacent to the gallbladder, may reflect an area of<br>focal fat. Spleen, pancreas, and adrenal glands are<br>unremarkable.<br><br>The stomach, small bowel, and large bowel are unremarkable. The<br>appendix is not definitively visualized, without secondary<br>findings to suggest acute \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    appendicitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>There is no free fluid or free air. Scattered retroperitoneal<br>nodes are seen, not meeting CT size criteria for pathologic<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    enlargement\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>Urinary bladder, rectum are unremarkable. There is no pelvic<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lymphadenopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or free fluid.<br>IMPRESSION:<br>Findings most compatible with bilateral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pyelonephritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ureteritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>Although no discrete \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abscess\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is identified, a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypodensity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " within<br>the left<br>upper pole is seen, which may be at risk for developing into an<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abscess\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Close interval followup is suggested.<br><br><br>Brief Hospital Course:<br>60 yo female with hx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic hepatitis C infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (without<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") presenting to the ED with 4 day hx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysuria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chills\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>and found to have a grossly positive U/A with evidence of<br>bilateral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pyelonephritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on CT Abd/pelvis who became \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>to 80/30.<br>.<br># Pyelonephritis/Sepsis: Pt w/ signs and sx of UTI for several<br>days; most likely with ascending GU \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The patient has<br>no recent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    UTIs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or hx of resistent organisms. The patient<br>presented to the ICU in stable condition.  CT scan of was<br>performed and consistent with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pyelonephritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " w/ no discrete<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abscess\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but showed a hypodensity that could represent possible<br>developing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abscess\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the left upper pole. She receieved \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cipro\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>in the ED prior to coming to the ICU and prior to blood<br>cultures.  The patient's blood pressures continued to range SBP<br>70-90's, but the patient had good mentation, urine output,<br>peripheral perfusion, and no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    compliants\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " indication adequate end<br>organ perfusion.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " remains \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (SBP 80-90) even after<br>receiving 7L of IVFs, but likely was dehydrated prior to<br>presentation and has high insensible losses due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Pt<br>also reports a &quot;low&quot; blood pressure at baseline. The patient was<br>also given one dose of stress dose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    steriods\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", but was<br>discontinued in the AM after her random \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cortisol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was 32.  The<br>patient was continued on IV \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ciprofloxacin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and and was<br>transitioned to po \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cipro\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 500mg Q12 x 14 day course.  The<br>patient's urine grew E. Coli and sensitivities were pending.<br>The patient's blood pressure ranged between SBP 90-110 on<br>discharge.  Pt was afebrile, ambulating, eating po, and feeling<br>back to her baseline.<br>.<br># \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Acute renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": The patient initial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was 1.1 and<br>stablized to 1.0 today.  Her baseline is around 0.7. This is<br>likely prerenal w/ combination of poor po intake, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vomiting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ",<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>.<br># Chronic hepatitis C \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": Stable, has not required<br>treatment.  LFT's were wnl.<br>.<br># \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lyme\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " disease/Bell's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palsy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " - resolving<br>.<br># \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FEN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": Tolerating regular diet, replete lytes prn<br>.<br># PPx: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heparin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sc, bowel regimen<br>.<br># Access: PIV<br>.<br># Code: full, confirmed w/ patient - ICU consent signed<br>.<br># Comm: [**Name (NI) 501**] [**Name (NI) 496**] (sister) [**Telephone/Fax (1) 502**]<br>.<br># Dispo: Pt will be discharged and will follow-up with her \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>[**Name Initial (PRE) 503**] ([**9-10**]) for vitals and CBC.<br><br>Medications on Admission:<br>- ASA 81mg daily<br>- [**Female First Name (un) 504**]-C<br>- \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Vitamin D\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>- MVI<br>- multiple herbal supplements<br><br>Discharge Medications:<br>1. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable<br>PO DAILY (Daily).<br>2. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Multivitamin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "     Tablet Sig: One (1) Tablet PO once a day.<br>3. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Vitamin D\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "  Oral<br>4. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ciprofloxacin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 500 mg Tablet Sig: One (1) Tablet PO \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Q12H\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>(every 12 hours) for 12 days.<br>Disp:*24 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tablet(s\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ")* Refills:*0*<br><br><br>Discharge Disposition:<br>Home<br><br>Discharge Diagnosis:<br>Primary:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pyelonephritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br>Secondary:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hepatitis C infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Osteopenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Herpes zoster\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Psoriasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lyme\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " disease/Bell's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palsy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>Thyroid nodule<br><br><br>Discharge Condition:<br>stable, normotensive, ambulating, tolerating normal diet, and<br>good \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    O2 sats\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on room air<br><br><br>Discharge Instructions:<br><br>It was a pleasure [**Last Name (un) 505**] care of you while you were in the<br>hospital.  You were admitted to [**Hospital1 18**] because of an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in<br>your kidney.  You had a CT scan performed of your kidney and it<br>was consistent with a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  You stayed in the ICU<br>because your blood pressure was low.  You were given fluids and<br>treated with antibiotics for your \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  You improved with<br>these treatments and were able to go home on oral antibiotics.<br><br>Please follow the medications prescibed below.<br><br>Please follow up with the appoints made below.<br><br>Please call your \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or go to the ED if you experience worsening<br>fevers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chills\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with urination, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea,\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " vomiting, chest<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", back \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or other worsening<br>symptoms.<br><br>***********<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ":<br>[**Name10 (NameIs) **] patient should have a CBC and BP check tomorrow.  The<br>patient was \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in ICU (not pressor dependent), but was<br>back to her baseline blood pressure at discharge and afebrile.<br>The patient's urine culture is growing E. Coli, but<br>sensitivities are not back.  Please call the ICU ([**Telephone/Fax (1) 506**])<br>to follow-up on sensitivies.  Additionally, the patient's CT<br>scan showed a hypodensity within the left upper pole, which may<br>be at risk for developing into an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abscess\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Close interval<br>followup is suggested. Imaging should be repeated if symptoms<br>worsen or recurrs after treatment.  The patient should be<br>continued for a 14 day course of antibiotics.<br><br><br>Followup Instructions:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PCP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": [**Name10 (NameIs) **],[**Name11 (NameIs) 507**] [**Name12 (NameIs) 508**] [**Telephone/Fax (1) 133**]<br>Appointment: [**9-10**] @ 11:15am<br><br><br><br>Completed by:[**2189-9-9**]</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "****************************************************************************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Admission Date:  [**2194-7-24**]     Discharge Date:  [**2194-8-3**]<br><br><br>Service:  [**Hospital1 139**] - Medicine and MICU<br><br>HISTORY OF PRESENT ILLNESS:  This 84-year-old female with a<br>history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diverticula\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CREST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    irritable bowel syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>presented to the Emergency Room with a chief complaint of<br>epigastric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lightheadedness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    emesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>dark stools.  She denied \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ",<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", fevers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chills\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and night sweats.  In the Emergency<br>Room she was found to have a blood pressure of 130/palp with<br>a heart rate of 72.  One hour later this was 119/39 with a<br>pulse of 100.  She had heme positive stool and hematocrit was<br>found to be 16.6.  The patient therefore had an emergent EGD<br>in the GI unit.  No nasogastric lavage was performed.<br><br>PAST MEDICAL HISTORY:  The patient has \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sjogren's with sicca\n",
       "syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and presumed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CREST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with a history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysphagia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspepsia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The patient's primary gastroenterologist is Dr.<br>[**Last Name (STitle) 1940**].  Patient has a history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ",<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    irritable bowel syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with chronic<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Raynaud\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "'s, history of TAH, cholecystectomy and<br>pericholecystectomy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hernia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " repair, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    COPD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bronchiectasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ",<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right bronchial sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sjogren\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "'s, history of bladder<br>stretchings, negative MRCP [**6-18**] except for some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver cysts\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ",<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diverticula\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on colonoscopy [**7-/2193**] with possibility of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Crohn's\n",
       "noted.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br><br>SOCIAL HISTORY:  The patient smoked some tobacco in the past<br>but it was a small amount.  She drinks no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>FAMILY HISTORY:  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Crohn's disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>ALLERGIES:  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Penicillin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bactrim\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Sulfa.<br><br>MEDICATIONS:  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Norvasc\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 10 mg q d, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 50 mg q d, Levoxyl<br>1.25 mg q d, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dyazide 37.5/25 q d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Serax\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " prn, occasional<br>NSAIDs, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Premarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " .625 mg q d and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>PHYSICAL EXAMINATION:  Temperature 97, blood pressure 95/69,<br>respiratory rate 14, satting 100% on two liters.  The patient<br>was alert and oriented times three, she was fully conversant<br>and awake, interactive and appropriate.  She was in no acute<br>distress.  Conjunctiva were pale.  She had dry mucus<br>membranes.  She was \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    normocephalic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", atraumatic, extraocular<br>movements intact, pupils were equal, round and reactive to<br>light.  There was no JVD.  Neck was supple.  TMs were normal.<br>There was no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lymphadenopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the neck, faint bibasilar<br>crackles were heard on lung exam.  The patient was<br>tachycardic with a normal S1 and S2 with 2/6 systolic<br>ejection murmur radiating to the axilla.  Abdomen was soft<br>and non distended with normal bowel sounds, was mildly tender<br>to deep palpation.  Extremities without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    clubbing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cyanosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Fingers were cool as were the toes but she had 1+<br>pulses times four.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cranial nerves II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " through XII were<br>intact.  Motor was 5/5 strength globally, symmetric.  Deep<br>tendon reflexes were 2+ globally and were symmetric.<br><br>LABORATORY DATA:  White count 12.8, hematocrit 16.6, platelet<br>count 282,000, MCV 89.  Chem 7, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium 140\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 4.8,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chloride\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 105, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CO2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 21, BUN 53 with a baseline of 10,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " .9, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 98, anion gap 14, ESR 60, ALT 52, AST<br>84, alkaline phosphatase 313, thyroid peroxidase antibody and<br>endomesial antibodies were positive.  Note was made of prior<br>alkaline phosphatase elevations as well as a GGT of 469 and a<br>lipase of 199.  TSH was 6.4.  [**Doctor First Name **] was positive at greater<br>than 1:1280.  Gastrin was normal in 9-00 at 92.  EKG showed<br>normal sinus rhythm at 100, left axis deviation, intervals<br>were 184/74/422.  There was a small T wave inversion in 1 and<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", question of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left anterior fascicular block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", small ST<br>deviation similar to prior on [**2193-7-21**].  CT done [**7-/2193**] for<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abdominal pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " showed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    emphysema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", no acute cardiopulmonary<br>disease, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoattenuation of liver and fibrotic lung\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " changes.<br><br>HOSPITAL COURSE:<br>1.  GI and Cardiovascular:  On [**7-24**] the patient presented with<br>malaise, epigastric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " for three days,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lightheadedness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", black stools and was found to have a<br>hematocrit of 15.6 from a baseline of 43 and BUN of 53.  The<br>patient was admitted to the MICU.  Two peripheral IVs were<br>placed, fluids and blood was applied, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Protonix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was begun IV.<br>Emergent EGD was performed that showed a stomach full of<br>blood, a probable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which was treated with electrocautery.<br>The patient ruled out for MI because she had inferolateral<br>EKG changes with ST \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which later resolved after a<br>blood transfusion.  She had relative \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " given her<br>history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  On the 7th she was evaluated by<br>surgery and told that operation for her \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " would be high<br>risk and high morbidity and would involve partial gastrectomy<br>so she declined the operation.  A groin line was placed.  On<br>the 8th a repeat EGD was similar to the first with large<br>amounts of blood and the patient was taken to interventional<br>radiology where she had her left gastric artery embolized.<br>No further IR options were available after this procedure.<br>In total the patient received 11 units of blood, ending on<br>the 8th and hematocrits through the 10th were approximately<br>40 and stable.  Vascular access was initiated during the stay<br>and on transfer to the floor [**7-28**], the patient had only one<br>PID.  Groin line was removed on the 8th because of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>stool contamination and on the 9th the triple lumen was<br>removed because the patient felt she had no definitive<br>options if she did have a massive bleed.  The patient was<br>made \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DNR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", DNI at her request and plans were to make her<br>comfort care if she had a large recurrent bleed, although she<br>later indicated that short-term central line would be<br>acceptable.  On transfer to the floor her issues were mild<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sinus tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " thought to be due to beta blocker<br>withdrawal since it persisted through blood and volume<br>repletion.  A repeat EGD was performed [**7-29**] since the<br>patient's lesion was never well visualized with all the blood<br>in her stomach.  This showed only \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with friability<br>and the same findings in the duodenum.  Beta blocker was<br>increased to treat her \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " but with<br>caution since she was at risk for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rebleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was<br>noted and C. diff and fecal leukocytes were checked and were<br>negative.  This was then attributed to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    melena\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and it trailed<br>off when she had stable hematocrit.  On the 12th the patient<br>was noted to have a decreased hematocrit which declined from<br>42 to 32.8 with an apparent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rebleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with increased melena<br>post EGD.  It remained stable thereafter through the 15th at<br>33.5.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Simethicone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was given for gassy distension and<br>ambulation was encouraged to decrease this as well.<br><br>2.  Fluids, Electrolytes &amp; Nutrition:  Lytes especially<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and phosphorus were repleted.<br><br>3.  Endocrine:  Synthroid was continued for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>and it increased to 150 since her TSH was high.  This needs<br>to be followed up with a repeat TSH.<br><br>4.  Pulmonary:  With her persistent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BVL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>replacement, concern for PE rose and a chest x-ray which<br>showed a right upper lobe process thought to be early<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pneumonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was performed.  CT angio was then done on the 12th<br>which showed no PE but a large right upper lobe consolidation<br>and left upper lobe and left lower lobe consolidations<br>adjacent to an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    effusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as well.  She was therefore treated<br>for multifocal PNA thought to be related to possible<br>aspiration at the time of her EGD with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Levofloxacin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Flagyl\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with resultant decrease in white blood count.  Nebs<br>were provided for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    wheezing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", most likely related to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    COPD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>5.  The patient was seen for question of aspiration and it<br>was felt her meds should be crushed and administered in apple<br>sauce and that soft moist \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    solids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and liquids would serve her<br>best but she was not a major aspiration risk.<br><br>6.  ID:  As per pulmonary, patient also had a positive<br>urinalysis and a culture showing 1,000 to 100,000 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proteus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>pseudomonas but since transferring to the floor, the patient<br>complained of no urinary discomfort so this was not treated.<br>Repeat urinalysis [**7-31**] showed no UTI.  The patient was<br>followed by physical therapy and assisted with ambulation.<br><br>7.  Patient's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CREST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sjogren\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "'s were treated with solutions<br>to mouth and eyes as per her routine. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blocker<br>for question \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    esophageal spasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was held given the risk of<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    re-bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>8.  Renal:  Patient's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " clearance was estimated at<br>slightly more than 50 cc per minute and was stable<br>throughout.<br><br>DISCHARGE MEDICATIONS:  Protonix 40 mg [**Hospital1 **], \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Simethicone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>80-125 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    qid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " prn, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Serax\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 10 mg po prn, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Trazodone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 25 mg po prn<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insomnia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Metoprolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 50 mg po tid, Synthroid 150 mcg q d,<br>Colace 100 mg po bid, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Milk of Magnesia prn.  Patient's own\n",
       "mouth rinses\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eyedrops\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sicca syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Levofloxacin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>500 mg po q d through [**2194-8-10**], \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Flagyl\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 500 mg po tid through<br>[**2194-8-10**].<br><br>DISCHARGE CONDITION:  Stable.<br><br>FOLLOW-UP:  To arrange with Dr. [**Last Name (STitle) 1940**] of gastroenterology<br>and the patient's primary care physician, [**Last Name (NamePattern4) **]. [**Last Name (STitle) 4427**].<br><br>DISCHARGE DIAGNOSIS:  As per HPI plus:<br>1.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GI bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " secondary to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arteriovenous\n",
       "malformation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ").<br><br><br><br><br>                          DR.[**Last Name (STitle) **],[**First Name3 (LF) 4514**] J. 12-424<br><br>Dictated By:[**Last Name (NamePattern1) **]<br><br>MEDQUIST36<br><br>D:  [**2194-8-4**]  08:20<br>T:  [**2194-8-7**]  20:35<br>JOB#:  [**Job Number 4515**]<br></div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "****************************************************************************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Admission Date:  [**2195-6-17**]       Discharge Date:  [**2195-7-7**]<br><br><br>Service:  [**Hospital1 **]<br>HISTORY OF PRESENT ILLNESS:  This is an 84 year-old female<br>with a history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CREST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diverticular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    irritable\n",
       "bowel syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and prior \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    upper GI bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in [**7-19**] secondary to<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Her previous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    UGIB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " required<br>hospitalization, which was notable for a hematocrit of 16 on<br>during stay, 2 units of fresh frozen platelets,<br>esophagogastroduodenoscopy showing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and normal<br>duodenum, cauterization of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric AVM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and angiography<br>followed by embolization of left gastric artery.<br><br>She presented to the Emergency Room at this time with a chief<br>complaint of two days of dark stools, left lower abdominal<br>breath, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lightheadedness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fevers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chills\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and night \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sweats\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>No bright red blood per rectum, no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hematemesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  In the<br>Emergency Room she was found to be in no acute distress and<br>with a temperature of 99.5, blood pressure 143/53, pulse 86,<br>respirations 16, 98% on room air.  Nasogastric suction<br>revealed 200 cc of coffee grounds and lavage with 250 cc H20<br>showed coffee grounds and a bright red tinge, but lavage was<br>stopped, because of patient discomfort.  Central line in<br>femoral vein was placed and she was given one liter of normal<br>saline.<br><br>PAST MEDICAL HISTORY:  1.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sjogren's with Sicca syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CREST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with a history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysphagia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspepsia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (followed by<br>gastroenterologist Dr. [**First Name4 (NamePattern1) **] [**Last Name (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NamePattern1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") 1940**]).  2.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>3.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  4.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Irritable bowel syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with<br>chronic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    constipation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abdominal pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  5.<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diverticula\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " seen on colonoscopy [**7-/2193**].  6.  Chronic<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstructive pulmonary disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bronchiectasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", right<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bronchial sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  7.  History of bladder stretching.<br><br>PAST SURGICAL HISTORY:  1.  Cholecystectomy.  2.<br>Pericholecystectomy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hernia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " repair.  3.  Hysterectomy.<br><br>SOCIAL HISTORY:  Three pack years of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", quit twenty<br>years ago.  Drinks no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>FAMILY HISTORY:  Son has \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Crohn's disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " times forty two<br>years.<br><br>ALLERGIES:  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Penicillin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sulfa\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>MEDICATIONS ON ADMISSION:  1.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 50 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  2.<br>Aldactone 25 mg t.i.d.  3.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lasix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 20 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  4.  Synthroid<br>175 micrograms \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  5.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Prevacid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 30 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  6.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Evoxac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 30<br>mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    t.i.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  7.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Serax\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 50 mg b.i.d.  8.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Multivitamin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " once a<br>day.<br><br>PHYSICAL EXAMINATION:  General, thin elderly woman in no<br>acute distress.  Vital signs temperature 99.5.  Blood<br>pressure 120/60.  Pulse 86.  Respiratory rate 18.  Skin<br>normal capillary refill, plus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    telangiectasias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on the back.<br>HEENT \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ptosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  No scleral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    icterus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Pupils are equal,<br>round and reactive to light.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Extraocular movements\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " intact.<br>Mucous membranes are dry.  No lower dentition.  Neck supple.<br>No \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lymphadenopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Jugular veins flat.  Chest clear to<br>auscultation bilaterally.  Cardiovascular regular rate and<br>rhythm.  S1 and S2.  3 out of 6 systolic murmur loudest at<br>right upper sternal border.  No gallops or rubs.  Abdomen<br>flat.  Scar along right abdomen.  Positive bowel sounds,<br>nondistended.  No \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tenderness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to palpation.  No<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatosplenomegaly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Extremities no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    clubbing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cyanosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Fingers and toes cool to touch.  2+ radial and<br>dorsalis pedis pulses.  Rectal guaiac positive in the<br>Emergency Department.  Neurological alert and oriented times<br>three.  Pleasant affect.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cranial nerves II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " through XII are<br>intact.  No asterixics.<br><br>LABORATORIES AND STUDIES:  White blood cell count 11.1,<br>hemoglobin 10.3, hematocrit 27.9, platelets 235, MCV 85, MCH<br>29.3, MCHC 34.4, neutrophils 87.9%, lymphocytes 8%, bands 0,<br>monocytes 2.6%, eosinophils 1.1%, basophils 0.1%, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 128,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 4.6, chloride 94, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bicarbonate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 27, BUN 47,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 1.1, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 122, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 8.5, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    magnesium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 1.8,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 2.8.  PT 13.4, PTT 30.1, INR 1.3.  Urinalysis<br>negative.  Electrocardiogram heart rate 84 beats per minute,<br>normal sinus rhythm, left axis deviation.  No acute ischemic<br>changes.<br><br>HOSPITAL COURSE:  1. Gastrointestinal:  The patient presented<br>with an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    upper gastrointestinal bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with a hematocrit of<br>29.9, melena left lower quadrant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and coffee grounds with<br>red tinge on nasogastric lavage.  To look for a source of<br>bleed, several procedures were done.  An<br>esophagogastroduodenoscopy was done on [**6-18**], which showed<br>diffuse \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a normal duodenum consistent with what<br>was seen during admission a year before.  On [**6-25**], enteroscopy<br>showed improved \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a normal duodenum and jejunum.<br>Colonoscopy on [**6-29**] showed retained \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    melena\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and multiple<br>nonbleeding diverticula, but no source of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  A tagged<br>red cell scan on [**6-23**] did not identify a source of<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " either.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    H-pylori\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " antibody test was<br>negative.  She was on supportive therapy with Protonix 40 mg<br>b.i.d. and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Carafate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", but she had continuous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal\n",
       "bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as manifested by guaiac positive stools, both melena<br>and bloody stool and unstable hematocrit throughout most of<br>her stay.<br><br>On the evening of [**7-1**] (hospital day fifteen), the patient<br>had a dramatic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with a hematocrit drop from 27.7<br>to 17.4.  The patient became more tachycardic then baseline<br>to 130s, but maintained her blood pressure.  Nasogastric<br>lavage at this point revealed bright red blood with clots<br>that did not clear with 420 cc of H20.  She was transferred<br>to the MICU where she received 6 units of packed red blood<br>cells and 2 units of fresh frozen platelets.  She was taken<br>to the IR the next morning where the left gastroduodenal<br>artery was embolized empirically.  By hospital day seventeen,<br>the patient decided that she wanted no more blood product<br>transfusions and wanted \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>On the evening of hospital day seventeen, the patient was<br>transferred back to the Medicine Floor with stable hematocrit<br>of 36.7.  However, one day after the transfer, her hematocrit<br>dropped to 24.1 with bloody \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The patient<br>reexpressed her wishes for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and did not want any more<br>laboratory tests or any blood product transfusions.<br><br>By hospital day twenty the patient appeared stable with<br>stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and blood pressure.  It appeared that<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " either slowed or stopped, so after<br>discussion between the patient and the family and a<br>hematocrit check was done, which at the value of 26.4 showed<br>that she had stopped \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Two more units of red blood<br>cells were transfused to increase her hematocrit to at least<br>greater then 30.<br><br>2.  Hematology:  At presentation the patient's hematocrit was<br>29.9 and was unstable throughout most of the admission.  She<br>received a total of 20 units of packed red blood cells.  Some<br>hematologic workup was done to look for other causes of<br>continued \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which was negative for GIC, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolysis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>[**First Name5 (NamePattern1) **] [**Last Name (Prefixes) 4516**] disease.  Two of five studies (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arachidonic acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    platelet aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " were abnormal<br>so she was given \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Desmopressin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " intravenous times two doses<br>([**6-24**] and [**6-27**]) and one bag of platelets, which did not help<br>stabilize her hematocrit.  A total of 5 units of fresh frozen<br>platelets were also given, because of multiple red blood<br>cells could have diluted the concentration of her clotting<br>factors and less likely, because of the possibility that she<br>had a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coagulopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " given one PTT value.  Hematology/oncology<br>consult did not feel that the patient had platelet<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aggregation abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coagulopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>3.  Cardiovascular:  The patient's antihypertensive<br>medications (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Aldactone, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lasix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") were held during her<br>hospital stay so that if she were to stop \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " briskly,<br>her sympathetic system may respond appropriately to maintain<br>blood pressure.  Her vital signs remained stable with a blood<br>pressure in the 140s/80s and heart rate in 80s until hospital<br>day five when she started having sinus tachycardic 100 to<br>130s.  At this time she also developed a urinary tract<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", so the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was thought to be secondary to<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dehydration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  She was given normal saline<br>intravenous to lower the heart rate to the 110s.  During the<br>remainder of th hospital course her heart rate remained<br>elevated in the 100s.  When it rose again to 120 to 130s or<br>the patient was symptomatic with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", administration<br>of normal saline intravenous helped control the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>After the precipitous hematocrit drop on hospital day<br>fifteen, the patient's cardiac enzymes were checked and they<br>revealed a mild enzyme leak with CK 118 and 128, MB 8 and 9<br>and troponin 0.9.  However, full enzyme cycling was not done,<br>because the patient decided on full CMO measures.  The<br>patient was also found to have 3 out of 6 systolic murmur<br>loudest at right upper sternal border, radiating to<br>subclavian arteries.  Consider outpatient workup with primary<br>care physician.<br><br>4.  Pulmonary:  During the MICU stay, where she was given 6<br>units of packed red blood cells and 2 units of fresh frozen<br>platelets she developed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspnea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and bilateral pleural<br>effusion.  She was given 2 doses of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lasix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 20 mg intravenous<br>after which her \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspnea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " improved.<br><br>5.  Infectious disease:  On hospital day five the patient<br>spiked a temperature to 101.5.  Urinalysis showed 245 white<br>blood cells and blood culture was negative.  She was treated<br>with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Levofloxacin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 500 mg once a day for eight days.  During<br>the MICU stay her white blood cells spiked to 19.9, but she<br>was afebrile and there was no clear source of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (no<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pneumonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on chest x-ray, negative urine culture).  The white<br>blood cells went down to 12.3 after transfer to the medicine<br>floor.<br><br>6.  Lines:  Access on this patient was difficult to obtain<br>and maintain.  Access ranged as follows, femoral central<br>line, peripheral line and left IJ central line by IR.<br><br>7.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FEN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ":  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    magnesium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were<br>repleted as needed.<br><br>8.  Endocrine:  Synthroid was continued for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>9.  CREST/Sjogren's:  The patient uses \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Evoxac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " at home for<br>[**Last Name (un) **], but this was held during hospitalization.  As it is a<br>cholinergic agonist it could have led to increased gastric<br>motility and dampen \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CVA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>DISCHARGE CONDITION:  Stable.  The patient will be discharged<br>to rehab with clear instructions on how she would like to be<br>cared for if she were to present with recurrent<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>DISCHARGE MEDICATIONS:  1.  Protonix 40 mg b.i.d.  2.<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 20 mg once a day hold for systolic blood pressure<br>less then 110, heart rate less then 60.  3.  Synthroid 175<br>micrograms \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  4.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ativan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 0.5 mg po b.i.d.  5.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Darvocet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>one tab prn q 6 hours.  6.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MSIR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (oral solution) 10 to 30 mg<br>po prn q 4 hours.  7.  Colace 100 mg po b.i.d. hold for<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  8.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Imodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 2 mg po prn q 6 hours.  9.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Zolpidem\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 5<br>mg po prn h.s.  10.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Evoxac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 30 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    t.i.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  11.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Multivitamin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>FOLLOW UP:  To arrange with Dr. [**First Name4 (NamePattern1) **] [**Last Name (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NamePattern1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") 1940**] of<br>gastroenterology and the patient's primary care physician [**Last Name (NamePattern4) **].<br>[**Last Name (STitle) 4427**].<br><br>DISCHARGE DIAGNOSIS:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Upper gastrointestinal bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " secondary to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br><br><br><br><br><br>                            [**First Name11 (Name Pattern1) 2515**] [**Last Name (NamePattern4) 4517**], M.D.  [**MD Number(1) 4518**]<br><br>Dictated By:[**Doctor Last Name 4519**]<br>MEDQUIST36<br><br>D:  [**2195-7-6**]  15:16<br>T:  [**2195-7-7**]  08:18<br>JOB#:  [**Job Number 4520**]<br></div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "****************************************************************************************************\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Admission Date:  [**2195-6-17**]       Discharge Date:  [**2195-7-7**]<br><br><br>Service:  [**Hospital1 **]<br><br>HISTORY OF PRESENT ILLNESS:  This is an 84 year-old female<br>with a history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CREST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diverticular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    irritable\n",
       "bowel syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and prior \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    upper GI bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in [**7-19**] secondary to<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Her previous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    UGIB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " required<br>hospitalization, which was notable for a hematocrit of 16 on<br>admission, 11 units of packed red blood cells transfusion<br>during stay, 2 units of fresh frozen platelets,<br>esophagogastroduodenoscopy showing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and normal<br>duodenum, cauterization of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric AVM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and angiography<br>followed by embolization of left gastric artery.<br><br>She presented to the Emergency Room at this time with a chief<br>complaint of two days of dark stools, left lower abdominal<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and weakness.  She denied \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of\n",
       "breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lightheadedness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fevers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chills\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and night \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sweats\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>No bright red blood per rectum, no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hematemesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  In the<br>Emergency Room she was found to be in no acute distress and<br>with a temperature of 99.5, blood pressure 143/53, pulse 86,<br>respirations 16, 98% on room air.  Nasogastric suction<br>revealed 200 cc of coffee grounds and lavage with 250 cc H20<br>showed coffee grounds and a bright red tinge, but lavage was<br>stopped, because of patient discomfort.  Central line in<br>femoral vein was placed and she was given one liter of normal<br>saline.<br><br>PAST MEDICAL HISTORY:  1.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sjogren's with Sicca syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CREST\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with a history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysphagia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspepsia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (followed by<br>gastroenterologist Dr. [**First Name4 (NamePattern1) **] [**Last Name (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NamePattern1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") 1940**]).  2.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>3.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  4.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Irritable bowel syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with<br>chronic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    constipation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abdominal pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  5.<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diverticula\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " seen on colonoscopy [**7-/2193**].  6.  Chronic<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstructive pulmonary disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bronchiectasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", right<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bronchial sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  7.  History of bladder stretching.<br><br>PAST SURGICAL HISTORY:  1.  Cholecystectomy.  2.<br>Pericholecystectomy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hernia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " repair.  3.  Hysterectomy.<br><br>SOCIAL HISTORY:  Three pack years of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", quit twenty<br>years ago.  Drinks no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>FAMILY HISTORY:  Son has \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Crohn's disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " times forty two<br>years.<br><br>ALLERGIES:  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Penicillin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sulfa\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>MEDICATIONS ON ADMISSION:  1.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 50 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  2.<br>Aldactone 25 mg t.i.d.  3.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lasix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 20 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  4.  Synthroid<br>175 micrograms \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  5.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Prevacid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 30 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  6.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Evoxac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 30<br>mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    t.i.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  7.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Serax\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 50 mg b.i.d.  8.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Multivitamin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " once a<br>day.<br><br>PHYSICAL EXAMINATION:  General, thin elderly woman in no<br>acute distress.  Vital signs temperature 99.5.  Blood<br>pressure 120/60.  Pulse 86.  Respiratory rate 18.  Skin<br>normal capillary refill, plus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    telangiectasias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on the back.<br>HEENT \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ptosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  No scleral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    icterus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Pupils are equal,<br>round and reactive to light.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Extraocular movements\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " intact.<br>Mucous membranes are dry.  No lower dentition.  Neck supple.<br>No \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lymphadenopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Jugular veins flat.  Chest clear to<br>auscultation bilaterally.  Cardiovascular regular rate and<br>rhythm.  S1 and S2.  3 out of 6 systolic murmur loudest at<br>right upper sternal border.  No gallops or rubs.  Abdomen<br>flat.  Scar along right abdomen.  Positive bowel sounds,<br>nondistended.  No \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tenderness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to palpation.  No<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatosplenomegaly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Extremities no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    clubbing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cyanosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Fingers and toes cool to touch.  2+ radial and<br>dorsalis pedis pulses.  Rectal guaiac positive in the<br>Emergency Department.  Neurological alert and oriented times<br>three.  Pleasant affect.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cranial nerves II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " through XII are<br>intact.  No asterixics.<br><br>LABORATORIES AND STUDIES:  White blood cell count 11.1,<br>hemoglobin 10.3, hematocrit 27.9, platelets 235, MCV 85, MCH<br>29.3, MCHC 34.4, neutrophils 87.9%, lymphocytes 8%, bands 0,<br>monocytes 2.6%, eosinophils 1.1%, basophils 0.1%, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 128,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 4.6, chloride 94, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bicarbonate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 27, BUN 47,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 1.1, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 122, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 8.5, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    magnesium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 1.8,<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 2.8.  PT 13.4, PTT 30.1, INR 1.3.  Urinalysis<br>negative.  Electrocardiogram heart rate 84 beats per minute,<br>normal sinus rhythm, left axis deviation.  No acute ischemic<br>changes.<br><br>HOSPITAL COURSE:  1. Gastrointestinal:  The patient presented<br>with an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    upper gastrointestinal bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with a hematocrit of<br>29.9, melena left lower quadrant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and coffee grounds with<br>red tinge on nasogastric lavage.  To look for a source of<br>bleed, several procedures were done.  An<br>esophagogastroduodenoscopy was done on [**6-18**], which showed<br>diffuse \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a normal duodenum consistent with what<br>was seen during admission a year before.  On [**6-25**], enteroscopy<br>showed improved \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a normal duodenum and jejunum.<br>Colonoscopy on [**6-29**] showed retained \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    melena\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and multiple<br>nonbleeding diverticula, but no source of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  A tagged<br>red cell scan on [**6-23**] did not identify a source of<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " either.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    H-pylori\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " antibody test was<br>negative.  She was on supportive therapy with Protonix 40 mg<br>b.i.d. and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Carafate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", but she had continuous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal\n",
       "bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as manifested by guaiac positive stools, both melena<br>and bloody stool and unstable hematocrit throughout most of<br>her stay.<br><br>On the evening of [**7-1**] (hospital day fifteen), the patient<br>had a dramatic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastric bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with a hematocrit drop from 27.7<br>to 17.4.  The patient became more tachycardic then baseline<br>to 130s, but maintained her blood pressure.  Nasogastric<br>lavage at this point revealed bright red blood with clots<br>that did not clear with 420 cc of H20.  She was transferred<br>to the MICU where she received 6 units of packed red blood<br>cells and 2 units of fresh frozen platelets.  She was taken<br>to the IR the next morning where the left gastroduodenal<br>artery was embolized empirically.  By hospital day seventeen,<br>the patient decided that she wanted no more blood product<br>transfusions and wanted \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>On the evening of hospital day seventeen, the patient was<br>transferred back to the Medicine Floor with stable hematocrit<br>of 36.7.  However, one day after the transfer, her hematocrit<br>dropped to 24.1 with bloody \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The patient<br>reexpressed her wishes for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CMO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and did not want any more<br>laboratory tests or any blood product transfusions.<br><br>By hospital day twenty the patient appeared stable with<br>stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and blood pressure.  It appeared that<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " either slowed or stopped, so after<br>discussion between the patient and the family and a<br>hematocrit check was done, which at the value of 26.4 showed<br>that she had stopped \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Two more units of red blood<br>cells were transfused to increase her hematocrit to at least<br>greater then 30.<br><br>2.  Hematology:  At presentation the patient's hematocrit was<br>29.9 and was unstable throughout most of the admission.  She<br>received a total of 20 units of packed red blood cells.  Some<br>hematologic workup was done to look for other causes of<br>continued \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which was negative for GIC, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolysis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and<br>[**First Name5 (NamePattern1) **] [**Last Name (Prefixes) 4516**] disease.  Two of five studies (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arachidonic acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    platelet aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " were abnormal<br>so she was given \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Desmopressin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " intravenous times two doses<br>([**6-24**] and [**6-27**]) and one bag of platelets, which did not help<br>stabilize her hematocrit.  A total of 5 units of fresh frozen<br>platelets were also given, because of multiple red blood<br>cells could have diluted the concentration of her clotting<br>factors and less likely, because of the possibility that she<br>had a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coagulopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " given one PTT value.  Hematology/oncology<br>consult did not feel that the patient had platelet<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aggregation abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coagulopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>3.  Cardiovascular:  The patient's antihypertensive<br>medications (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Aldactone, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lasix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") were held during her<br>hospital stay so that if she were to stop \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " briskly,<br>her sympathetic system may respond appropriately to maintain<br>blood pressure.  Her vital signs remained stable with a blood<br>pressure in the 140s/80s and heart rate in 80s until hospital<br>day five when she started having sinus tachycardic 100 to<br>130s.  At this time she also developed a urinary tract<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", so the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was thought to be secondary to<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dehydration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  She was given normal saline<br>intravenous to lower the heart rate to the 110s.  During the<br>remainder of th hospital course her heart rate remained<br>elevated in the 100s.  When it rose again to 120 to 130s or<br>the patient was symptomatic with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", administration<br>of normal saline intravenous helped control the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br>After the precipitous hematocrit drop on hospital day<br>fifteen, the patient's cardiac enzymes were checked and they<br>revealed a mild enzyme leak with CK 118 and 128, MB 8 and 9<br>and troponin 0.9.  However, full enzyme cycling was not done,<br>because the patient decided on full CMO measures.  The<br>patient was also found to have 3 out of 6 systolic murmur<br>loudest at right upper sternal border, radiating to<br>subclavian arteries.  Consider outpatient workup with primary<br>care physician.<br><br>4.  Pulmonary:  During the MICU stay, where she was given 6<br>units of packed red blood cells and 2 units of fresh frozen<br>platelets she developed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspnea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and bilateral pleural<br>effusion.  She was given 2 doses of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lasix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 20 mg intravenous<br>after which her \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyspnea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " improved.<br><br>5.  Infectious disease:  On hospital day five the patient<br>spiked a temperature to 101.5.  Urinalysis showed 245 white<br>blood cells and blood culture was negative.  She was treated<br>with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Levofloxacin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 500 mg once a day for eight days.  During<br>the MICU stay her white blood cells spiked to 19.9, but she<br>was afebrile and there was no clear source of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (no<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pneumonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on chest x-ray, negative urine culture).  The white<br>blood cells went down to 12.3 after transfer to the medicine<br>floor.<br><br>6.  Lines:  Access on this patient was difficult to obtain<br>and maintain.  Access ranged as follows, femoral central<br>line, peripheral line and left IJ central line by IR.<br><br>7.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FEN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ":  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    magnesium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were<br>repleted as needed.<br><br>8.  Endocrine:  Synthroid was continued for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>9.  CREST/Sjogren's:  The patient uses \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Evoxac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " at home for<br>[**Last Name (un) **], but this was held during hospitalization.  As it is a<br>cholinergic agonist it could have led to increased gastric<br>motility and dampen \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CVA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>DISCHARGE CONDITION:  Stable.  The patient will be discharged<br>to rehab with clear instructions on how she would like to be<br>cared for if she were to present with recurrent<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br>DISCHARGE MEDICATIONS:  1.  Protonix 40 mg b.i.d.  2.<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 20 mg once a day hold for systolic blood pressure<br>less then 110, heart rate less then 60.  3.  Synthroid 175<br>micrograms \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  4.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ativan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 0.5 mg po b.i.d.  5.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Darvocet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>one tab prn q 6 hours.  6.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MSIR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (oral solution) 10 to 30 mg<br>po prn q 4 hours.  7.  Colace 100 mg po b.i.d. hold for<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  8.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Imodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 2 mg po prn q 6 hours.  9.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Zolpidem\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 5<br>mg po prn h.s.  10.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Evoxac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 30 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    t.i.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  11.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Multivitamin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    q.d\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".<br><br>FOLLOW UP:  To arrange with Dr. [**First Name4 (NamePattern1) **] [**Last Name (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    NamePattern1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") 1940**] of<br>gastroenterology and the patient's primary care physician [**Last Name (NamePattern4) **].<br>[**Last Name (STitle) 4427**].<br><br>DISCHARGE DIAGNOSIS:<br>\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Upper gastrointestinal bleed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " secondary to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".<br><br><br><br><br><br><br>                            [**First Name11 (Name Pattern1) 2515**] [**Last Name (NamePattern4) 4517**], M.D.  [**MD Number(1) 4521**]<br><br>Dictated By:[**Doctor Last Name 4519**]<br>MEDQUIST36<br><br>D:  [**2195-7-6**]  15:16<br>T:  [**2195-7-7**]  08:18<br>JOB#:  [**Job Number 4520**]<br></div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "****************************************************************************************************\n"
     ]
    }
   ],
   "source": [
    "import en_ner_bc5cdr_md\n",
    "import pandas as pd\n",
    "\n",
    "df = pd.read_csv(\"liver_notes.csv\")[:5] # only use the 5 for performance\n",
    "nlp = en_ner_bc5cdr_md.load()\n",
    "# Process and extract entities\n",
    "for idx, row in df.iterrows():\n",
    "    text = row['TEXT']\n",
    "    entities, doc = extract_entities(text)  # Now correctly returning two values\n",
    "    \n",
    "    if entities:  # Only display if there are entities\n",
    "        displacy.render(doc, style=\"ent\", jupyter=True)\n",
    "        print('*' * 100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# **Word2Vec**"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Word2Vec Spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import spacy\n",
    "import scispacy\n",
    "import en_core_sci_lg\n",
    "from spacy import displacy\n",
    "from gensim.models import Word2Vec\n",
    "\n",
    "# Load dataset\n",
    "df = pd.read_csv(\"liver_notes.csv\")[:100] # set to 100\n",
    "\n",
    "# Load spacy NLP model\n",
    "nlp = spacy.load(\"en_core_web_sm\")  # Using standard SpaCy model\n",
    "\n",
    "# Function to extract named entities using SciSpaCy\n",
    "def extract_entities(text):\n",
    "    doc = nlp(text)\n",
    "    return [(ent.text, ent.label_) for ent in doc.ents], doc\n",
    "\n",
    "sentences = []\n",
    "for idx, row in df.iterrows():\n",
    "    text = row['TEXT']\n",
    "    entities, doc = extract_entities(text)  # Now correctly returning two values\n",
    "    sentences.append([token.text for token in doc if not token.is_stop and not token.is_punct])\n",
    "\n",
    "# Train Word2Vec model on extracted text\n",
    "w2v_model_spacy = Word2Vec(sentences, vector_size=100, window=5, min_count=1, workers=4)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[('HS', 0.996829628944397), ('Solution', 0.9954865574836731), ('HCl', 0.9953999519348145), ('Divalproex', 0.9949305653572083), ('QHS', 0.9942290782928467), ('Plavix', 0.9941669702529907), ('b.i.d', 0.9940879940986633), ('QAM', 0.9938725829124451), ('Nadolol', 0.9936785697937012), ('Capsule', 0.9936450719833374)]\n"
     ]
    }
   ],
   "source": [
    "# Print word vector and similar words in a formatted output\n",
    "word = 'Furosemide'\n",
    "if word in w2v_model_spacy.wv:\n",
    "    print(w2v_model_spacy.wv.similar_by_word(word))\n",
    "else:\n",
    "    print(f\"Word '{word}' not found in vocabulary.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##  Word2Vec Scispacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/jesusminjares/Desktop/UT Austin MSAI/Courses/ AI395T AI in Healthcare/ai_healthcare/lib/python3.12/site-packages/spacy/util.py:910: UserWarning: [W095] Model 'en_core_sci_lg' (0.5.4) was trained with spaCy v3.7.4 and may not be 100% compatible with the current version (3.8.4). If you see errors or degraded performance, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n",
      "  warnings.warn(warn_msg)\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import spacy\n",
    "import scispacy\n",
    "import en_core_sci_lg\n",
    "from spacy import displacy\n",
    "from gensim.models import Word2Vec\n",
    "\n",
    "# Load dataset\n",
    "df = pd.read_csv(\"liver_notes.csv\")[:100] # set to 100\n",
    "\n",
    "# Load SciSpaCy NLP model\n",
    "nlp = en_core_sci_lg.load()  # Using larger SciSpaCy model for better medical term recognition\n",
    "\n",
    "# Function to extract named entities using SciSpaCy\n",
    "def extract_entities(text):\n",
    "    doc = nlp(text)\n",
    "    return [(ent.text, ent.label_) for ent in doc.ents], doc\n",
    "\n",
    "sentences = []\n",
    "for idx, row in df.iterrows():\n",
    "    text = row['TEXT']\n",
    "    entities, doc = extract_entities(text)  # Now correctly returning two values\n",
    "    sentences.append([token.text for token in doc if not token.is_stop and not token.is_punct])\n",
    "\n",
    "# Train Word2Vec model on extracted text\n",
    "w2v_model_scispacy = Word2Vec(sentences, vector_size=100, window=5, min_count=1, workers=4)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[('500', 0.9979904294013977), ('Lasix', 0.9978922009468079), ('po', 0.9975515007972717), ('bedtime', 0.9974295496940613), ('q.', 0.9973838329315186), ('q', 0.9973596930503845), ('mg', 0.9972935914993286), ('p.o', 0.9971017837524414), ('QID', 0.997079074382782), ('Aldactone', 0.996779203414917)]\n"
     ]
    }
   ],
   "source": [
    "# Print word vector and similar words in a formatted output\n",
    "word = 'Furosemide'\n",
    "if word in w2v_model_scispacy.wv:\n",
    "    print(w2v_model_scispacy.wv.similar_by_word(word))\n",
    "else:\n",
    "    print(f\"Word '{word}' not found in vocabulary.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **tSNE Plots**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "from sklearn.manifold import TSNE\n",
    "import matplotlib.pyplot as plt\n",
    "def tsne_plot(model,words, preTrained=False):\n",
    "    \"Creates and TSNE model and plots it\"\n",
    "    labels = []\n",
    "    tokens = []\n",
    "\n",
    "    for word in words:\n",
    "      if preTrained:\n",
    "          tokens.append(model[word])\n",
    "      else:\n",
    "          tokens.append(model.wv[word])\n",
    "      labels.append(word)\n",
    "\n",
    "    tokens = np.array(tokens)\n",
    "    tsne_model = TSNE(perplexity=30, early_exaggeration=12, n_components=2, init='pca', n_iter=1000, random_state=23)\n",
    "    new_values = tsne_model.fit_transform(tokens)\n",
    "\n",
    "    x = []\n",
    "    y = []\n",
    "    for value in new_values:\n",
    "        x.append(value[0])\n",
    "        y.append(value[1])\n",
    "\n",
    "    plt.figure(figsize=(16, 16))\n",
    "    for i in range(len(x)):\n",
    "        plt.scatter(x[i],y[i])\n",
    "        plt.annotate(labels[i],\n",
    "                     xy=(x[i], y[i]),\n",
    "                     xytext=(5, 2),\n",
    "                     textcoords='offset points',\n",
    "                     ha='right',\n",
    "                     va='bottom')\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Spacy tSNE plot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/jesusminjares/Desktop/UT Austin MSAI/Courses/ AI395T AI in Healthcare/ai_healthcare/lib/python3.12/site-packages/sklearn/manifold/_t_sne.py:1164: FutureWarning: 'n_iter' was renamed to 'max_iter' in version 1.5 and will be removed in 1.7.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x1600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "vocabs = list(w2v_model_spacy.wv.index_to_key)[:250]  # Limit to 250 words for clarity\n",
    "new_v = np.array(vocabs)\n",
    "tsne_plot(w2v_model_spacy,new_v)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Scispacy tSNE plot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/jesusminjares/Desktop/UT Austin MSAI/Courses/ AI395T AI in Healthcare/ai_healthcare/lib/python3.12/site-packages/sklearn/manifold/_t_sne.py:1164: FutureWarning: 'n_iter' was renamed to 'max_iter' in version 1.5 and will be removed in 1.7.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x1600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "vocabs = list(w2v_model_scispacy.wv.index_to_key)[:250]  # Limit to 250 words for clarity\n",
    "new_v = np.array(vocabs)\n",
    "tsne_plot(w2v_model_scispacy,new_v)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ai_healthcare",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
